status: 200
encoding: ISO-8859-1
Server: nginx/1.13.4
Date: Tue, 11 Feb 2020 22:38:46 GMT
Content-Type: text/html
Transfer-Encoding: chunked
Connection: keep-alive
X-Powered-By: PHP/5.4.16
Expires: Thu, 19 Nov 1981 08:52:00 GMT
Cache-Control: no-store, no-cache, must-revalidate, post-check=0, pre-check=0
Pragma: no-cache
Strict-Transport-Security: max-age=15768000; includeSubDomains

<!DOCTYPE html>
<html lang="en">

       <head>        
        <title>HF 400 6th  Engrossment - 91st Legislature (2019 - 2020)</title>
        <meta charset="utf-8" />  <!-- for html5 -->
        <meta content="width=device-width, initial-scale=1, shrink-to-fit=no" name="viewport">
        <meta content="ie=edge" http-equiv="x-ua-compatible">

        <link rel="stylesheet" href="https://stackpath.bootstrapcdn.com/bootstrap/4.3.1/css/bootstrap.min.css" integrity="sha384-ggOyR0iXCbMQv3Xipma34MD+dH/1fQ784/j6cY/iJTQUOhcWr7x9JvoRxT2MZw1T" crossorigin="anonymous">
        <link href="/static/js/jquery-ui-1.12.1.custom/jquery-ui.min.css" rel="stylesheet">
        <link href="/static/css/app.css" rel="stylesheet"><!-- jQuery first, then Bootstrap JS. -->
        <link href="/static/css/revisor_bootstrap.css" rel="stylesheet">
        <link href="/static/css/navbar-form.css" rel="stylesheet">
        
        <style>
          .img-joint {
            background-image: url('/static/images/banners/cap_quadrangle.jpg');
          }
        </style>
        <link rel="stylesheet" type="text/css" media="screen, print" href="/static/css/doc.css"/><link rel="stylesheet" type="text/css" media="screen, print" href="/css/bills_new.css?v=04-26-2019_17-09-09"/>
        
        <script src="https://code.jquery.com/jquery-3.2.1.min.js"></script>
        <script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jqueryui/1.10.3/jquery-ui.min.js"></script>
        <script src="/static/js/getParameterByName.js"></script>
        <script src="/static/js/calendar.js"></script>
        <script src="/static/js/navbarhelper.js"></script>
        <script src="/static/js/bootstrapWindowHelper.js"></script>
        <script defer src="https://use.fontawesome.com/releases/v5.2.0/js/all.js"></script>
        <script type="text/javascript" src="/static/js/base_js.js"></script>
        <script src="/static/js/revisor.js"></script>
        <script src="/static/js/spin.js.js"></script>
        

      </head>  

<body class="joint">
                <script>
                (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
                (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
                m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
                })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

                ga('create', 'UA-20900283-1', 'mn.gov');
                ga('require', 'linkid', 'linkid.js');
                ga('send', 'pageview');

                </script>


<!--skip nav for accessibility-->
<a href="#legContainerMain" class="skip-navigation">Skip to main content</a>
<a href="#legSubNav" class="skip-navigation">Skip to office menu</a>
<a href="#legFooter" class="skip-navigation">Skip to footer</a>

<div class="container-fluid"> <!-- closing tag in footer -->

    <div class="leg-brand-container bg-darkgray py-1 pl-0 d-print-none">
        <div class="container pl-0 pl-md-3">
            <a class="leg-brand-text text-white" href="https://www.leg.state.mn.us/" >
                <img src="https://www.gis.leg.mn/assets/img/icons/capitol2.svg" alt="Capital Icon" style="margin-top:-8px; opacity: 0.95;height:24px" class="mr-1">Minnesota Legislature
            </a>

            <form class="form-inline float-right ml-auto d-none d-md-block p-0">
                <a href="https://www.leg.state.mn.us/search.aspx"  class="text-white js-search-adv mr-1 text-nowrap  btn btn-darkgray btn-sm"  style="display: none;">Advanced Search</a>
                <label class="sr-only" for="main-search">Search Legislature</label>
                <input class="form-control form-control-sm align-top mr-2 js-search" id="main-search" name="search"  style="display: none;" placeholder="Search..." type="text">
                <button class="js-search-btn btn btn-darkgray btn-sm"><i class="fas fa-search"></i><span class="p-1"> Search</span></button>
            </form>

            <!-- <form class="form-inline float-sm-right ml-auto p-0 leg-search-form">
            <div class="input-group py-0 mr-2 js-search">
              <input type="text" class="form-control form-control-sm py-0" placeholder="Search" aria-label="Search" aria-describedby="basic-addon2">
              <div class="input-group-append">
                <button class="btn btn-outline-secondary btn-sm js-search-btn" type="button"><i class="fas fa-search"></i></button>
              </div>
            </div>
            </form>  -->



        </div>
    </div>

    <!-- We can change *-dark to *-house, *-senate, *-joint and add that color to variables -->
    <nav class="navbar navbar-dark bg-dark navbar-expand-lg px-0 py-1 d-block d-print-none">
        <div class="container">
            <div class="w-100 px-auto">
                <div class="col-12 position-static pl-sm-0 pl-md-3 pl-lg-0">
                    <button aria-controls="navbarNav" aria-expanded="false" aria-label="Toggle navigation" class="navbar-toggler" data-target="#top-nav" data-toggle="collapse" type="button"><span class="navbar-toggler-icon"></span></button>
                    <span class="d-lg-none pl-1 text-white leg-menu-text" data-toggle="collapse" data-target="#top-nav"> Menu</span>

                    <div class="collapse navbar-collapse py-0" id="top-nav">
                        <ul class="navbar-nav mt-2 mt-lg-0 px-2 pl-lg-0">
                            <!--  <li class="nav-item mr-3">
                               <a  class="nav-link" data-parent="#top-nav"  href="https://www.leg.state.mn.us/">Legislature</a>
                             </li> -->

                            <li class="nav-item">
                                <a aria-controls="houseExternalContent" aria-expanded="false" class="nav-link dropdown-toggle pl-0" data-parent="#top-nav" data-toggle="collapse" href="#houseExternalContent">House</a>
                            </li>
                            <div class="dropdown collapse navbar-nav-collapse" id="houseExternalContent">
                                <div class="bg-dark">
                                    <div class="container px-3">
                                        <div class="row">
                                            <div class="col nav-header"><a href="https://www.house.leg.state.mn.us/">Minnesota House of Representatives</a></div>
                                        </div>
                                        <hr class="my-1 bg-secondary">
                                        <div class="row">
                                            <div class="col-12 col-sm-6 col-md-3">
                                                <!-- <h2 class="text-white">Minnesota House of Representatives</h2> -->
                                                <dl>
                                                    <dt class="text-white">House Members and Staff</dt>
                                                    <dd><a href="https://www.house.leg.state.mn.us/members/hmem.asp">House Members</a></dd>
                                                    <dd><a href="https://www.house.leg.state.mn.us/members/houseleaders.asp">Leadership</a></dd>
                                                    <dd><a href="https://www.house.leg.state.mn.us/hinfo/staff.asp">Staff</a></dd>
                                                    <dd><a href="https://www.house.leg.state.mn.us/has/employment.asp">Employment</a></dd>

                                                    <dd><a href="https://www.gis.leg.mn/iMaps/districts/">Who Represents Me?</a></dd>
                                                </dl>
                                            </div>
                                            <div class="col-12 col-sm-6 col-md-3">
                                                <dl>
                                                    <dt class="text-white">Committees</dt>
                                                    <dd><a href="https://www.house.leg.state.mn.us/comm/commemlist.asp">Committee List</a></dd>
                                                    <dd><a href="https://www.house.leg.state.mn.us/hinfo/leginfo/comroster.pdf">Committee Roster</a></dd>
                                                    <dd><a href="https://www.house.leg.state.mn.us/hinfo/scheduleall.asp">Upcoming Meetings</a></dd>
                                                    <dd><a href="https://www.house.leg.state.mn.us/hinfo/comgrid.pdf">Standing Committee Schedule</a></dd>
                                                    <dd><a href="https://www.house.leg.state.mn.us/comm/commminutes.asp">Minutes</a></dd>
                                                    <dd><a href="https://www.leg.state.mn.us/leg/deadlines.aspx">Committee Deadlines</a></dd>
                                                </dl>
                                            </div>
                                            <div class="col-12 col-sm-6 col-md-3 ">
                                                <dl>
                                                    <dt class="text-white">Offices</dt>
                                                    <dd><a href="https://www.house.leg.state.mn.us/cco/cco.asp">Chief Clerk</a></dd>
                                                    <dd><a href="https://www.house.leg.state.mn.us/fiscal/fahome.asp">Fiscal Analysis</a></dd>
                                                    <dd><a href="https://www.house.leg.state.mn.us/hrd/hrd.aspx">House Research</a></dd>
                                                    <dd><a href="https://www.house.leg.state.mn.us/hinfo/hinfo.asp">Public Information</a></dd>
                                                    <dd><a href="https://www.house.leg.state.mn.us/sergeant/sergeant.asp">Sergeant-at-Arms</a></dd>
                                                    <dd><a href="https://www.house.leg.state.mn.us/caucuses.asp">Caucuses - DFL/GOP</a></dd>
                                                </dl>
                                            </div>
                                            <div class="col-12 col-sm-6 col-md-3">
                                                <dl>
                                                    <dt class="text-white">Other Information</dt>
                                                    <dd><a href="https://www.house.leg.state.mn.us/cco/journals/journl.htm">House Journal</a></dd>
                                                    <dd><a href="https://www.house.leg.state.mn.us/cco/rules/permrule/permrule.asp">House Rules</a></dd>
                                                    <dd><a href="https://www.house.leg.state.mn.us/cco/rules/jtrule/jtrule.asp">Joint Rules</a></dd>
                                                    <dd><a href="https://www.house.leg.state.mn.us/sergeant/education.asp">Educational Programs</a></dd>
                                                    <dd><a href="https://www.house.leg.state.mn.us/members/pronunciation.asp">Pronunciation Guide</a></dd>
                                                    <dd><a href="https://www.house.leg.state.mn.us/members/meminfo.xls">Address Spreadsheet</a></dd>
                                                </dl>
                                            </div>
                                        </div>
                                    </div>
                                </div>
                            </div>

                            <li class="nav-item">
                                <a aria-controls="senateExternalContent" aria-expanded="false" class="nav-link dropdown-toggle" data-parent="#top-nav" data-toggle="collapse" href="#senateExternalContent">Senate</a>
                            </li>
                            <div class="dropdown collapse navbar-nav-collapse" id="senateExternalContent">
                                <div class="bg-dark">
                                    <div class="container px-3">
                                        <div class="row">
                                            <div class="col nav-header"><a href="https://www.senate.mn/">Minnesota Senate</a></div>
                                        </div>
                                        <hr class="my-1 bg-secondary">
                                        <div class="row">
                                            <div class="col-12 col-sm-6 col-md-3">
                                                <!-- <h2 class="text-white">Minnesota House of Representatives</h2> -->
                                                <dl>
                                                    <dt class="text-white">Senators and Staff</dt>
                                                    <dd><a href="https://www.senate.mn/members/index.php">Senators</a></dd>
                                                    <dd><a href="https://www.senate.mn/members/index.php?tab=leader">Leadership</a></dd>
                                                    <dd><a href="https://www.senate.mn/employees/index.php">Staff</a></dd>
                                                    <dd><a href="https://www.senate.mn/jobs/index.php">Employment</a></dd>
                                                    <dd><a href="https://www.gis.leg.mn/iMaps/districts/">Who Represents Me?</a></dd>
                                                    <!-- <dd class="text-muted">Employment</dd> -->
                                                </dl>
                                            </div>
                                            <div class="col-12 col-sm-6 col-md-3">
                                                <dl>
                                                    <dt class="text-white">Committees</dt>
                                                    <dd><a href="https://www.senate.mn/committees">Committee List</a></dd>
                                                    <!--<li><a href="/committees/2017-2018/info/comlegal.pdf">Committee Roster</a></li>-->
                                                    <dd><a href="https://www.senate.mn/committees/display_pdf_cmte_roster.php">Committee Roster</a></dd>
                                                    <dd><a href="https://www.senate.mn/schedule/index.php?type=upcoming">Upcoming Meetings</a></dd>
                                                    <dd><a href="https://www.senate.mn/committees/cmte_meeting_schedule.php">Standing Committee Schedule</a></dd>
                                                    <dd><a href="https://www.leg.state.mn.us/leg/deadlines.aspx">Committee Deadlines</a></dd>
                                                </dl>
                                            </div>
                                            <div class="col-12 col-sm-6 col-md-3">
                                                <dl>
                                                    <dt class="text-white">Offices</dt>
                                                    <dd><a href="https://www.senate.mn/departments/secretary/index.php">Secretary of the Senate</a></dd>
                                                    <dd><a href="https://www.senate.mn/departments/scrfa/">Senate Counsel, Research &amp; Fiscal Analysis</a></dd>
                                                    <dd><a href="https://www.senate.mn/caucus/index.php">Caucuses - DFL/GOP</a></dd>
                                                </dl>
                                            </div>
                                            <div class="col-12 col-sm-6 col-md-3">
                                                <dl>
                                                    <dt class="text-white">Other Information</dt>
                                                    <dd><a href="https://www.senate.mn/journals/journal_list.php">Senate Journal</a></dd>
                                                    <dd><a href="https://www.senate.mn/rules/rules_senate.php">Senate Rules</a></dd>
                                                    <dd><a href="https://www.senate.mn/rules/rules_joint">Joint Rules</a></dd>
                                                    <dd><a href="https://www.senate.mn/departments/secretary/info/interns/index.php">Educational Programs</a></dd>
                                                    <dd><a href="https://www.senate.mn/members/member_labels_page.php">Address Labels</a></dd>
                                                    <dd><a href="https://www.senate.mn/subscription/index.php">Subscriptions</a></dd>

                                                </dl>
                                            </div>
                                        </div>
                                    </div>
                                </div>
                            </div>

                            <li class="nav-item">
                                <a aria-controls="jointExternalContent" aria-expanded="false" class="nav-link dropdown-toggle" data-parent="#top-nav" data-toggle="collapse" href="#jointExternalContent">Joint</a>
                            </li>
                            <div class="dropdown collapse navbar-nav-collapse" id="jointExternalContent">
                                <div class="bg-dark">
                                    <div class="container px-3">
                                        <div class="row">
                                            <div class="col nav-header"><a href="https://www.commissions.leg.state.mn.us/">Joint Departments, Offices, and Commissions</a></div>
                                        </div>
                                        <hr class="my-1 bg-secondary">
                                        <div class="row">
                                            <!-- <div class="col"></div> -->
                                            <div class="col-12 col-sm-4">
                                                <!-- <h2 class="text-white">Minnesota House of Representatives</h2> -->
                                                <dl>
                                                    <dt class="text-white">Joint Legislative Offices</dt>
                                                    <dd><a href="/">Revisor of Statutes</a></dd>
                                                    <dd><a href="https://www.leg.state.mn.us/lrl/lrl.aspx">Legislative Reference Library</a></dd>
                                                    <dd><a href="https://www.auditor.leg.state.mn.us/">Office of the Legislative Auditor</a></dd>
                                                    <dd><a href="https://www.lbo.leg.mn/">Legislative Budget Office</a></dd>
                                                </dl>
                                            </div>
                                            <div class="col-12 col-sm-4">
                                                <dl  class="mb-0">
                                                    <dt class="text-white">Commissions</dt>
                                                    <dd><a href="https://www.lcc.leg.mn/">Legislative Coordinating Commission (LCC)</a></dd>
                                                    <dd><a href="https://www.lccmr.leg.mn/">Legislative-Citizen Commission on MN Resources (LCCMR)</a></dd>

                                                </dl>
                                            </div>
                                            <div class="col-12 col-sm-4">
                                                <dl>

                                                    <dd class="mt-md-4"><a href="https://www.lcpr.leg.mn/">Legislative Commission on Pensions &amp; Retirement (LCPR)</a></dd>
                                                    <dd><a href="https://www.lsohc.leg.mn/">Lessard-Sams Outdoor Heritage Council</a></dd>
                                                    <dd><a href="https://www.legacy.mn.gov/">Legacy Amendment</a></dd>
                                                    <dd><a href="https://www.commissions.leg.state.mn.us/">More...</a></dd>
                                                </dl>
                                            </div>
                                        </div>
                                    </div>
                                </div>
                            </div>

                            <li class="nav-item">
                                <a aria-controls="schedulesExternalContent" aria-expanded="false" class="nav-link dropdown-toggle" data-parent="#top-nav" data-toggle="collapse" href="#schedulesExternalContent">Schedules</a>
                            </li>
                            <div class="dropdown collapse navbar-nav-collapse" id="schedulesExternalContent">
                                <div class="bg-dark">
                                    <div class="container px-3">
                                        <div class="row">
                                            <div class="col nav-header"><a href="https://www.leg.state.mn.us/leg/schedules">Schedules, Calendars, and Legislative Business</a></div>
                                        </div>
                                        <hr class="my-1 bg-secondary">
                                        <div class="row">

                                            <div class="col-12 col-sm-4">
                                                <!-- <h2 class="text-white">Minnesota House of Representatives</h2> -->
                                                <dl>
                                                    <dt class="text-white">House</dt>
                                                    <dd><a href="https://www.house.leg.state.mn.us/hinfo/hinfosched.asp">House Schedules</a></dd>
                                                    <dd><a href="https://www.house.leg.state.mn.us/cco/orders/orders.htm">Order of Business</a></dd>
                                                    <dd><a href="https://www.house.leg.state.mn.us/cco/calendar.asp">Calendar for the Day</a></dd>
                                                    <dd><a href="https://www.house.leg.state.mn.us/cco/calendarsup.asp">Supplemental Calendar for the Day</a></dd>
                                                    <dd><a href="https://www.house.leg.state.mn.us/cco/fiscal.asp">Fiscal Calendar</a></dd>
                                                </dl>
                                            </div>
                                            <div class="col-12 col-sm-4">
                                                <dl>
                                                    <dt class="text-white">Senate</dt>
                                                    <dd><a href="https://www.senate.leg.state.mn.us/schedule/index.php?type=upcoming">Senate Schedules</a></dd>
                                                    <dd><a href="https://www.senate.mn/orders/index.php">Order of Business</a></dd>
                                                    <dd><a href="https://www.senate.mn/orders/calendar.html">Senate Calendar</a></dd>
                                                    <dd><a href="https://www.senate.mn/orders/go.html">General Orders of the Day</a></dd>
                                                </dl>
                                            </div>
                                            <div class="col-12 col-sm-4">
                                                <dl>
                                                    <dt class="text-white">Joint</dt>
                                                    <dd><a href="https://www.leg.state.mn.us/calendarday.aspx">Combined Upcoming Meetings</a></dd>
                                                    <dd><a href="https://www.house.leg.state.mn.us/htv/htv.asp">Broadcast TV Schedule</a></dd>
                                                    <dd><a href="https://www.leg.state.mn.us/leg/deadlines.aspx">Committee Deadlines</a></dd>
                                                </dl>
                                            </div>
                                        </div>
                                    </div>
                                </div>
                            </div>

                            <li class="nav-item">
                                <a aria-controls="committeesExternalContent" aria-expanded="false" class="nav-link dropdown-toggle" data-parent="#top-nav" data-toggle="collapse" href="#committeesExternalContent">Committees</a>
                            </li>
                            <div class="dropdown collapse navbar-nav-collapse" id="committeesExternalContent">
                                <div class="bg-dark">
                                    <div class="container px-3">
                                        <div class="row">
                                            <div class="col nav-header"><a href="https://www.leg.state.mn.us/leg/committees">Legislative Committees</a></div>
                                        </div>
                                        <hr class="my-1 bg-secondary">
                                        <div class="row">
                                            <div class="col-12 col-sm-4">
                                                <!-- <h2 class="text-white">Minnesota House of Representatives</h2> -->
                                                <dl>
                                                    <dt class="text-white">House</dt>
                                                    <dd>
                                                        <a href="https://www.house.leg.state.mn.us/comm/commemlist.asp">Committee List</a>
                                                    </dd>
                                                    <dd>
                                                        <a href="https://www.house.leg.state.mn.us/hinfo/leginfo/comroster.pdf">Committee Roster</a>
                                                    </dd>
                                                    <dd>
                                                        <a href="https://www.house.leg.state.mn.us/hinfo/scheduleall.asp">Upcoming Meetings</a>
                                                    </dd>
                                                    <dd>
                                                        <a href="https://www.house.leg.state.mn.us/hinfo/11comgrid.pdf">Standing Committee Schedule</a>
                                                    </dd>
                                                    <dd>
                                                        <a href="https://www.house.leg.state.mn.us/comm/commminutes.asp">Minutes</a>
                                                    </dd>
                                                </dl>
                                            </div>
                                            <div class="col-12 col-sm-4">
                                                <dl>
                                                    <dt class="text-white">Senate</dt>
                                                    <dd>
                                                        <a href="https://www.senate.mn/committees/">Committee List</a>
                                                    </dd>
                                                    <dd>
                                                        <a href="https://www.senate.leg.state.mn.us/committees/display_pdf_cmte_roster.php">Committee Roster</a>
                                                    </dd>
                                                    <dd>
                                                        <a href="https://www.senate.mn/schedule/schedule.php?type=upcoming">Upcoming Meetings</a>
                                                    </dd>
                                                    <dd>
                                                        <a href="https://www.senate.mn/committees/cmte_meeting_schedule.php">Standing Committee Schedule</a>
                                                    </dd>
                                                </dl>
                                            </div>
                                            <div class="col-12 col-sm-4">
                                                <dl>
                                                    <dt class="text-white">Joint</dt>
                                                    <dd>
                                                        <a href="https://www.commissions.leg.state.mn.us/">Joint Committees &amp; Task Forces</a>
                                                    </dd>
                                                    <dd>
                                                        <a href="https://www.leg.state.mn.us/leg/deadlines.aspx">Committee Deadlines</a>
                                                    </dd>
                                                    <dd>
                                                        <a href="https://www.leg.state.mn.us/leg/cc/">Bills In Conference Committee</a>
                                                    </dd>
                                                    <dd>
                                                        <a href="/bin/sbs.php">Side by Side Comparisons</a>
                                                    </dd>
                                                </dl>
                                            </div>
                                        </div>
                                    </div>
                                </div>
                            </div>

                            <li class="nav-item">
                                <a aria-controls="billsExternalContent" aria-expanded="false" class="nav-link dropdown-toggle" data-parent="#top-nav" data-toggle="collapse" href="#billsExternalContent">Bills</a>
                            </li>
                            <div class="dropdown collapse navbar-nav-collapse" id="billsExternalContent">
                                <div class="bg-dark">
                                    <div class="container px-3">
                                        <div class="row">
                                            <div class="col nav-header"><a href="https://www.leg.state.mn.us/leg/legis">Bills</a></div>
                                        </div>
                                        <hr class="my-1 bg-secondary">
                                        <div class="row">
                                            <div class="col-12 col-sm-4">
                                                <!-- <h2 class="text-white">Minnesota House of Representatives</h2> -->
                                                <dl>
                                                    <dt class="text-white">House</dt>
                                                    <dd><a href="/bills/status_search.php?body=House">Bill Search &amp; Status (House)</a></dd>
                                                    <dd><a href="https://www.house.leg.state.mn.us/cco/introductions.asp">Bill Introductions</a></dd>
                                                    <dd class="text-white">Summaries: <a href="https://www.house.leg.state.mn.us/hrd/billsum.aspx">Bill</a> | <a href="https://www.house.leg.state.mn.us/hrd/actsum.aspx">Act</a></dd>
                                                    <dd><a href="https://www.house.leg.state.mn.us/fiscal/tracking.asp">Fiscal Tracking Sheets</a></dd>
                                                    <dd><a href="https://www.house.leg.state.mn.us/bills/hotlistarchives.asp">Hot List</a></dd>
                                                </dl>
                                            </div>
                                            <div class="col-12 col-sm-4">
                                                <dl>
                                                    <dt class="text-white">Senate</dt>
                                                    <dd><a href="/bills/status_search.php?body=Senate">Bill Search &amp; Status (Senate)</a></dd>
                                                    <dd><a href="https://www.senate.mn/orders/intros/intro_list_from_db.php">Bill Introductions</a></dd>
                                                    <dd class="text-white">Summaries: <a href="/departments/scr/billsumm/index.php?summary_type=bill">Bill</a> |
                                                        <a href="https://www.senate.mn/departments/scr/billsumm/index.php?sumtype=act">Act</a></dd>
                                                    <dd><a href="https://www.senate.mn/departments/fiscalpol/tracking/index.php">Fiscal Tracking Sheets</a></dd>
                                                    <dd><a href="https://www.senate.mn/departments/secretary/info/publications/popularbills.php">Hot List</a>
                                                    </dd>
                                                </dl>
                                            </div>
                                            <div class="col-12 col-sm-4">
                                                <dl>
                                                    <dt class="text-white">Joint</dt>
                                                    <dd><a href="https://www.leg.state.mn.us/leg/legis.aspx">Bill Search &amp; Status</a></dd>
                                                    <dd><a href="https://www.house.leg.state.mn.us/leg/billsublogin.asp">MyBills</a></dd>
                                                    <dd><a href="/bin/sbs.php">Side by Side Comparisons</a></dd>
                                                    <dd><a href="https://www.leg.state.mn.us/leg/cc/">Bills In Conference Committee</a></dd>
                                                    <dd><a href="https://www.leg.state.mn.us/lrl/vetoes/vetodetails.aspx">Vetoes</a></dd>
                                                    <dd><a href="/laws/current/">Current Session Laws</a></dd>
                                                </dl>
                                            </div>
                                        </div>
                                    </div>
                                </div>
                            </div>

                            <li class="nav-item">
                                <a aria-controls="lawExternalContent" aria-expanded="false" class="nav-link dropdown-toggle" data-parent="#top-nav" data-toggle="collapse" href="#lawExternalContent">Law</a>
                            </li>
                            <div class="dropdown collapse navbar-nav-collapse" id="lawExternalContent">
                                <div class="bg-dark">
                                    <div class="container px-3">
                                        <div class="row">
                                            <div class="col nav-header"><a href="/pubs/">Statutes, Laws, and Rules</a></div>
                                        </div>
                                        <hr class="my-1 bg-secondary">
                                        <div class="row">
                                            <div class="col-12 col-sm-6 col-md-3">
                                                <!-- <h2 class="text-white">Minnesota House of Representatives</h2> -->
                                                <dl>
                                                    <dt class="text-white">Statutes</dt>

                                                    <dd><a href="/search/?search=all&amp;stat=1&amp;laws=1&amp;rule=1&amp;court=1">Keyword Search</a>
                                                    </dd>
                                                    <dd><a href="/statutes/">Current Statutes</a>
                                                    </dd>
                                                    <dd><a href="/statutes/?view=index">Statutes by Topic (Index)</a>
                                                    </dd>
                                                    <dd><a href="/statutes/?view=archive">Statutes Archive</a>
                                                    </dd>
                                                </dl>
                                            </div>
                                            <div class="col-12 col-sm-6 col-md-3">
                                                <dl>
                                                    <dt class="text-white">Session Laws</dt>
                                                    <dd><a href="/search/?search=all&amp;stat=0&amp;laws=1&amp;rule=0&amp;court=0">Keyword Search</a></dd>
                                                    <dd><a href="/laws/current/">Current Session Laws</a></dd>
                                                    <dd><a href="/topics/?type=laws">Session Laws by Topic (Index)</a></dd>
                                                    <dd><a href="/laws/">Session Laws Archive</a></dd>
                                                    <dd><a href="/laws/law_action.php">Session Laws Changed (Table 1)</a></dd>
                                                    <dd><a href="/statutes/statute_action.php?full=0">Statutes Changed (Table 2)</a></dd>
                                                </dl>
                                            </div>
                                            <div class="col-12 col-sm-6 col-md-3">
                                                <dl>
                                                    <dt class="text-white">Administrative Rules</dt>
                                                    <dd><a href="/search/?search=all&amp;stat=0&amp;laws=0&amp;rule=1&amp;court=0">Keyword Search</a></dd>
                                                    <dd><a href="/rules/">Current Rules</a></dd>
                                                    <dd><a href="/topics/?type=rule">Rules by Topic (Index)</a></dd>
                                                    <dd><a href="/rules/?view=archive">Rules Archive</a></dd>
                                                    <dd><a href="/rules/rule_search.php">Minnesota Rule Status</a></dd>
                                                    <dd><a href="/state_register/">State Register</a></dd>
                                                </dl>
                                            </div>
                                            <div class="col-12 col-sm-6 col-md-3">
                                                <dl>
                                                    <dt class="text-white">Other Legal Materials</dt>
                                                    <dd><a href="/constitution/">Minnesota Constitution</a></dd>
                                                    <dd><a href="https://www.leg.state.mn.us/lrl/mngov/constitutionalamendments.aspx">State Constitutional Amendments</a></dd>
                                                    <dd><a href="/court_rules/">Court Rules</a></dd>
                                                </dl>
                                            </div>
                                        </div>
                                    </div>
                                </div>
                            </div>

                            <li class="nav-item">
                                <a aria-controls="multimediaExternalContent" aria-expanded="false" class="nav-link dropdown-toggle" data-parent="#top-nav" data-toggle="collapse" href="#multimediaExternalContent">Multimedia</a>
                            </li>
                            <div class="dropdown collapse navbar-nav-collapse" id="multimediaExternalContent">
                                <div class="bg-dark">
                                    <div class="container px-3">
                                        <div class="row">
                                            <div class="col nav-header"><a href="https://www.leg.state.mn.us/leg/multimedia">Multimedia — Audio, Video, Broadcast TV, News, & Photos</a></div>
                                        </div>
                                        <hr class="my-1 bg-secondary">
                                        <div class="row">
                                            <div class="col-12 col-sm-4">
                                                <!-- <h2 class="text-white">Minnesota House of Representatives</h2> -->
                                                <dl>
                                                    <dt class="text-white">House</dt>
                                                    <dd><a href="https://www.house.leg.state.mn.us/live/1">Live Video</a> <span class="text-white">/</span> <a href="https://www.leg.state.mn.us/leg/multimedia">Audio</a></dd>
                                                    <dd><a href="https://www.house.leg.state.mn.us/htv/schedule.asp">Webcast Schedule</a></dd>
                                                    <dd><a href="https://www.house.leg.state.mn.us/audio/default.asp">Audio &amp; Video Archives</a></dd>
                                                    <dd><a href="https://www.house.leg.state.mn.us/hinfo/sdaily.asp">Session Daily</a></dd>
                                                    <dd><a href="https://www.house.leg.state.mn.us/hinfo/images.asp">Photos</a></dd>
                                                </dl>
                                            </div>
                                            <div class="col-12 col-sm-4">
                                                <dl>
                                                    <dt class="text-white">Senate</dt>
                                                    <dd>
                                                        <a href="https://mnsenate.granicus.com/ViewPublisher.php?view_id=1">Live Video</a> <span class="text-white">/</span> <a href="https://www.leg.state.mn.us/leg/multimedia">Audio</a></dd>
                                                    <dd><a href="https://mnsenate.granicus.com/ViewPublisher.php?view_id=1">Webcast Schedule</a></dd>
                                                    <dd><a href="https://www.senate.mn/media/index.php?type=audio">Audio Archives</a></dd>
                                                    <dd><a href="https://www.senate.mn/media/index.php?type=video">Video Archives</a></dd>
                                                    <!--<dd><a href="/media/media_photos.php">Photos</a></dd>-->
                                                </dl>
                                            </div>
                                            <div class="col-12 col-sm-4">
                                                <dl>
                                                    <dt class="text-white">Joint</dt>
                                                    <dd><a href="https://www.leg.state.mn.us/leg/multimedia">Combined Media Page</a></dd>
                                                    <dd><a href="https://www.house.leg.state.mn.us/htv/htv.asp">Broadcast TV Schedule</a></dd>
                                                    <dd><a href="https://www.commissions.leg.state.mn.us/meetings-all.htm">Commission Audio/Video</a></dd>
                                                </dl>
                                            </div>
                                        </div>
                                    </div>
                                </div>
                            </div>

                            <li class="nav-item">
                                <a aria-controls="publicationsExternalContent" aria-expanded="false" class="nav-link dropdown-toggle" data-parent="#top-nav" data-toggle="collapse" href="#publicationsExternalContent">Publications</a>
                            </li>
                            <div class="dropdown collapse navbar-nav-collapse" id="publicationsExternalContent">
                                <div class="bg-dark">
                                    <div class="container px-3">
                                        <div class="row">
                                            <div class="col nav-header"><a href="https://www.leg.state.mn.us/leg/publicat">Legislative Research, Reports & Information</a></div>
                                        </div>
                                        <hr class="my-1 bg-secondary">
                                        <div class="row">
                                            <div class="col-12 col-sm-6 col-md-3">
                                                <!-- <h2 class="text-white">Minnesota House of Representatives</h2> -->
                                                <dl>
                                                    <dt class="text-white">Office Research &amp; Reports</dt>
                                                    <dd><a href="https://www.house.leg.state.mn.us/fiscal/fahome.asp">House Fiscal Analysis</a></dd>
                                                    <dd><a href="https://www.house.leg.state.mn.us/hrd/publications.aspx">House Research</a></dd>
                                                    <dd><a href="https://www.auditor.leg.state.mn.us/allreports.htm">Legislative Auditor</a></dd>
                                                    <dd><a href="/office/publications.php">Revisor Publications</a></dd>
                                                    <dd><a href="https://www.senate.mn/publications">Senate Publications</a></dd>
                                                    <dd><a href="https://www.leg.state.mn.us/lrl/">Legislative Reference Library</a></dd>
                                                </dl>
                                            </div>
                                            <div class="col-12 col-sm-6 col-md-3">
                                                <dl>
                                                    <dt class="text-white">News</dt>
                                                    <dd><a href="https://www.house.leg.state.mn.us/hinfo/sdaily.asp">House Session Daily</a></dd>
                                                    <dd><a href="https://www.senate.mn/media/index.php">Senate Media Services</a></dd>
                                                    <dd><a href="https://www.house.leg.state.mn.us/hinfo/leginfo/memroster.pdf">Legislators Roster</a></dd>
                                                    <dd><a href="https://www.house.mn/hinfo/leginfo/elecdir.htm">Election Directory</a></dd>

                                                </dl>
                                            </div>
                                            <div class="col-12 col-sm-6 col-md-3">
                                                <dl>
                                                    <dt class="text-white">Legislative History</dt>
                                                    <dd><a href="https://www.leg.state.mn.us/leg/leghist/histstep.aspx">Legislative History Guide</a></dd>
                                                    <dd><a href="https://www.leg.state.mn.us/legdb/">Legislators Past &amp; Present</a></dd>
                                                    <dd><a href="https://www.house.leg.state.mn.us/cco/journals/journl.asp">House Journal</a></dd>
                                                    <dd><a href="https://www.senate.mn/journals/journal_list.php">Senate Journal</a></dd>
                                                    <dd><a href="https://www.leg.state.mn.us/lrl/timecapsule/index.aspx">Legislative Time Capsule</a></dd>
                                                    <dd><a href="https://www.leg.state.mn.us/lrl/vetoes/vetoes.aspx">Vetoes</a></dd>
                                                </dl>
                                            </div>
                                            <div class="col-12 col-sm-6 col-md-3">
                                                <dl>
                                                    <dt class="text-white">Notable Documents</dt>
                                                    <dd><a href="https://www.senate.mn/departments/scr/report/index.php">Fiscal Review</a></dd>
                                                    <dd><a href="https://www.leg.state.mn.us/lrl/issues/">Minnesota Issues Guides</a></dd>
                                                    <dd><a href="https://www.house.leg.state.mn.us/newlaws/">New Laws</a></dd>
                                                    <dd><a href="https://www.leg.state.mn.us/lrl/booksreports.aspx">Books &amp; reports</a></dd>
                                                </dl>
                                            </div>
                                        </div>
                                    </div>
                                </div>
                            </div>
                        </ul>
                        <form class="form-inline ml-auto d-block d-md-none p-2">
                            <label class="sr-only js-search-sm-label" for="sm-search">Search Legislature</label>
                            <div class="input-group mb-2 mr-sm-2">

                                <input class="form-control form-control-sm js-sm-search" id="sm-search" name="search" aria-label="Search Legislature" aria-describedby="searchButton" placeholder="Search..." type="text">

                                <div class="input-group-append">
                                    <button class="js-search-sm-btn btn btn-darkgray btn-sm" type="button" id="searchButton"  alt="Search Button"><i class="fa fa-search"></i><span class="sr-only sr-only-focusable">Search</span></button>
                                </div>

                            </div>
                        </form>

                    </div>

                </div>
            </div>
        </div>
    </nav>
    <div class="leg-banner img-joint">
        <div class="position-relative h-100">
            <div class="leg-title-container pl-0">
                <div class="container pl-sm-0 pl-md-3">
                    <a class="leg-title-text text-white" href="/" id="leg-title-text" style="">Office of the Revisor of Statutes</a><br>
                </div>
            </div>
        </div>
    </div>

      <nav id="legSubNav" class="navbar navbar-expand-md navbar-joint bg-joint  d-print-none">
                    <div class="container">
                 <div class="d-block ml-0">
                   <button aria-controls="navbarNav" aria-expanded="false" aria-label="Toggle navigation" class="navbar-toggler" data-target="#navbarNav" data-toggle="collapse" type="button"><span class="navbar-toggler-icon"></span></button>
                   <span class="d-md-none pl-1 text-white" data-toggle="collapse" data-target="#navbarNav">Revisor Menu</span>
                 </div>
               <div class="collapse navbar-collapse" id="navbarNav">
                 <ul class="navbar-nav">
                   <li class="nav-item pl-md-0 d-none d-lg-inline">
                             <form id="docbox" class="retrieve form-inline justify-content-center mt-1" action="/pubs/getdoc.php" method="post">
        <input class="bg-light navbar-form form-control mr-1" name="docnum" type="text"
                               placeholder="Retrieve by number" maxlength="200"/>

        <div class="input-group">
            <select class="bg-light custom-select custom-select-sm form-control navbar-form" id="doctype" name="type"><option value="statutes">Statutes</option><option value="laws">Laws</option><option value="rules">Rules</option><option value="bills" selected="selected">Bills</option>        </select>
        <div class="input-group-append">
          <button class="btn btn-sm btn-secondary navbar-form pb-2">GO</button>
        </div>
    </div>
</form>
                   </li>
                   
                 </ul>
     
                 <ul class="navbar-nav ml-auto mr-3">
                   <!--<li class="nav-item" data-toggle="tooltip" data-placement="bottom" title="Email">-->
                     <!--<a class="nav-link test" href="#"><i class="far fa-lg fa-envelope"></i></a>-->
                   <!--</li>-->
                   <li class="nav-item" data-toggle="tooltip" data-placement="bottom" title="Print">
                     <a class="nav-link" href="javascript:window.print();"><i class="fas fa-lg fa-print"></i></a>
                   </li>
                 </ul>
               </div>
             </div>
          
      </nav>
      
      <div id="legContainerMain" class="container leg-content py-4">
          <div class="row">
            <div class="col">
            
            
            
            

    
<div class="house_bill">
    <div class="card mb-4">
        <div class="card-header">
            <h1 class="card-title float-left mr-4">HF 400</h1>
            <p class="mb-0 pt-2">6th  Engrossment - 91st Legislature (2019 - 2020) Posted on 05/23/2019 09:51am</p>
        </div>
        <div class="card-body">
            <div class="row">
                <div class="col-auto">
                    KEY: <s>stricken</s> = removed, old language. 
                </div>
                <div class="col-auto"> 
                    <u>underscored</u> = added, new language.
                </div>
            </div>
        </div>
    </div>

<div class="row pb-2">
        
    <div class="col-auto mr-auto">
                    <a class="expander mr-2" href="#" onclick="$('#versions').slideToggle('fast'); return false;">Version List</a>
                <a href="/bills/bill.php?b=house&f=HF0400&ssn=0&y=2019">Authors and Status</a>

    </div>
    <div class="col-auto">
        <a href="/bills/text.php?session_year=2019&session_number=0&number=HF0400&version=list&format=pdf"><i class="far fa-file-pdf fa-2x" style="color:#990033;"></i> Pdf</a>        <a class="ml-2" href="/bills/text.php?session_year=2019&session_number=0&number=HF0400&version=list&format=rtf"><i class="far fa-file-alt fa-2x" style="color: #000"></i> Rtf</a>
    </div>
</div>

<div id="versions" 
>
<h2>Bill Text Versions</h2>
    
    <table class="table table-sm " style="margin-top: 0px">
        <col width="70%"/>
    <col width="10%"/>
    <col width="20%" align="right"/>
        
    <th colspan="3">
                Engrossments
            </th>
        
            <tr>
            <td><a href="text.php?number=HF400&version=0&session=ls91&session_year=2019&session_number=0">
                Introduction                </a>
            </td>
            <td>
                                <a aria-label="PDF document" href="text.php?number=HF400&version=0&session=ls91&session_year=2019&session_number=0&format=pdf"><i class="far fa-file-pdf fa-2x" style="color:#990033;"></i></a>
                            </td>
            <td>
                Posted on 01/28/2019                
                            </td>
                    </tr>
            <tr>
            <td><a href="text.php?number=HF400&version=1&session=ls91&session_year=2019&session_number=0">
                1st  Engrossment                </a>
            </td>
            <td>
                                <a aria-label="PDF document" href="text.php?number=HF400&version=1&session=ls91&session_year=2019&session_number=0&format=pdf"><i class="far fa-file-pdf fa-2x" style="color:#990033;"></i></a>
                            </td>
            <td>
                Posted on 01/31/2019                
                            </td>
                    </tr>
            <tr>
            <td><a href="text.php?number=HF400&version=2&session=ls91&session_year=2019&session_number=0">
                2nd  Engrossment                </a>
            </td>
            <td>
                                <a aria-label="PDF document" href="text.php?number=HF400&version=2&session=ls91&session_year=2019&session_number=0&format=pdf"><i class="far fa-file-pdf fa-2x" style="color:#990033;"></i></a>
                            </td>
            <td>
                Posted on 02/07/2019                
                            </td>
                    </tr>
            <tr>
            <td><a href="text.php?number=HF400&version=3&session=ls91&session_year=2019&session_number=0">
                3rd  Engrossment                </a>
            </td>
            <td>
                                <a aria-label="PDF document" href="text.php?number=HF400&version=3&session=ls91&session_year=2019&session_number=0&format=pdf"><i class="far fa-file-pdf fa-2x" style="color:#990033;"></i></a>
                            </td>
            <td>
                Posted on 02/14/2019                
                            </td>
                    </tr>
            <tr>
            <td><a href="text.php?number=HF400&version=4&session=ls91&session_year=2019&session_number=0">
                4th  Engrossment                </a>
            </td>
            <td>
                                <a aria-label="PDF document" href="text.php?number=HF400&version=4&session=ls91&session_year=2019&session_number=0&format=pdf"><i class="far fa-file-pdf fa-2x" style="color:#990033;"></i></a>
                            </td>
            <td>
                Posted on 03/07/2019                
                            </td>
                    </tr>
            <tr>
            <td><a href="text.php?number=HF400&version=5&session=ls91&session_year=2019&session_number=0">
                5th  Engrossment                </a>
            </td>
            <td>
                                <a aria-label="PDF document" href="text.php?number=HF400&version=5&session=ls91&session_year=2019&session_number=0&format=pdf"><i class="far fa-file-pdf fa-2x" style="color:#990033;"></i></a>
                            </td>
            <td>
                Posted on 03/18/2019                
                            </td>
                    </tr>
            <tr>
            <td><a href="text.php?number=HF400&version=6&session=ls91&session_year=2019&session_number=0">
                6th  Engrossment                </a>
            </td>
            <td>
                                <a aria-label="PDF document" href="text.php?number=HF400&version=6&session=ls91&session_year=2019&session_number=0&format=pdf"><i class="far fa-file-pdf fa-2x" style="color:#990033;"></i></a>
                            </td>
            <td>
                Posted on 05/21/2019                
                            </td>
                    </tr>
        
    </table>
    
    <table class="table table-sm " style="margin-top: 0px">
        <col width="70%"/>
    <col width="10%"/>
    <col width="20%" align="right"/>
        
    <th colspan="3">
                    Unofficial Engrossments
            </th>
        
            <tr>
            <td><a href="text.php?number=HF400&version=1&session=ls91&session_year=2019&session_number=0&type=ue">
                1st  Unofficial Engrossment                </a>
            </td>
            <td>
                                <a aria-label="PDF document" href="text.php?number=HF400&version=1&session=ls91&session_year=2019&session_number=0&type=ue&format=pdf"><i class="far fa-file-pdf fa-2x" style="color:#990033;"></i></a>
                            </td>
            <td>
                Posted on 03/26/2019                
                            </td>
                    </tr>
            <tr>
            <td><a href="text.php?number=HF400&version=2&session=ls91&session_year=2019&session_number=0&type=ue">
                2nd  Unofficial Engrossment                </a>
            </td>
            <td>
                                <a aria-label="PDF document" href="text.php?number=HF400&version=2&session=ls91&session_year=2019&session_number=0&type=ue&format=pdf"><i class="far fa-file-pdf fa-2x" style="color:#990033;"></i></a>
                            </td>
            <td>
                Posted on 04/02/2019                
                            </td>
                    </tr>
        
    </table>
    
    <table class="table table-sm " style="margin-top: 0px">
        <col width="70%"/>
    <col width="10%"/>
    <col width="20%" align="right"/>
        
    <th colspan="3">
                    Division Engrossments
            </th>
        
            <tr>
            <td><a href="text.php?number=HF400&version=1&session=ls91&session_year=2019&session_number=0&type=div">
                1st  Division Engrossment                </a>
            </td>
            <td>
                                <a aria-label="PDF document" href="text.php?number=HF400&version=1&session=ls91&session_year=2019&session_number=0&type=div&format=pdf"><i class="far fa-file-pdf fa-2x" style="color:#990033;"></i></a>
                            </td>
            <td>
                Posted on 02/21/2019                
                            </td>
                    </tr>
            <tr>
            <td><a href="text.php?number=HF400&version=2&session=ls91&session_year=2019&session_number=0&type=div">
                2nd  Division Engrossment                </a>
            </td>
            <td>
                                <a aria-label="PDF document" href="text.php?number=HF400&version=2&session=ls91&session_year=2019&session_number=0&type=div&format=pdf"><i class="far fa-file-pdf fa-2x" style="color:#990033;"></i></a>
                            </td>
            <td>
                Posted on 03/03/2019                
                            </td>
                    </tr>
        
    </table>
    
    <table class="table table-sm " style="margin-top: 0px">
        <col width="70%"/>
    <col width="10%"/>
    <col width="20%" align="right"/>
        
    <th colspan="3">
                    Conference Committee Reports
            </th>
        
            <tr>
            <td><a href="text.php?number=HF400&version=0&session=ls91&session_year=2019&session_number=0&type=ccr">
                CCR-HF0400                </a>
            </td>
            <td>
                                <a aria-label="PDF document" href="text.php?number=HF400&version=0&session=ls91&session_year=2019&session_number=0&type=ccr&format=pdf"><i class="far fa-file-pdf fa-2x" style="color:#990033;"></i></a>
                            </td>
            <td>
                Posted on 05/20/2019                
                            </td>
                    </tr>
        
    </table>
</div>


    <form id="page_line_form" class="form-inline" action="">
                <label for="page_line_number" class="mr-2">Jump to page/line #</label>
                <input class="form-control" type="text" id="page_line_number_input" maxlength="7" placeholder="eg. 2.1" title="Enter a page and line number and press enter." accesskey="p"/>
            </form>
            <script>
                function scrollToAnchor(){
                    var number = $('#page_line_number_input').val();
                    $(document).scrollTop( $("#pl\\."+number.replace( /(:|\.|\[|\]|,)/g, "\\$1" )).offset().top);
                    //$('html,body').animate({scrollTop: $("#pl."+number)},'slow');
                    //location.hash = "pl."+number;
                    //return false;
                }
            $('#page_line_form').submit(function(event){
                event.preventDefault();
                scrollToAnchor(); 
                return false;
            });
            </script>

<h2 class="mt-3">Current Version - 6th  Engrossment</h2><div>

    
</div>

<!--<ul class="bill_nav" style="top: -.4em; border-bottom: solid 1px #000">
    <li ><a href="/bills/text.php?session_year=2019&session_number=0&number=HF0400&version=list&pl=1">Numbered</a></li>
    <li class="selected"><a href="/bills/text.php?session_year=2019&session_number=0&number=HF0400&version=list&pl=0">Not Numbered</a></li>
</div>-->
    <div id="xtend" class="pt-4">
<div xmlns="http://www.w3.org/1999/xhtml" class="row">
  <div id="line_numbers" class="d-none d-md-block col-md-1">
    <span class="sr-only">Line numbers</span>
    <var class="ln">1.1</var>
    <var class="ln">1.2</var>
    <var class="ln">1.3</var>
    <var class="ln">1.4</var>
    <var class="ln">1.5</var>
    <var class="ln">1.6</var>
    <var class="ln">1.7</var>
    <var class="ln">1.8</var>
    <var class="ln">1.9</var>
    <var class="ln">1.10</var>
    <var class="ln">1.11</var>
    <br/>
    <var class="ln">1.12</var>
    <var class="ln">1.13</var>
    <br/>
    <var class="ln">1.14</var>
    <var class="ln">1.15</var>
    <var class="ln">1.16</var>
    <var class="ln">1.17</var>
    <var class="ln">1.18</var>
    <var class="ln">1.19</var>
    <var class="ln">1.20</var>
    <var class="ln">1.21</var>
    <var class="ln">1.22</var>
    <var class="ln">1.23</var>
    <var class="ln">2.1</var>
    <var class="ln">2.2</var>
    <var class="ln">2.3</var>
    <var class="ln">2.4</var>
    <var class="ln">2.5</var>
    <var class="ln">2.6</var>
    <var class="ln">2.7</var>
    <var class="ln">2.8</var>
    <var class="ln">2.9</var>
    <var class="ln">2.10</var>
    <var class="ln">2.11</var>
    <var class="ln">2.12</var>
    <var class="ln">2.13</var>
    <var class="ln">2.14</var>
    <var class="ln">2.15</var>
    <var class="ln">2.16</var>
    <var class="ln">2.17</var>
    <var class="ln">2.18</var>
    <var class="ln">2.19</var>
    <var class="ln">2.20</var>
    <var class="ln">2.21</var>
    <var class="ln">2.22</var>
    <var class="ln">2.23</var>
    <var class="ln">2.24</var>
    <var class="ln">2.25</var>
    <var class="ln">2.26</var>
    <var class="ln">2.27</var>
    <var class="ln">2.28</var>
    <br/>
    <var class="ln">2.29</var>
    <var class="ln">2.30</var>
    <var class="ln">2.31</var>
    <var class="ln">2.32</var>
    <var class="ln">2.33</var>
    <var class="ln">3.1</var>
    <var class="ln">3.2</var>
    <var class="ln">3.3</var>
    <var class="ln">3.4</var>
    <var class="ln">3.5</var>
    <var class="ln">3.6</var>
    <var class="ln">3.7</var>
    <var class="ln">3.8</var>
    <var class="ln">3.9</var>
    <var class="ln">3.10</var>
    <var class="ln">3.11</var>
    <var class="ln">3.12</var>
    <var class="ln">3.13</var>
    <var class="ln">3.14</var>
    <var class="ln">3.15</var>
    <var class="ln">3.16</var>
    <var class="ln">3.17</var>
    <var class="ln">3.18</var>
    <br/>
    <var class="ln">3.19</var>
    <var class="ln">3.20</var>
    <br/>
    <var class="ln">3.21</var>
    <var class="ln">3.22</var>
    <var class="ln">3.23</var>
    <var class="ln">3.24</var>
    <var class="ln">3.25</var>
    <var class="ln">3.26</var>
    <var class="ln">3.27</var>
    <var class="ln">3.28</var>
    <var class="ln">4.1</var>
    <var class="ln">4.2</var>
    <var class="ln">4.3</var>
    <var class="ln">4.4</var>
    <var class="ln">4.5</var>
    <var class="ln">4.6</var>
    <var class="ln">4.7</var>
    <var class="ln">4.8</var>
    <var class="ln">4.9</var>
    <var class="ln">4.10</var>
    <var class="ln">4.11</var>
    <var class="ln">4.12</var>
    <var class="ln">4.13</var>
    <br/>
    <var class="ln">4.14</var>
    <var class="ln">4.15</var>
    <br/>
    <var class="ln">4.16</var>
    <var class="ln">4.17</var>
    <var class="ln">4.18</var>
    <var class="ln">4.19</var>
    <var class="ln">4.20</var>
    <var class="ln">4.21</var>
    <var class="ln">4.22</var>
    <var class="ln">4.23</var>
    <var class="ln">4.24</var>
    <var class="ln">4.25</var>
    <var class="ln">4.26</var>
    <var class="ln">4.27</var>
    <br/>
    <var class="ln">5.1</var>
    <var class="ln">5.2</var>
    <var class="ln">5.3</var>
    <var class="ln">5.4</var>
    <var class="ln">5.5</var>
    <var class="ln">5.6</var>
    <var class="ln">5.7</var>
    <var class="ln">5.8</var>
    <var class="ln">5.9</var>
    <var class="ln">5.10</var>
    <var class="ln">5.11</var>
    <var class="ln">5.12</var>
    <var class="ln">5.13</var>
    <var class="ln">5.14</var>
    <var class="ln">5.15</var>
    <var class="ln">5.16</var>
    <var class="ln">5.17</var>
    <var class="ln">5.18</var>
    <var class="ln">5.19</var>
    <var class="ln">5.20</var>
    <var class="ln">5.21</var>
    <var class="ln">5.22</var>
    <var class="ln">5.23</var>
    <var class="ln">5.24</var>
    <var class="ln">5.25</var>
    <var class="ln">5.26</var>
    <var class="ln">5.27</var>
    <var class="ln">5.28</var>
    <var class="ln">5.29</var>
    <var class="ln">5.30</var>
    <var class="ln">5.31</var>
    <var class="ln">5.32</var>
    <var class="ln">6.1</var>
    <var class="ln">6.2</var>
    <var class="ln">6.3</var>
    <var class="ln">6.4</var>
    <var class="ln">6.5</var>
    <var class="ln">6.6</var>
    <var class="ln">6.7</var>
    <var class="ln">6.8</var>
    <var class="ln">6.9</var>
    <var class="ln">6.10</var>
    <var class="ln">6.11</var>
    <var class="ln">6.12</var>
    <var class="ln">6.13</var>
    <var class="ln">6.14</var>
    <var class="ln">6.15</var>
    <var class="ln">6.16</var>
    <var class="ln">6.17</var>
    <var class="ln">6.18</var>
    <var class="ln">6.19</var>
    <var class="ln">6.20</var>
    <var class="ln">6.21</var>
    <var class="ln">6.22</var>
    <var class="ln">6.23</var>
    <var class="ln">6.24</var>
    <var class="ln">6.25</var>
    <var class="ln">6.26</var>
    <var class="ln">6.27</var>
    <var class="ln">6.28</var>
    <var class="ln">6.29</var>
    <var class="ln">6.30</var>
    <var class="ln">6.31</var>
    <var class="ln">6.32</var>
    <var class="ln">6.33</var>
    <var class="ln">6.34</var>
    <var class="ln">7.1</var>
    <var class="ln">7.2</var>
    <var class="ln">7.3</var>
    <var class="ln">7.4</var>
    <var class="ln">7.5</var>
    <br/>
    <var class="ln">7.6</var>
    <var class="ln">7.7</var>
    <var class="ln">7.8</var>
    <var class="ln">7.9</var>
    <var class="ln">7.10</var>
    <var class="ln">7.11</var>
    <var class="ln">7.12</var>
    <var class="ln">7.13</var>
    <var class="ln">7.14</var>
    <var class="ln">7.15</var>
    <var class="ln">7.16</var>
    <var class="ln">7.17</var>
    <var class="ln">7.18</var>
    <var class="ln">7.19</var>
    <var class="ln">7.20</var>
    <var class="ln">7.21</var>
    <var class="ln">7.22</var>
    <var class="ln">7.23</var>
    <var class="ln">7.24</var>
    <var class="ln">7.25</var>
    <var class="ln">7.26</var>
    <var class="ln">7.27</var>
    <var class="ln">7.28</var>
    <var class="ln">7.29</var>
    <var class="ln">7.30</var>
    <var class="ln">7.31</var>
    <var class="ln">7.32</var>
    <var class="ln">7.33</var>
    <var class="ln">8.1</var>
    <var class="ln">8.2</var>
    <var class="ln">8.3</var>
    <var class="ln">8.4</var>
    <var class="ln">8.5</var>
    <var class="ln">8.6</var>
    <var class="ln">8.7</var>
    <var class="ln">8.8</var>
    <var class="ln">8.9</var>
    <var class="ln">8.10</var>
    <var class="ln">8.11</var>
    <var class="ln">8.12</var>
    <var class="ln">8.13</var>
    <var class="ln">8.14</var>
    <br/>
    <var class="ln">8.15</var>
    <var class="ln">8.16</var>
    <var class="ln">8.17</var>
    <var class="ln">8.18</var>
    <var class="ln">8.19</var>
    <var class="ln">8.20</var>
    <var class="ln">8.21</var>
    <var class="ln">8.22</var>
    <var class="ln">8.23</var>
    <var class="ln">8.24</var>
    <var class="ln">8.25</var>
    <var class="ln">8.26</var>
    <var class="ln">8.27</var>
    <var class="ln">8.28</var>
    <var class="ln">8.29</var>
    <var class="ln">8.30</var>
    <var class="ln">8.31</var>
    <var class="ln">8.32</var>
    <var class="ln">8.33</var>
    <var class="ln">9.1</var>
    <var class="ln">9.2</var>
    <var class="ln">9.3</var>
    <var class="ln">9.4</var>
    <var class="ln">9.5</var>
    <var class="ln">9.6</var>
    <var class="ln">9.7</var>
    <var class="ln">9.8</var>
    <var class="ln">9.9</var>
    <var class="ln">9.10</var>
    <var class="ln">9.11</var>
    <var class="ln">9.12</var>
    <var class="ln">9.13</var>
    <var class="ln">9.14</var>
    <var class="ln">9.15</var>
    <var class="ln">9.16</var>
    <var class="ln">9.17</var>
    <var class="ln">9.18</var>
    <var class="ln">9.19</var>
    <var class="ln">9.20</var>
    <var class="ln">9.21</var>
    <var class="ln">9.22</var>
    <var class="ln">9.23</var>
    <var class="ln">9.24</var>
    <var class="ln">9.25</var>
    <var class="ln">9.26</var>
    <var class="ln">9.27</var>
    <var class="ln">9.28</var>
    <var class="ln">9.29</var>
    <var class="ln">9.30</var>
    <var class="ln">9.31</var>
    <var class="ln">9.32</var>
    <var class="ln">9.33</var>
    <var class="ln">10.1</var>
    <var class="ln">10.2</var>
    <var class="ln">10.3</var>
    <var class="ln">10.4</var>
    <var class="ln">10.5</var>
    <var class="ln">10.6</var>
    <var class="ln">10.7</var>
    <var class="ln">10.8</var>
    <var class="ln">10.9</var>
    <var class="ln">10.10</var>
    <var class="ln">10.11</var>
    <var class="ln">10.12</var>
    <var class="ln">10.13</var>
    <var class="ln">10.14</var>
    <var class="ln">10.15</var>
    <var class="ln">10.16</var>
    <var class="ln">10.17</var>
    <var class="ln">10.18</var>
    <var class="ln">10.19</var>
    <var class="ln">10.20</var>
    <var class="ln">10.21</var>
    <var class="ln">10.22</var>
    <var class="ln">10.23</var>
    <var class="ln">10.24</var>
    <var class="ln">10.25</var>
    <var class="ln">10.26</var>
    <var class="ln">10.27</var>
    <var class="ln">10.28</var>
    <var class="ln">10.29</var>
    <var class="ln">10.30</var>
    <var class="ln">10.31</var>
    <var class="ln">10.32</var>
    <var class="ln">11.1</var>
    <var class="ln">11.2</var>
    <var class="ln">11.3</var>
    <var class="ln">11.4</var>
    <var class="ln">11.5</var>
    <var class="ln">11.6</var>
    <var class="ln">11.7</var>
    <var class="ln">11.8</var>
    <var class="ln">11.9</var>
    <var class="ln">11.10</var>
    <var class="ln">11.11</var>
    <var class="ln">11.12</var>
    <var class="ln">11.13</var>
    <var class="ln">11.14</var>
    <var class="ln">11.15</var>
    <var class="ln">11.16</var>
    <var class="ln">11.17</var>
    <var class="ln">11.18</var>
    <var class="ln">11.19</var>
    <var class="ln">11.20</var>
    <var class="ln">11.21</var>
    <var class="ln">11.22</var>
    <var class="ln">11.23</var>
    <var class="ln">11.24</var>
    <var class="ln">11.25</var>
    <var class="ln">11.26</var>
    <var class="ln">11.27</var>
    <var class="ln">11.28</var>
    <var class="ln">11.29</var>
    <var class="ln">11.30</var>
    <var class="ln">11.31</var>
    <var class="ln">12.1</var>
    <var class="ln">12.2</var>
    <var class="ln">12.3</var>
    <var class="ln">12.4</var>
    <var class="ln">12.5</var>
    <var class="ln">12.6</var>
    <var class="ln">12.7</var>
    <var class="ln">12.8</var>
    <var class="ln">12.9</var>
    <var class="ln">12.10</var>
    <var class="ln">12.11</var>
    <var class="ln">12.12</var>
    <var class="ln">12.13</var>
    <var class="ln">12.14</var>
    <var class="ln">12.15</var>
    <var class="ln">12.16</var>
    <var class="ln">12.17</var>
    <var class="ln">12.18</var>
    <var class="ln">12.19</var>
    <var class="ln">12.20</var>
    <var class="ln">12.21</var>
    <var class="ln">12.22</var>
    <var class="ln">12.23</var>
    <var class="ln">12.24</var>
    <var class="ln">12.25</var>
    <var class="ln">12.26</var>
    <var class="ln">12.27</var>
    <var class="ln">12.28</var>
    <var class="ln">12.29</var>
    <var class="ln">12.30</var>
    <var class="ln">12.31</var>
    <var class="ln">12.32</var>
    <var class="ln">12.33</var>
    <var class="ln">12.34</var>
    <var class="ln">13.1</var>
    <var class="ln">13.2</var>
    <var class="ln">13.3</var>
    <var class="ln">13.4</var>
    <var class="ln">13.5</var>
    <var class="ln">13.6</var>
    <var class="ln">13.7</var>
    <var class="ln">13.8</var>
    <var class="ln">13.9</var>
    <var class="ln">13.10</var>
    <var class="ln">13.11</var>
    <var class="ln">13.12</var>
    <var class="ln">13.13</var>
    <var class="ln">13.14</var>
    <var class="ln">13.15</var>
    <var class="ln">13.16</var>
    <var class="ln">13.17</var>
    <var class="ln">13.18</var>
    <var class="ln">13.19</var>
    <var class="ln">13.20</var>
    <var class="ln">13.21</var>
    <br/>
    <var class="ln">13.22</var>
    <var class="ln">13.23</var>
    <var class="ln">13.24</var>
    <var class="ln">13.25</var>
    <var class="ln">13.26</var>
    <var class="ln">13.27</var>
    <var class="ln">13.28</var>
    <var class="ln">13.29</var>
    <var class="ln">13.30</var>
    <var class="ln">13.31</var>
    <var class="ln">13.32</var>
    <var class="ln">13.33</var>
    <var class="ln">14.1</var>
    <var class="ln">14.2</var>
    <var class="ln">14.3</var>
    <var class="ln">14.4</var>
    <var class="ln">14.5</var>
    <var class="ln">14.6</var>
    <var class="ln">14.7</var>
    <var class="ln">14.8</var>
    <var class="ln">14.9</var>
    <var class="ln">14.10</var>
    <var class="ln">14.11</var>
    <var class="ln">14.12</var>
    <var class="ln">14.13</var>
    <var class="ln">14.14</var>
    <var class="ln">14.15</var>
    <var class="ln">14.16</var>
    <var class="ln">14.17</var>
    <var class="ln">14.18</var>
    <var class="ln">14.19</var>
    <var class="ln">14.20</var>
    <var class="ln">14.21</var>
    <var class="ln">14.22</var>
    <var class="ln">14.23</var>
    <var class="ln">14.24</var>
    <var class="ln">14.25</var>
    <var class="ln">14.26</var>
    <var class="ln">14.27</var>
    <var class="ln">14.28</var>
    <var class="ln">14.29</var>
    <var class="ln">14.30</var>
    <var class="ln">14.31</var>
    <var class="ln">14.32</var>
    <var class="ln">14.33</var>
    <var class="ln">14.34</var>
    <var class="ln">14.35</var>
    <var class="ln">15.1</var>
    <var class="ln">15.2</var>
    <var class="ln">15.3</var>
    <var class="ln">15.4</var>
    <var class="ln">15.5</var>
    <var class="ln">15.6</var>
    <var class="ln">15.7</var>
    <var class="ln">15.8</var>
    <br/>
    <var class="ln">15.9</var>
    <var class="ln">15.10</var>
    <var class="ln">15.11</var>
    <var class="ln">15.12</var>
    <br/>
    <var class="ln">15.13</var>
    <var class="ln">15.14</var>
    <var class="ln">15.15</var>
    <var class="ln">15.16</var>
    <var class="ln">15.17</var>
    <var class="ln">15.18</var>
    <br/>
    <var class="ln">15.19</var>
    <var class="ln">15.20</var>
    <br/>
    <var class="ln">15.21</var>
    <var class="ln">15.22</var>
    <var class="ln">15.23</var>
    <var class="ln">15.24</var>
    <var class="ln">15.25</var>
    <var class="ln">15.26</var>
    <var class="ln">15.27</var>
    <var class="ln">15.28</var>
    <var class="ln">15.29</var>
    <var class="ln">15.30</var>
    <var class="ln">16.1</var>
    <var class="ln">16.2</var>
    <var class="ln">16.3</var>
    <var class="ln">16.4</var>
    <var class="ln">16.5</var>
    <var class="ln">16.6</var>
    <var class="ln">16.7</var>
    <var class="ln">16.8</var>
    <var class="ln">16.9</var>
    <var class="ln">16.10</var>
    <var class="ln">16.11</var>
    <var class="ln">16.12</var>
    <var class="ln">16.13</var>
    <var class="ln">16.14</var>
    <var class="ln">16.15</var>
    <var class="ln">16.16</var>
    <var class="ln">16.17</var>
    <var class="ln">16.18</var>
    <var class="ln">16.19</var>
    <var class="ln">16.20</var>
    <var class="ln">16.21</var>
    <var class="ln">16.22</var>
    <var class="ln">16.23</var>
    <var class="ln">16.24</var>
    <var class="ln">16.25</var>
    <var class="ln">16.26</var>
    <var class="ln">16.27</var>
    <var class="ln">16.28</var>
    <var class="ln">16.29</var>
    <var class="ln">16.30</var>
    <var class="ln">16.31</var>
    <var class="ln">17.1</var>
    <var class="ln">17.2</var>
    <var class="ln">17.3</var>
    <var class="ln">17.4</var>
    <var class="ln">17.5</var>
    <var class="ln">17.6</var>
    <var class="ln">17.7</var>
    <var class="ln">17.8</var>
    <var class="ln">17.9</var>
    <var class="ln">17.10</var>
    <var class="ln">17.11</var>
    <br/>
    <var class="ln">17.12</var>
    <var class="ln">17.13</var>
    <var class="ln">17.14</var>
    <var class="ln">17.15</var>
    <br/>
    <var class="ln">17.16</var>
    <var class="ln">17.17</var>
    <var class="ln">17.18</var>
    <var class="ln">17.19</var>
    <var class="ln">17.20</var>
    <var class="ln">17.21</var>
    <var class="ln">17.22</var>
    <var class="ln">17.23</var>
    <var class="ln">17.24</var>
    <var class="ln">17.25</var>
    <var class="ln">17.26</var>
    <var class="ln">17.27</var>
    <var class="ln">17.28</var>
    <var class="ln">17.29</var>
    <var class="ln">17.30</var>
    <var class="ln">17.31</var>
    <var class="ln">18.1</var>
    <var class="ln">18.2</var>
    <var class="ln">18.3</var>
    <var class="ln">18.4</var>
    <var class="ln">18.5</var>
    <var class="ln">18.6</var>
    <var class="ln">18.7</var>
    <var class="ln">18.8</var>
    <var class="ln">18.9</var>
    <var class="ln">18.10</var>
    <var class="ln">18.11</var>
    <var class="ln">18.12</var>
    <var class="ln">18.13</var>
    <var class="ln">18.14</var>
    <var class="ln">18.15</var>
    <var class="ln">18.16</var>
    <var class="ln">18.17</var>
    <var class="ln">18.18</var>
    <var class="ln">18.19</var>
    <var class="ln">18.20</var>
    <var class="ln">18.21</var>
    <var class="ln">18.22</var>
    <var class="ln">18.23</var>
    <var class="ln">18.24</var>
    <var class="ln">18.25</var>
    <var class="ln">18.26</var>
    <var class="ln">18.27</var>
    <var class="ln">18.28</var>
    <var class="ln">18.29</var>
    <var class="ln">18.30</var>
    <var class="ln">18.31</var>
    <var class="ln">19.1</var>
    <var class="ln">19.2</var>
    <var class="ln">19.3</var>
    <var class="ln">19.4</var>
    <var class="ln">19.5</var>
    <var class="ln">19.6</var>
    <var class="ln">19.7</var>
    <var class="ln">19.8</var>
    <var class="ln">19.9</var>
    <var class="ln">19.10</var>
    <var class="ln">19.11</var>
    <var class="ln">19.12</var>
    <var class="ln">19.13</var>
    <var class="ln">19.14</var>
    <var class="ln">19.15</var>
    <var class="ln">19.16</var>
    <var class="ln">19.17</var>
    <var class="ln">19.18</var>
    <var class="ln">19.19</var>
    <var class="ln">19.20</var>
    <var class="ln">19.21</var>
    <var class="ln">19.22</var>
    <var class="ln">19.23</var>
    <var class="ln">19.24</var>
    <var class="ln">19.25</var>
    <var class="ln">19.26</var>
    <var class="ln">19.27</var>
    <var class="ln">19.28</var>
    <var class="ln">19.29</var>
    <var class="ln">19.30</var>
    <var class="ln">19.31</var>
    <var class="ln">19.32</var>
    <var class="ln">19.33</var>
    <br/>
    <var class="ln">20.1</var>
    <var class="ln">20.2</var>
    <var class="ln">20.3</var>
    <var class="ln">20.4</var>
    <var class="ln">20.5</var>
    <var class="ln">20.6</var>
    <var class="ln">20.7</var>
    <var class="ln">20.8</var>
    <var class="ln">20.9</var>
    <var class="ln">20.10</var>
    <var class="ln">20.11</var>
    <var class="ln">20.12</var>
    <var class="ln">20.13</var>
    <var class="ln">20.14</var>
    <var class="ln">20.15</var>
    <var class="ln">20.16</var>
    <var class="ln">20.17</var>
    <var class="ln">20.18</var>
    <var class="ln">20.19</var>
    <var class="ln">20.20</var>
    <var class="ln">20.21</var>
    <var class="ln">20.22</var>
    <var class="ln">20.23</var>
    <br/>
    <var class="ln">20.24</var>
    <br/>
    <var class="ln">20.25</var>
    <var class="ln">20.26</var>
    <var class="ln">20.27</var>
    <var class="ln">20.28</var>
    <var class="ln">20.29</var>
    <var class="ln">20.30</var>
    <var class="ln">20.31</var>
    <var class="ln">21.1</var>
    <var class="ln">21.2</var>
    <var class="ln">21.3</var>
    <var class="ln">21.4</var>
    <var class="ln">21.5</var>
    <var class="ln">21.6</var>
    <var class="ln">21.7</var>
    <var class="ln">21.8</var>
    <br/>
    <var class="ln">21.9</var>
    <var class="ln">21.10</var>
    <var class="ln">21.11</var>
    <var class="ln">21.12</var>
    <var class="ln">21.13</var>
    <var class="ln">21.14</var>
    <var class="ln">21.15</var>
    <var class="ln">21.16</var>
    <var class="ln">21.17</var>
    <var class="ln">21.18</var>
    <var class="ln">21.19</var>
    <var class="ln">21.20</var>
    <var class="ln">21.21</var>
    <var class="ln">21.22</var>
    <var class="ln">21.23</var>
    <var class="ln">21.24</var>
    <var class="ln">21.25</var>
    <var class="ln">21.26</var>
    <var class="ln">21.27</var>
    <var class="ln">21.28</var>
    <var class="ln">21.29</var>
    <var class="ln">21.30</var>
    <var class="ln">21.31</var>
    <var class="ln">21.32</var>
    <var class="ln">21.33</var>
    <var class="ln">21.34</var>
    <var class="ln">22.1</var>
    <var class="ln">22.2</var>
    <var class="ln">22.3</var>
    <var class="ln">22.4</var>
    <var class="ln">22.5</var>
    <var class="ln">22.6</var>
    <var class="ln">22.7</var>
    <var class="ln">22.8</var>
    <var class="ln">22.9</var>
    <var class="ln">22.10</var>
    <var class="ln">22.11</var>
    <br/>
    <var class="ln">22.12</var>
    <var class="ln">22.13</var>
    <var class="ln">22.14</var>
    <var class="ln">22.15</var>
    <var class="ln">22.16</var>
    <var class="ln">22.17</var>
    <var class="ln">22.18</var>
    <var class="ln">22.19</var>
    <var class="ln">22.20</var>
    <var class="ln">22.21</var>
    <var class="ln">22.22</var>
    <br/>
    <var class="ln">22.23</var>
    <var class="ln">22.24</var>
    <var class="ln">22.25</var>
    <var class="ln">22.26</var>
    <var class="ln">22.27</var>
    <var class="ln">22.28</var>
    <var class="ln">22.29</var>
    <var class="ln">22.30</var>
    <var class="ln">22.31</var>
    <var class="ln">22.32</var>
    <var class="ln">23.1</var>
    <var class="ln">23.2</var>
    <var class="ln">23.3</var>
    <var class="ln">23.4</var>
    <var class="ln">23.5</var>
    <var class="ln">23.6</var>
    <var class="ln">23.7</var>
    <var class="ln">23.8</var>
    <var class="ln">23.9</var>
    <var class="ln">23.10</var>
    <var class="ln">23.11</var>
    <var class="ln">23.12</var>
    <var class="ln">23.13</var>
    <var class="ln">23.14</var>
    <var class="ln">23.15</var>
    <br/>
    <var class="ln">23.16</var>
    <var class="ln">23.17</var>
    <var class="ln">23.18</var>
    <var class="ln">23.19</var>
    <var class="ln">23.20</var>
    <var class="ln">23.21</var>
    <var class="ln">23.22</var>
    <var class="ln">23.23</var>
    <var class="ln">23.24</var>
    <var class="ln">23.25</var>
    <var class="ln">23.26</var>
    <var class="ln">23.27</var>
    <var class="ln">23.28</var>
    <var class="ln">23.29</var>
    <var class="ln">23.30</var>
    <var class="ln">23.31</var>
    <var class="ln">23.32</var>
    <var class="ln">24.1</var>
    <var class="ln">24.2</var>
    <var class="ln">24.3</var>
    <var class="ln">24.4</var>
    <var class="ln">24.5</var>
    <var class="ln">24.6</var>
    <var class="ln">24.7</var>
    <var class="ln">24.8</var>
    <var class="ln">24.9</var>
    <var class="ln">24.10</var>
    <var class="ln">24.11</var>
    <var class="ln">24.12</var>
    <var class="ln">24.13</var>
    <var class="ln">24.14</var>
    <var class="ln">24.15</var>
    <var class="ln">24.16</var>
    <var class="ln">24.17</var>
    <var class="ln">24.18</var>
    <var class="ln">24.19</var>
    <var class="ln">24.20</var>
    <var class="ln">24.21</var>
    <var class="ln">24.22</var>
    <var class="ln">24.23</var>
    <var class="ln">24.24</var>
    <var class="ln">24.25</var>
    <var class="ln">24.26</var>
    <var class="ln">24.27</var>
    <var class="ln">24.28</var>
    <var class="ln">24.29</var>
    <var class="ln">24.30</var>
    <var class="ln">24.31</var>
    <var class="ln">24.32</var>
    <var class="ln">24.33</var>
    <var class="ln">24.34</var>
    <var class="ln">25.1</var>
    <var class="ln">25.2</var>
    <var class="ln">25.3</var>
    <var class="ln">25.4</var>
    <var class="ln">25.5</var>
    <var class="ln">25.6</var>
    <var class="ln">25.7</var>
    <var class="ln">25.8</var>
    <var class="ln">25.9</var>
    <var class="ln">25.10</var>
    <var class="ln">25.11</var>
    <var class="ln">25.12</var>
    <var class="ln">25.13</var>
    <var class="ln">25.14</var>
    <var class="ln">25.15</var>
    <var class="ln">25.16</var>
    <var class="ln">25.17</var>
    <var class="ln">25.18</var>
    <var class="ln">25.19</var>
    <var class="ln">25.20</var>
    <var class="ln">25.21</var>
    <var class="ln">25.22</var>
    <var class="ln">25.23</var>
    <var class="ln">25.24</var>
    <var class="ln">25.25</var>
    <var class="ln">25.26</var>
    <var class="ln">25.27</var>
    <var class="ln">25.28</var>
    <var class="ln">25.29</var>
    <var class="ln">25.30</var>
    <var class="ln">25.31</var>
    <var class="ln">25.32</var>
    <var class="ln">26.1</var>
    <var class="ln">26.2</var>
    <var class="ln">26.3</var>
    <var class="ln">26.4</var>
    <var class="ln">26.5</var>
    <var class="ln">26.6</var>
    <var class="ln">26.7</var>
    <var class="ln">26.8</var>
    <var class="ln">26.9</var>
    <var class="ln">26.10</var>
    <var class="ln">26.11</var>
    <var class="ln">26.12</var>
    <var class="ln">26.13</var>
    <var class="ln">26.14</var>
    <var class="ln">26.15</var>
    <var class="ln">26.16</var>
    <var class="ln">26.17</var>
    <var class="ln">26.18</var>
    <var class="ln">26.19</var>
    <var class="ln">26.20</var>
    <var class="ln">26.21</var>
    <var class="ln">26.22</var>
    <var class="ln">26.23</var>
    <var class="ln">26.24</var>
    <var class="ln">26.25</var>
    <var class="ln">26.26</var>
    <var class="ln">26.27</var>
    <var class="ln">26.28</var>
    <var class="ln">26.29</var>
    <var class="ln">26.30</var>
    <var class="ln">26.31</var>
    <var class="ln">27.1</var>
    <var class="ln">27.2</var>
    <var class="ln">27.3</var>
    <var class="ln">27.4</var>
    <var class="ln">27.5</var>
    <var class="ln">27.6</var>
    <var class="ln">27.7</var>
    <var class="ln">27.8</var>
    <var class="ln">27.9</var>
    <var class="ln">27.10</var>
    <var class="ln">27.11</var>
    <var class="ln">27.12</var>
    <var class="ln">27.13</var>
    <var class="ln">27.14</var>
    <var class="ln">27.15</var>
    <var class="ln">27.16</var>
    <var class="ln">27.17</var>
    <var class="ln">27.18</var>
    <var class="ln">27.19</var>
    <var class="ln">27.20</var>
    <var class="ln">27.21</var>
    <var class="ln">27.22</var>
    <var class="ln">27.23</var>
    <var class="ln">27.24</var>
    <var class="ln">27.25</var>
    <var class="ln">27.26</var>
    <var class="ln">27.27</var>
    <var class="ln">27.28</var>
    <var class="ln">27.29</var>
    <var class="ln">27.30</var>
    <var class="ln">27.31</var>
    <var class="ln">27.32</var>
    <var class="ln">27.33</var>
    <br/>
    <var class="ln">28.1</var>
    <var class="ln">28.2</var>
    <var class="ln">28.3</var>
    <var class="ln">28.4</var>
    <var class="ln">28.5</var>
    <var class="ln">28.6</var>
    <var class="ln">28.7</var>
    <var class="ln">28.8</var>
    <var class="ln">28.9</var>
    <var class="ln">28.10</var>
    <var class="ln">28.11</var>
    <var class="ln">28.12</var>
    <var class="ln">28.13</var>
    <var class="ln">28.14</var>
    <var class="ln">28.15</var>
    <var class="ln">28.16</var>
    <var class="ln">28.17</var>
    <var class="ln">28.18</var>
    <br/>
    <var class="ln">28.19</var>
    <br/>
    <var class="ln">28.20</var>
    <var class="ln">28.21</var>
    <br/>
    <var class="ln">28.22</var>
    <var class="ln">28.23</var>
    <var class="ln">28.24</var>
    <var class="ln">28.25</var>
    <var class="ln">28.26</var>
    <var class="ln">28.27</var>
    <var class="ln">28.28</var>
    <var class="ln">28.29</var>
    <var class="ln">28.30</var>
    <var class="ln">28.31</var>
    <var class="ln">28.32</var>
    <var class="ln">28.33</var>
    <var class="ln">29.1</var>
    <var class="ln">29.2</var>
    <var class="ln">29.3</var>
    <var class="ln">29.4</var>
    <var class="ln">29.5</var>
    <var class="ln">29.6</var>
    <var class="ln">29.7</var>
    <var class="ln">29.8</var>
    <var class="ln">29.9</var>
    <var class="ln">29.10</var>
    <var class="ln">29.11</var>
    <var class="ln">29.12</var>
    <var class="ln">29.13</var>
    <var class="ln">29.14</var>
    <var class="ln">29.15</var>
    <var class="ln">29.16</var>
    <var class="ln">29.17</var>
    <var class="ln">29.18</var>
    <var class="ln">29.19</var>
    <var class="ln">29.20</var>
    <var class="ln">29.21</var>
    <var class="ln">29.22</var>
    <var class="ln">29.23</var>
    <var class="ln">29.24</var>
    <var class="ln">29.25</var>
    <var class="ln">29.26</var>
    <var class="ln">29.27</var>
    <var class="ln">29.28</var>
    <var class="ln">29.29</var>
    <var class="ln">29.30</var>
    <var class="ln">29.31</var>
    <var class="ln">29.32</var>
    <var class="ln">29.33</var>
    <var class="ln">30.1</var>
    <var class="ln">30.2</var>
    <var class="ln">30.3</var>
    <var class="ln">30.4</var>
    <var class="ln">30.5</var>
    <var class="ln">30.6</var>
    <var class="ln">30.7</var>
    <var class="ln">30.8</var>
    <var class="ln">30.9</var>
    <var class="ln">30.10</var>
    <var class="ln">30.11</var>
    <var class="ln">30.12</var>
    <var class="ln">30.13</var>
    <var class="ln">30.14</var>
    <var class="ln">30.15</var>
    <var class="ln">30.16</var>
    <var class="ln">30.17</var>
    <var class="ln">30.18</var>
    <var class="ln">30.19</var>
    <var class="ln">30.20</var>
    <var class="ln">30.21</var>
    <var class="ln">30.22</var>
    <var class="ln">30.23</var>
    <var class="ln">30.24</var>
    <var class="ln">30.25</var>
    <var class="ln">30.26</var>
    <var class="ln">30.27</var>
    <var class="ln">30.28</var>
    <var class="ln">30.29</var>
    <var class="ln">30.30</var>
    <var class="ln">30.31</var>
    <var class="ln">30.32</var>
    <var class="ln">30.33</var>
    <var class="ln">31.1</var>
    <var class="ln">31.2</var>
    <var class="ln">31.3</var>
    <var class="ln">31.4</var>
    <var class="ln">31.5</var>
    <var class="ln">31.6</var>
    <var class="ln">31.7</var>
    <var class="ln">31.8</var>
    <var class="ln">31.9</var>
    <var class="ln">31.10</var>
    <var class="ln">31.11</var>
    <var class="ln">31.12</var>
    <var class="ln">31.13</var>
    <var class="ln">31.14</var>
    <br/>
    <var class="ln">31.15</var>
    <var class="ln">31.16</var>
    <var class="ln">31.17</var>
    <br/>
    <var class="ln">31.18</var>
    <var class="ln">31.19</var>
  </div>
  <div id="document" class="col">
    <div class="bill_title">
      <p><span class="btitle_prolog"><span id="pl.1.1" class="pl"> </span>A bill for an act<br/></span><span id="pl.1.2" class="pl"> </span>relating to health; establishing the opiate product registration fee and the Opiate <br/><span id="pl.1.3" class="pl"> </span>Epidemic Response Advisory Council; modifying certain licensure and registration <br/><span id="pl.1.4" class="pl"> </span>fees; modifying sections relating to prescription drugs and controlled substances; <br/><span id="pl.1.5" class="pl"> </span>requiring reports; appropriating money; amending Minnesota Statutes 2018, sections <br/><span id="pl.1.6" class="pl"> </span>16A.151, subdivision 2; 145C.05, subdivision 2; 151.01, subdivision 27; 151.065, <br/><span id="pl.1.7" class="pl"> </span>subdivisions 1, 3, by adding a subdivision; 151.252, subdivision 1; 151.37, <br/><span id="pl.1.8" class="pl"> </span>subdivision 12; 152.105, subdivision 2; 152.11, subdivisions 1, 2d, 4; 152.126, <br/><span id="pl.1.9" class="pl"> </span>subdivision 6; 214.12, by adding a subdivision; proposing coding for new law in <br/><span id="pl.1.10" class="pl"> </span>Minnesota Statutes, chapters 145C; 151; 256.<br/></p>
    </div>
    <p style="text-indent: 0em; margin: 0em 0em 0px 0em"><span id="pl.1.11" class="pl"> </span>BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:<br/></p>
    <div class="article" id="bill.1.0.0">
      <h1 class="article_no"><span id="pl.1.12" class="pl"> </span>ARTICLE 1<br/></h1>
      <h1 class="article_header"><span id="pl.1.13" class="pl"> </span>OPIATE EPIDEMIC RESPONSE<br/></h1>
      <div class="bill_section am_subd" id="bill.1.1.0">
        <h2 class="section_number"><span id="pl.1.14" class="pl"> </span>Section 1. </h2>
        <p class="first">Minnesota Statutes 2018, section 16A.151, subdivision 2, is amended to read:<br/></p>
        <br/>
        <div class="subd" id="bill.1.1.1">
          <h2 class="subd_no"><span id="pl.1.15" class="pl"> </span>Subd. 2.</h2>
          <h3 class="headnote">Exceptions.</h3>
          <p>(a) If a state official litigates or settles a matter on behalf of specific <br/><span id="pl.1.16" class="pl"> </span>injured persons or entities, this section does not prohibit distribution of money to the specific <br/><span id="pl.1.17" class="pl"> </span>injured persons or entities on whose behalf the litigation or settlement efforts were initiated. <br/><span id="pl.1.18" class="pl"> </span>If money recovered on behalf of injured persons or entities cannot reasonably be distributed <br/><span id="pl.1.19" class="pl"> </span>to those persons or entities because they cannot readily be located or identified or because <br/><span id="pl.1.20" class="pl"> </span>the cost of distributing the money would outweigh the benefit to the persons or entities, the <br/><span id="pl.1.21" class="pl"> </span>money must be paid into the general fund.<br/></p>
          <p><span id="pl.1.22" class="pl"> </span>(b) Money recovered on behalf of a fund in the state treasury other than the general fund <br/><span id="pl.1.23" class="pl"> </span>may be deposited in that fund.<br/></p>
          <p><span id="pl.2.1" class="pl"> </span>(c) This section does not prohibit a state official from distributing money to a person or <br/><span id="pl.2.2" class="pl"> </span>entity other than the state in litigation or potential litigation in which the state is a defendant <br/><span id="pl.2.3" class="pl"> </span>or potential defendant.<br/></p>
          <p><span id="pl.2.4" class="pl"> </span>(d) State agencies may accept funds as directed by a federal court for any restitution or <br/><span id="pl.2.5" class="pl"> </span>monetary penalty under United States Code, title 18, section 3663(a)(3) or United States <br/><span id="pl.2.6" class="pl"> </span>Code, title 18, section 3663A(a)(3). Funds received must be deposited in a special revenue <br/><span id="pl.2.7" class="pl"> </span>account and are appropriated to the commissioner of the agency for the purpose as directed <br/><span id="pl.2.8" class="pl"> </span>by the federal court.<br/></p>
          <p><span id="pl.2.9" class="pl"> </span>(e) Tobacco settlement revenues as defined in section <a href="/statutes/cite/16A.98#stat.16A.98.1">16A.98, subdivision 1</a>, paragraph <br/><span id="pl.2.10" class="pl"> </span>(t), may be deposited as provided in section <a href="/statutes/cite/16A.98#stat.16A.98.12">16A.98, subdivision 12</a>.<br/></p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.2.11" class="pl"> </span>(f) Any money received by the state resulting from a settlement agreement or an assurance <br/><span id="pl.2.12" class="pl"> </span>of discontinuance entered into by the attorney general of the state, or a court order in litigation <br/><span id="pl.2.13" class="pl"> </span>brought by the attorney general of the state, on behalf of the state or a state agency, against <br/><span id="pl.2.14" class="pl"> </span>one or more opioid manufacturers or opioid wholesale drug distributors related to alleged <br/><span id="pl.2.15" class="pl"> </span>violations of consumer fraud laws in the marketing, sale, or distribution of opioids in this <br/><span id="pl.2.16" class="pl"> </span>state or other alleged illegal actions that contributed to the excessive use of opioids, must <br/><span id="pl.2.17" class="pl"> </span>be deposited in a separate account in the state treasury and the commissioner shall notify <br/><span id="pl.2.18" class="pl"> </span>the chairs and ranking minority members of the finance committee in the senate and the <br/><span id="pl.2.19" class="pl"> </span>ways and means committee in the house of representatives that an account has been created. <br/><span id="pl.2.20" class="pl"> </span>This paragraph does not apply to attorney fees and costs awarded to the state or the Attorney <br/><span id="pl.2.21" class="pl"> </span>General's Office, to contract attorneys hired by the state or Attorney General's Office, or to <br/><span id="pl.2.22" class="pl"> </span>other state agency attorneys. If the licensing fees under section 151.065, subdivision 1, <br/><span id="pl.2.23" class="pl"> </span>clause (16), and section 151.065, subdivision 3, clause (14), are reduced and the registration <br/><span id="pl.2.24" class="pl"> </span>fee under section 151.066, subdivision 3, is repealed in accordance with section 256.043, <br/><span id="pl.2.25" class="pl"> </span>subdivision 4, then the commissioner shall transfer from the separate account created in <br/><span id="pl.2.26" class="pl"> </span>this paragraph to the opiate epidemic response account under section 256.043 an amount <br/><span id="pl.2.27" class="pl"> </span>that ensures that $20,940,000 each fiscal year is available for distribution in accordance <br/><span id="pl.2.28" class="pl"> </span>with section 256.043, subdivisions 2 and 3.<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
        </div>
      </div>
      <div class="bill_section am_subd" id="bill.1.2.0">
        <h2 class="section_number"><span id="pl.2.29" class="pl"> </span>Sec. 2. </h2>
        <p class="first">Minnesota Statutes 2018, section 151.065, subdivision 1, is amended to read:<br/></p>
        <br/>
        <div class="subd" id="bill.1.2.1">
          <h2 class="subd_no"><span id="pl.2.30" class="pl"> </span>Subdivision 1.</h2>
          <h3 class="headnote">Application fees.</h3>
          <p>Application fees for licensure and registration are as <br/><span id="pl.2.31" class="pl"> </span>follows:<br/></p>
          <p><span id="pl.2.32" class="pl"> </span>(1) pharmacist licensed by examination, $145;<br/></p>
          <p><span id="pl.2.33" class="pl"> </span>(2) pharmacist licensed by reciprocity, $240;<br/></p>
          <p><span id="pl.3.1" class="pl"> </span>(3) pharmacy intern, $37.50;<br/></p>
          <p><span id="pl.3.2" class="pl"> </span>(4) pharmacy technician, $37.50;<br/></p>
          <p><span id="pl.3.3" class="pl"> </span>(5) pharmacy, $225;<br/></p>
          <p><span id="pl.3.4" class="pl"> </span>(6) drug wholesaler, legend drugs only, <span class="sr-only">deleted text begin</span><span style="text-decoration: line-through" class="del">$235</span><span class="sr-only">deleted text end</span><span class="sr-only">new text begin</span><ins style="text-decoration: underline"> $5,000</ins><span class="sr-only">new text end</span>;<br/></p>
          <p><span id="pl.3.5" class="pl"> </span>(7) drug wholesaler, legend and nonlegend drugs, <span class="sr-only">deleted text begin</span><span style="text-decoration: line-through" class="del">$235</span><span class="sr-only">deleted text end</span><span class="sr-only">new text begin</span><ins style="text-decoration: underline"> $5,000</ins><span class="sr-only">new text end</span>;<br/></p>
          <p><span id="pl.3.6" class="pl"> </span>(8) drug wholesaler, nonlegend drugs, veterinary legend drugs, or both, <span class="sr-only">deleted text begin</span><span style="text-decoration: line-through" class="del">$210</span><span class="sr-only">deleted text end</span><span class="sr-only">new text begin</span><ins style="text-decoration: underline"> $5,000</ins><span class="sr-only">new text end</span>;<br/></p>
          <p><span id="pl.3.7" class="pl"> </span>(9) drug wholesaler, medical gases, <span class="sr-only">deleted text begin</span><span style="text-decoration: line-through" class="del">$175</span><span class="sr-only">deleted text end</span><span class="sr-only">new text begin</span><ins style="text-decoration: underline"> $5,000</ins><span class="sr-only">new text end</span>;<br/></p>
          <p><span id="pl.3.8" class="pl"> </span>(10) drug wholesaler, also licensed as a pharmacy in Minnesota, <span class="sr-only">deleted text begin</span><span style="text-decoration: line-through" class="del">$150</span><span class="sr-only">deleted text end</span><span class="sr-only">new text begin</span><ins style="text-decoration: underline"> $5,000</ins><span class="sr-only">new text end</span>;<br/></p>
          <p><span id="pl.3.9" class="pl"> </span>(11) drug manufacturer, <span class="sr-only">new text begin</span><ins style="text-decoration: underline">nonopiate </ins><span class="sr-only">new text end</span>legend drugs only, <span class="sr-only">deleted text begin</span><span style="text-decoration: line-through" class="del">$235</span><span class="sr-only">deleted text end</span><span class="sr-only">new text begin</span><ins style="text-decoration: underline"> $5,000</ins><span class="sr-only">new text end</span>;<br/></p>
          <p><span id="pl.3.10" class="pl"> </span>(12) drug manufacturer, <span class="sr-only">new text begin</span><ins style="text-decoration: underline">nonopiate </ins><span class="sr-only">new text end</span>legend and nonlegend drugs, <span class="sr-only">deleted text begin</span><span style="text-decoration: line-through" class="del">$235</span><span class="sr-only">deleted text end</span><span class="sr-only">new text begin</span><ins style="text-decoration: underline"> $5,000</ins><span class="sr-only">new text end</span>;<br/></p>
          <p><span id="pl.3.11" class="pl"> </span>(13) drug manufacturer, nonlegend or veterinary legend drugs, <span class="sr-only">deleted text begin</span><span style="text-decoration: line-through" class="del">$210</span><span class="sr-only">deleted text end</span><span class="sr-only">new text begin</span><ins style="text-decoration: underline"> $5,000</ins><span class="sr-only">new text end</span>;<br/></p>
          <p><span id="pl.3.12" class="pl"> </span>(14) drug manufacturer, medical gases, <span class="sr-only">deleted text begin</span><span style="text-decoration: line-through" class="del">$185</span><span class="sr-only">deleted text end</span><span class="sr-only">new text begin</span><ins style="text-decoration: underline"> $5,000</ins><span class="sr-only">new text end</span>;<br/></p>
          <p><span id="pl.3.13" class="pl"> </span>(15) drug manufacturer, also licensed as a pharmacy in Minnesota, <span class="sr-only">deleted text begin</span><span style="text-decoration: line-through" class="del">$150</span><span class="sr-only">deleted text end</span><span class="sr-only">new text begin</span><ins style="text-decoration: underline"> $5,000</ins><span class="sr-only">new text end</span>;<br/></p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.3.14" class="pl"> </span>(16) drug manufacturer of opiate-containing controlled substances listed in section <br/><span id="pl.3.15" class="pl"> </span>152.02, subdivisions 3 to 5, $55,000;<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p><span class="sr-only">deleted text begin</span><span style="text-decoration: line-through" class="del"><span id="pl.3.16" class="pl"> </span>(16)</span><span class="sr-only">deleted text end</span><span class="sr-only">new text begin</span><ins style="text-decoration: underline"> (17)</ins><span class="sr-only">new text end</span> medical gas distributor, <span class="sr-only">deleted text begin</span><span style="text-decoration: line-through" class="del">$110</span><span class="sr-only">deleted text end</span><span class="sr-only">new text begin</span><ins style="text-decoration: underline"> $5,000</ins><span class="sr-only">new text end</span>;<br/></p>
          <p><span class="sr-only">deleted text begin</span><span style="text-decoration: line-through" class="del"><span id="pl.3.17" class="pl"> </span>(17)</span><span class="sr-only">deleted text end</span><span class="sr-only">new text begin</span><ins style="text-decoration: underline"> (18)</ins><span class="sr-only">new text end</span> controlled substance researcher, $75; and<br/></p>
          <p><span class="sr-only">deleted text begin</span><span style="text-decoration: line-through" class="del"><span id="pl.3.18" class="pl"> </span>(18)</span><span class="sr-only">deleted text end</span><span class="sr-only">new text begin</span><ins style="text-decoration: underline"> (19)</ins><span class="sr-only">new text end</span> pharmacy professional corporation, $125.<br/></p>
        </div>
        <div class="sec_eff_date">
          <h2 class="effective_date">
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.3.19" class="pl"> </span>EFFECTIVE DATE.</ins>
            <span class="sr-only">new text end</span>
          </h2>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline">This section is effective July 1, 2019, and applies to any license <br/><span id="pl.3.20" class="pl"> </span>issued on or after that date.<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
        </div>
      </div>
      <div class="bill_section am_subd" id="bill.1.3.0">
        <h2 class="section_number"><span id="pl.3.21" class="pl"> </span>Sec. 3. </h2>
        <p class="first">Minnesota Statutes 2018, section 151.065, subdivision 3, is amended to read:<br/></p>
        <br/>
        <div class="subd" id="bill.1.3.1">
          <h2 class="subd_no"><span id="pl.3.22" class="pl"> </span>Subd. 3.</h2>
          <h3 class="headnote">Annual renewal fees.</h3>
          <p>Annual licensure and registration renewal fees are as <br/><span id="pl.3.23" class="pl"> </span>follows:<br/></p>
          <p><span id="pl.3.24" class="pl"> </span>(1) pharmacist, $145;<br/></p>
          <p><span id="pl.3.25" class="pl"> </span>(2) pharmacy technician, $37.50;<br/></p>
          <p><span id="pl.3.26" class="pl"> </span>(3) pharmacy, $225;<br/></p>
          <p><span id="pl.3.27" class="pl"> </span>(4) drug wholesaler, legend drugs only, <span class="sr-only">deleted text begin</span><span style="text-decoration: line-through" class="del">$235</span><span class="sr-only">deleted text end</span><span class="sr-only">new text begin</span><ins style="text-decoration: underline"> $5,000</ins><span class="sr-only">new text end</span>;<br/></p>
          <p><span id="pl.3.28" class="pl"> </span>(5) drug wholesaler, legend and nonlegend drugs, <span class="sr-only">deleted text begin</span><span style="text-decoration: line-through" class="del">$235</span><span class="sr-only">deleted text end</span><span class="sr-only">new text begin</span><ins style="text-decoration: underline">  $5,000</ins><span class="sr-only">new text end</span>;<br/></p>
          <p><span id="pl.4.1" class="pl"> </span>(6) drug wholesaler, nonlegend drugs, veterinary legend drugs, or both, <span class="sr-only">deleted text begin</span><span style="text-decoration: line-through" class="del">$210</span><span class="sr-only">deleted text end</span><span class="sr-only">new text begin</span><ins style="text-decoration: underline"> $5,000</ins><span class="sr-only">new text end</span>;<br/></p>
          <p><span id="pl.4.2" class="pl"> </span>(7) drug wholesaler, medical gases, <span class="sr-only">deleted text begin</span><span style="text-decoration: line-through" class="del">$185</span><span class="sr-only">deleted text end</span><span class="sr-only">new text begin</span><ins style="text-decoration: underline"> $5,000</ins><span class="sr-only">new text end</span>;<br/></p>
          <p><span id="pl.4.3" class="pl"> </span>(8) drug wholesaler, also licensed as a pharmacy in Minnesota, <span class="sr-only">deleted text begin</span><span style="text-decoration: line-through" class="del">$150</span><span class="sr-only">deleted text end</span><span class="sr-only">new text begin</span><ins style="text-decoration: underline"> $5,000</ins><span class="sr-only">new text end</span>;<br/></p>
          <p><span id="pl.4.4" class="pl"> </span>(9) drug manufacturer, <span class="sr-only">new text begin</span><ins style="text-decoration: underline">nonopiate </ins><span class="sr-only">new text end</span>legend drugs only, <span class="sr-only">deleted text begin</span><span style="text-decoration: line-through" class="del">$235</span><span class="sr-only">deleted text end</span><span class="sr-only">new text begin</span><ins style="text-decoration: underline"> $5,000</ins><span class="sr-only">new text end</span>;<br/></p>
          <p><span id="pl.4.5" class="pl"> </span>(10) drug manufacturer, <span class="sr-only">new text begin</span><ins style="text-decoration: underline">nonopiate </ins><span class="sr-only">new text end</span>legend and nonlegend drugs, <span class="sr-only">deleted text begin</span><span style="text-decoration: line-through" class="del">$235</span><span class="sr-only">deleted text end</span><span class="sr-only">new text begin</span><ins style="text-decoration: underline"> $5,000</ins><span class="sr-only">new text end</span>;<br/></p>
          <p><span id="pl.4.6" class="pl"> </span>(11) drug manufacturer, nonlegend, veterinary legend drugs, or both, <span class="sr-only">deleted text begin</span><span style="text-decoration: line-through" class="del">$210</span><span class="sr-only">deleted text end</span><span class="sr-only">new text begin</span><ins style="text-decoration: underline"> $5,000</ins><span class="sr-only">new text end</span>;<br/></p>
          <p><span id="pl.4.7" class="pl"> </span>(12) drug manufacturer, medical gases, <span class="sr-only">deleted text begin</span><span style="text-decoration: line-through" class="del">$185</span><span class="sr-only">deleted text end</span><span class="sr-only">new text begin</span><ins style="text-decoration: underline"> $5,000</ins><span class="sr-only">new text end</span>;<br/></p>
          <p><span id="pl.4.8" class="pl"> </span>(13) drug manufacturer, also licensed as a pharmacy in Minnesota, <span class="sr-only">deleted text begin</span><span style="text-decoration: line-through" class="del">$150</span><span class="sr-only">deleted text end</span><span class="sr-only">new text begin</span><ins style="text-decoration: underline"> $5,000</ins><span class="sr-only">new text end</span>;<br/></p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.4.9" class="pl"> </span>(14) drug manufacturer of opiate-containing controlled substances listed in section <br/><span id="pl.4.10" class="pl"> </span>152.02, subdivisions 3 to 5, $55,000;<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p><span class="sr-only">deleted text begin</span><span style="text-decoration: line-through" class="del"><span id="pl.4.11" class="pl"> </span>(14)</span><span class="sr-only">deleted text end</span><span class="sr-only">new text begin</span><ins style="text-decoration: underline"> (15)</ins><span class="sr-only">new text end</span> medical gas distributor, <span class="sr-only">deleted text begin</span><span style="text-decoration: line-through" class="del">$110</span><span class="sr-only">deleted text end</span><span class="sr-only">new text begin</span><ins style="text-decoration: underline"> $5,000</ins><span class="sr-only">new text end</span>;<br/></p>
          <p><span class="sr-only">deleted text begin</span><span style="text-decoration: line-through" class="del"><span id="pl.4.12" class="pl"> </span>(15)</span><span class="sr-only">deleted text end</span><span class="sr-only">new text begin</span><ins style="text-decoration: underline"> (16)</ins><span class="sr-only">new text end</span> controlled substance researcher, $75; and<br/></p>
          <p><span class="sr-only">deleted text begin</span><span style="text-decoration: line-through" class="del"><span id="pl.4.13" class="pl"> </span>(16)</span><span class="sr-only">deleted text end</span><span class="sr-only">new text begin</span><ins style="text-decoration: underline"> (17)</ins><span class="sr-only">new text end</span> pharmacy professional corporation, $75.<br/></p>
        </div>
        <div class="sec_eff_date">
          <h2 class="effective_date">
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.4.14" class="pl"> </span>EFFECTIVE DATE.</ins>
            <span class="sr-only">new text end</span>
          </h2>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline">This section is effective July 1, 2019, and applies to any license <br/><span id="pl.4.15" class="pl"> </span>renewed on or after that date.<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
        </div>
      </div>
      <div class="bill_section add_subd" id="bill.1.4.0">
        <h2 class="section_number"><span id="pl.4.16" class="pl"> </span>Sec. 4. </h2>
        <p class="first">Minnesota Statutes 2018, section 151.065, is amended by adding a subdivision to <br/><span id="pl.4.17" class="pl"> </span>read:<br/></p>
        <br/>
        <div class="subd" id="bill.1.4.1">
          <h2 class="subd_no">
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.4.18" class="pl"> </span>Subd. 7.</ins>
            <span class="sr-only">new text end</span>
          </h2>
          <h3 class="headnote">
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline">Deposit of fees.</ins>
            <span class="sr-only">new text end</span>
          </h3>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline">(a) The license fees collected under this section, with the <br/><span id="pl.4.19" class="pl"> </span>exception of the fees identified in paragraphs (b) and (c), shall be deposited in the state <br/><span id="pl.4.20" class="pl"> </span>government special revenue fund.<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.4.21" class="pl"> </span>(b) $5,000 of each fee collected under subdivision 1, clauses (6) to (15) and (17), and <br/><span id="pl.4.22" class="pl"> </span>subdivision 3, clauses (4) to (13) and (15), and the fees collected under subdivision 1, clause <br/><span id="pl.4.23" class="pl"> </span>(16), and subdivision 3, clause (14), shall be deposited in the opiate epidemic response <br/><span id="pl.4.24" class="pl"> </span>account established in section 256.043.<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.4.25" class="pl"> </span>(c) If the fees collected under subdivision 1, clause (16), or subdivision 3, clause (14), <br/><span id="pl.4.26" class="pl"> </span>are reduced, $5,000 of the reduced fee shall be deposited in the opiate epidemic response <br/><span id="pl.4.27" class="pl"> </span>account in section 256.043.<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
        </div>
      </div>
      <div class="bill_section newstatute" id="bill.1.5.0">
        <h2 class="section_number"><span id="pl.5.1" class="pl"> </span>Sec. 5. </h2>
        <h1 class="shn">
          <span class="sr-only">new text begin</span>
          <ins style="text-decoration: underline">[151.066] OPIATE PRODUCT REGISTRATION FEE.<br/></ins>
          <span class="sr-only">new text end</span>
        </h1>
        <div class="subd" id="bill.1.5.1">
          <h2 class="subd_no">
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.5.2" class="pl"> </span>Subdivision 1.</ins>
            <span class="sr-only">new text end</span>
          </h2>
          <h3 class="headnote">
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline">Definition.</ins>
            <span class="sr-only">new text end</span>
          </h3>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline">(a) For purposes of this section, the following terms have the <br/><span id="pl.5.3" class="pl"> </span>meanings given to them in this subdivision.<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.5.4" class="pl"> </span>(b) "Manufacturer" means a manufacturer licensed under section 151.252 that is engaged <br/><span id="pl.5.5" class="pl"> </span>in the manufacturing of an opiate.<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.5.6" class="pl"> </span>(c) "Opiate" means any opiate-containing controlled substance listed in section 152.02, <br/><span id="pl.5.7" class="pl"> </span>subdivisions 3 to 5, that is distributed, delivered, sold, or dispensed into or within this state.<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.5.8" class="pl"> </span>(d) "Wholesaler" means a wholesale drug distributor licensed under section 151.47 that <br/><span id="pl.5.9" class="pl"> </span>is engaged in the wholesale drug distribution of an opiate.<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
        </div>
        <div class="subd" id="bill.1.5.2">
          <h2 class="subd_no">
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.5.10" class="pl"> </span>Subd. 2.</ins>
            <span class="sr-only">new text end</span>
          </h2>
          <h3 class="headnote">
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline">Reporting requirements.</ins>
            <span class="sr-only">new text end</span>
          </h3>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline">(a) By March 1 of each year, beginning March 1, <br/><span id="pl.5.11" class="pl"> </span>2020, each manufacturer and each wholesaler must report to the board every sale, delivery, <br/><span id="pl.5.12" class="pl"> </span>or other distribution within or into this state of any opiate that is made to any practitioner, <br/><span id="pl.5.13" class="pl"> </span>pharmacy, hospital, veterinary hospital, or other person who is permitted by section 151.37 <br/><span id="pl.5.14" class="pl"> </span>to possess controlled substances for administration or dispensing to patients that occurred <br/><span id="pl.5.15" class="pl"> </span>during the previous calendar year. Reporting must be in the automation of reports and <br/><span id="pl.5.16" class="pl"> </span>consolidated orders system format unless otherwise specified by the board. If a manufacturer <br/><span id="pl.5.17" class="pl"> </span>or wholesaler fails to provide information required under this paragraph on a timely basis, <br/><span id="pl.5.18" class="pl"> </span>the board may assess an administrative penalty of $500 per day. This penalty shall not be <br/><span id="pl.5.19" class="pl"> </span>considered a form of disciplinary action.<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.5.20" class="pl"> </span>(b) By March 1 of each year, beginning March 1, 2020, each owner of a pharmacy with <br/><span id="pl.5.21" class="pl"> </span>at least one location within this state must report to the board any intracompany delivery <br/><span id="pl.5.22" class="pl"> </span>or distribution into this state, of any opiate, to the extent that those deliveries and distributions <br/><span id="pl.5.23" class="pl"> </span>are not reported to the board by a licensed wholesaler owned by, under contract to, or <br/><span id="pl.5.24" class="pl"> </span>otherwise operating on behalf of the owner of the pharmacy. Reporting must be in the <br/><span id="pl.5.25" class="pl"> </span>manner and format specified by the board for deliveries and distributions that occurred <br/><span id="pl.5.26" class="pl"> </span>during the previous calendar year. The report must include the name of the manufacturer <br/><span id="pl.5.27" class="pl"> </span>or wholesaler from which the owner of the pharmacy ultimately purchased the opiate, and <br/><span id="pl.5.28" class="pl"> </span>the amount and date that the purchase occurred.<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
        </div>
        <div class="subd" id="bill.1.5.3">
          <h2 class="subd_no">
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.5.29" class="pl"> </span>Subd. 3.</ins>
            <span class="sr-only">new text end</span>
          </h2>
          <h3 class="headnote">
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline">Determination of an opiate product registration fee.</ins>
            <span class="sr-only">new text end</span>
          </h3>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline">(a) The board shall <br/><span id="pl.5.30" class="pl"> </span>annually assess an opiate product registration fee on any manufacturer of an opiate that <br/><span id="pl.5.31" class="pl"> </span>annually sells, delivers, or distributes an opiate within or into the state 2,000,000 or more <br/><span id="pl.5.32" class="pl"> </span>units as reported to the board under subdivision 2.<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.6.1" class="pl"> </span>(b) The annual registration fee for each manufacturer meeting the requirement under <br/><span id="pl.6.2" class="pl"> </span>paragraph (a) is $250,000.<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.6.3" class="pl"> </span>(c) In conjunction with the data reported under this section, and notwithstanding section <br/><span id="pl.6.4" class="pl"> </span>152.126, subdivision 6, the board may use the data reported under section 152.126, <br/><span id="pl.6.5" class="pl"> </span>subdivision 4, to determine which manufacturers meet the requirement under paragraph (a) <br/><span id="pl.6.6" class="pl"> </span>and are required to pay the registration fees under this subdivision.<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.6.7" class="pl"> </span>(d) By April 1 of each year, beginning April 1, 2020, the board shall notify a manufacturer <br/><span id="pl.6.8" class="pl"> </span>that the manufacturer meets the requirement in paragraph (a) and is required to pay the <br/><span id="pl.6.9" class="pl"> </span>annual registration fee in accordance with section 151.252, subdivision 1, paragraph (b).<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.6.10" class="pl"> </span>(e) A manufacturer may dispute the board's determination that the manufacturer must <br/><span id="pl.6.11" class="pl"> </span>pay the registration fee no later than 30 days after the date of notification. However, the <br/><span id="pl.6.12" class="pl"> </span>manufacturer must still remit the fee as required by section 151.252, subdivision 1, paragraph <br/><span id="pl.6.13" class="pl"> </span>(b). The dispute must be filed with the board in the manner and using the forms specified <br/><span id="pl.6.14" class="pl"> </span>by the board. A manufacturer must submit, with the required forms, data satisfactory to the <br/><span id="pl.6.15" class="pl"> </span>board that demonstrates that the assessment of the registration fee was incorrect. The board <br/><span id="pl.6.16" class="pl"> </span>must make a decision concerning a dispute no later than 60 days after receiving the required <br/><span id="pl.6.17" class="pl"> </span>dispute forms. If the board determines that the manufacturer has satisfactorily demonstrated <br/><span id="pl.6.18" class="pl"> </span>that the fee was incorrectly assessed, the board must refund the amount paid in error.<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.6.19" class="pl"> </span>(f) For purposes of this subdivision, a unit means the individual dosage form of the <br/><span id="pl.6.20" class="pl"> </span>particular drug product that is prescribed to the patient. One unit equals one tablet, capsule, <br/><span id="pl.6.21" class="pl"> </span>patch, syringe, milliliter, or gram.<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
        </div>
        <div class="subd" id="bill.1.5.4">
          <h2 class="subd_no">
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.6.22" class="pl"> </span>Subd. 4.</ins>
            <span class="sr-only">new text end</span>
          </h2>
          <h3 class="headnote">
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline">Report.</ins>
            <span class="sr-only">new text end</span>
          </h3>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline">(a) The Board of Pharmacy shall evaluate the registration fee on drug <br/><span id="pl.6.23" class="pl"> </span>manufacturers established under this section, and whether the registration fee and the <br/><span id="pl.6.24" class="pl"> </span>increased licensure fees have impacted the prescribing practices of opiates by reducing the <br/><span id="pl.6.25" class="pl"> </span>number of opiate prescriptions issued during calendar years 2021, 2022, and 2023, or creating <br/><span id="pl.6.26" class="pl"> </span>any unintended consequences in the availability of opiates for the treatment of chronic or <br/><span id="pl.6.27" class="pl"> </span>intractable pain to the extent the board has the ability to effectively identify a correlation. <br/><span id="pl.6.28" class="pl"> </span>Notwithstanding section 152.126, subdivision 6, the board may access the data reported <br/><span id="pl.6.29" class="pl"> </span>under section 152.126, subdivision 4, to conduct this evaluation.<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.6.30" class="pl"> </span>(b) The board shall submit the results of its evaluation to the chairs and ranking minority <br/><span id="pl.6.31" class="pl"> </span>members of the legislative committees with jurisdiction over health and human services <br/><span id="pl.6.32" class="pl"> </span>policy and finance by March 1, 2024.<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
        </div>
        <div class="subd" id="bill.1.5.5">
          <h2 class="subd_no">
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.6.33" class="pl"> </span>Subd. 5.</ins>
            <span class="sr-only">new text end</span>
          </h2>
          <h3 class="headnote">
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline">Legislative review.</ins>
            <span class="sr-only">new text end</span>
          </h3>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline">The legislature shall review the reports from the Opiate <br/><span id="pl.6.34" class="pl"> </span>Epidemic Response Advisory Council under section 256.042, subdivision 5, paragraph (a), <br/><span id="pl.7.1" class="pl"> </span>the reports from the commissioner of management and budget on the Results First evaluation <br/><span id="pl.7.2" class="pl"> </span>activities under section 256.042, subdivision 5, paragraph (b), the report from the Board of <br/><span id="pl.7.3" class="pl"> </span>Pharmacy under subdivision 4, and any other relevant report or information related to the <br/><span id="pl.7.4" class="pl"> </span>opioid crisis in Minnesota, to make a determination about whether the opiate product <br/><span id="pl.7.5" class="pl"> </span>registration fee assessed under this section should continue beyond July 1, 2024.<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
        </div>
      </div>
      <div class="bill_section am_subd" id="bill.1.6.0">
        <h2 class="section_number"><span id="pl.7.6" class="pl"> </span>Sec. 6. </h2>
        <p class="first">Minnesota Statutes 2018, section 151.252, subdivision 1, is amended to read:<br/></p>
        <br/>
        <div class="subd" id="bill.1.6.1">
          <h2 class="subd_no"><span id="pl.7.7" class="pl"> </span>Subdivision 1.</h2>
          <h3 class="headnote">Requirements.</h3>
          <p class="in">(a) No person shall act as a drug manufacturer without <br/><span id="pl.7.8" class="pl"> </span>first obtaining a license from the board and paying any applicable fee specified in section <br/><a href="/statutes/cite/151.065"><span id="pl.7.9" class="pl"> </span>151.065</a>.<br/></p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.7.10" class="pl"> </span>(b) In addition to the license required under paragraph (a), each manufacturer required <br/><span id="pl.7.11" class="pl"> </span>to pay the registration fee under section 151.066 must pay the fee by June 1 of each year, <br/><span id="pl.7.12" class="pl"> </span>beginning June 1, 2020. In the event of a change of ownership of the manufacturer, the new <br/><span id="pl.7.13" class="pl"> </span>owner must pay the registration fee specified under section 151.066, subdivision 3, that the <br/><span id="pl.7.14" class="pl"> </span>original owner would have been assessed had the original owner retained ownership. The <br/><span id="pl.7.15" class="pl"> </span>registration fee collected under this paragraph shall be deposited in the opiate epidemic <br/><span id="pl.7.16" class="pl"> </span>response account established under section 256.043.<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p class="in"><span class="sr-only">deleted text begin</span><span style="text-decoration: line-through" class="del"><span id="pl.7.17" class="pl"> </span>(b)</span><span class="sr-only">deleted text end</span><span class="sr-only">new text begin</span><ins style="text-decoration: underline"> (c)</ins><span class="sr-only">new text end</span> Application for a drug manufacturer license under this section shall be made in <br/><span id="pl.7.18" class="pl"> </span>a manner specified by the board.<br/></p>
          <p class="in"><span class="sr-only">deleted text begin</span><span style="text-decoration: line-through" class="del"><span id="pl.7.19" class="pl"> </span>(c)</span><span class="sr-only">deleted text end</span><span class="sr-only">new text begin</span><ins style="text-decoration: underline"> (d)</ins><span class="sr-only">new text end</span> No license shall be issued or renewed for a drug manufacturer unless the applicant <br/><span id="pl.7.20" class="pl"> </span>agrees to operate in a manner prescribed by federal and state law and according to Minnesota <br/><span id="pl.7.21" class="pl"> </span>Rules.<br/></p>
          <p class="in"><span class="sr-only">deleted text begin</span><span style="text-decoration: line-through" class="del"><span id="pl.7.22" class="pl"> </span>(d)</span><span class="sr-only">deleted text end</span><span class="sr-only">new text begin</span><ins style="text-decoration: underline"> (e)</ins><span class="sr-only">new text end</span> No license shall be issued or renewed for a drug manufacturer that is required to <br/><span id="pl.7.23" class="pl"> </span>be registered pursuant to United States Code, title 21, section 360, unless the applicant <br/><span id="pl.7.24" class="pl"> </span>supplies the board with proof of registration. The board may establish by rule the standards <br/><span id="pl.7.25" class="pl"> </span>for licensure of drug manufacturers that are not required to be registered under United States <br/><span id="pl.7.26" class="pl"> </span>Code, title 21, section 360.<br/></p>
          <p class="in"><span class="sr-only">deleted text begin</span><span style="text-decoration: line-through" class="del"><span id="pl.7.27" class="pl"> </span>(e)</span><span class="sr-only">deleted text end</span><span class="sr-only">new text begin</span><ins style="text-decoration: underline"> (f)</ins><span class="sr-only">new text end</span> No license shall be issued or renewed for a drug manufacturer that is required to <br/><span id="pl.7.28" class="pl"> </span>be licensed or registered by the state in which it is physically located unless the applicant <br/><span id="pl.7.29" class="pl"> </span>supplies the board with proof of licensure or registration. The board may establish, by rule, <br/><span id="pl.7.30" class="pl"> </span>standards for the licensure of a drug manufacturer that is not required to be licensed or <br/><span id="pl.7.31" class="pl"> </span>registered by the state in which it is physically located.<br/></p>
          <p class="in"><span class="sr-only">deleted text begin</span><span style="text-decoration: line-through" class="del"><span id="pl.7.32" class="pl"> </span>(f)</span><span class="sr-only">deleted text end</span><span class="sr-only">new text begin</span><ins style="text-decoration: underline"> (g)</ins><span class="sr-only">new text end</span> The board shall require a separate license for each facility located within the state <br/><span id="pl.7.33" class="pl"> </span>at which drug manufacturing occurs and for each facility located outside of the state at <br/><span id="pl.8.1" class="pl"> </span>which drugs that are shipped into the state are manufactured<span class="sr-only">new text begin</span><ins style="text-decoration: underline">, except a manufacturer of <br/><span id="pl.8.2" class="pl"> </span>opiate-containing controlled substances shall not be required to pay the fee under section <br/><span id="pl.8.3" class="pl"> </span>151.065, subdivision 1, clause (16), or 151.065, subdivision 3, clause (14), for more than <br/><span id="pl.8.4" class="pl"> </span>one facility</ins><span class="sr-only">new text end</span>.<br/></p>
          <p class="in"><span class="sr-only">deleted text begin</span><span style="text-decoration: line-through" class="del"><span id="pl.8.5" class="pl"> </span>(g)</span><span class="sr-only">deleted text end</span><span class="sr-only">new text begin</span><ins style="text-decoration: underline"> (h)</ins><span class="sr-only">new text end</span> The board shall not issue an initial or renewed license for a drug manufacturing <br/><span id="pl.8.6" class="pl"> </span>facility unless the facility passes an inspection conducted by an authorized representative <br/><span id="pl.8.7" class="pl"> </span>of the board. In the case of a drug manufacturing facility located outside of the state, the <br/><span id="pl.8.8" class="pl"> </span>board may require the applicant to pay the cost of the inspection, in addition to the license <br/><span id="pl.8.9" class="pl"> </span>fee in section <a href="/statutes/cite/151.065">151.065</a>, unless the applicant furnishes the board with a report, issued by the <br/><span id="pl.8.10" class="pl"> </span>appropriate regulatory agency of the state in which the facility is located or by the United <br/><span id="pl.8.11" class="pl"> </span>States Food and Drug Administration, of an inspection that has occurred within the 24 <br/><span id="pl.8.12" class="pl"> </span>months immediately preceding receipt of the license application by the board. The board <br/><span id="pl.8.13" class="pl"> </span>may deny licensure unless the applicant submits documentation satisfactory to the board <br/><span id="pl.8.14" class="pl"> </span>that any deficiencies noted in an inspection report have been corrected.<br/></p>
        </div>
      </div>
      <div class="bill_section newstatute" id="bill.1.7.0">
        <h2 class="section_number"><span id="pl.8.15" class="pl"> </span>Sec. 7. </h2>
        <h1 class="shn">
          <span class="sr-only">new text begin</span>
          <ins style="text-decoration: underline">[256.042] OPIATE EPIDEMIC RESPONSE ADVISORY COUNCIL.<br/></ins>
          <span class="sr-only">new text end</span>
        </h1>
        <div class="subd" id="bill.1.7.1">
          <h2 class="subd_no">
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.8.16" class="pl"> </span>Subdivision 1.</ins>
            <span class="sr-only">new text end</span>
          </h2>
          <h3 class="headnote">
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline">Establishment of the advisory council.</ins>
            <span class="sr-only">new text end</span>
          </h3>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline">(a) The Opiate Epidemic <br/><span id="pl.8.17" class="pl"> </span>Response Advisory Council is established to develop and implement a comprehensive and <br/><span id="pl.8.18" class="pl"> </span>effective statewide effort to address the opioid addiction and overdose epidemic in Minnesota. <br/><span id="pl.8.19" class="pl"> </span>The council shall focus on:<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.8.20" class="pl"> </span>(1) prevention and education, including public education and awareness for adults and <br/><span id="pl.8.21" class="pl"> </span>youth, prescriber education, the development and sustainability of opioid overdose prevention <br/><span id="pl.8.22" class="pl"> </span>and education programs, the role of adult protective services in prevention and response, <br/><span id="pl.8.23" class="pl"> </span>and providing financial support to local law enforcement agencies for opiate antagonist <br/><span id="pl.8.24" class="pl"> </span>programs;<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.8.25" class="pl"> </span>(2) training on the treatment of opioid addiction, including the use of all Food and Drug <br/><span id="pl.8.26" class="pl"> </span>Administration approved opioid addiction medications, detoxification, relapse prevention, <br/><span id="pl.8.27" class="pl"> </span>patient assessment, individual treatment planning, counseling, recovery supports, diversion <br/><span id="pl.8.28" class="pl"> </span>control, and other best practices;<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.8.29" class="pl"> </span>(3) the expansion and enhancement of a continuum of care for opioid-related substance <br/><span id="pl.8.30" class="pl"> </span>use disorders, including primary prevention, early intervention, treatment, recovery, and <br/><span id="pl.8.31" class="pl"> </span>aftercare services; and<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.8.32" class="pl"> </span>(4)  the development of measures to assess and protect the ability of cancer patients and <br/><span id="pl.8.33" class="pl"> </span>survivors, persons battling life threatening illnesses, persons suffering from severe chronic <br/><span id="pl.9.1" class="pl"> </span>pain, and persons at the end stages of life, who legitimately need prescription pain <br/><span id="pl.9.2" class="pl"> </span>medications, to maintain their quality of life by accessing these pain medications without <br/><span id="pl.9.3" class="pl"> </span>facing unnecessary barriers. The measures must also address the needs of individuals <br/><span id="pl.9.4" class="pl"> </span>described in this clause who are elderly or who reside in underserved or rural areas of the <br/><span id="pl.9.5" class="pl"> </span>state.<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.9.6" class="pl"> </span>(b) The council shall:<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.9.7" class="pl"> </span>(1) review local, state, and federal initiatives and activities related to education, <br/><span id="pl.9.8" class="pl"> </span>prevention, treatment, and services for individuals and families experiencing and affected <br/><span id="pl.9.9" class="pl"> </span>by opioid use disorder;<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.9.10" class="pl"> </span>(2) establish priorities to address the state's opioid epidemic, for the purpose of <br/><span id="pl.9.11" class="pl"> </span>recommending initiatives to fund;<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.9.12" class="pl"> </span>(3) recommend to the commissioner of human services specific projects and initiatives <br/><span id="pl.9.13" class="pl"> </span>to be funded;<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.9.14" class="pl"> </span>(4) ensure that available funding is allocated to align with other state and federal funding, <br/><span id="pl.9.15" class="pl"> </span>to achieve the greatest impact and ensure a coordinated state effort;<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.9.16" class="pl"> </span>(5) consult with the commissioners of human services, health, and management and <br/><span id="pl.9.17" class="pl"> </span>budget to develop measurable outcomes to determine the effectiveness of funds allocated; <br/><span id="pl.9.18" class="pl"> </span>and<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.9.19" class="pl"> </span>(6) develop recommendations for an administrative and organizational framework for <br/><span id="pl.9.20" class="pl"> </span>the allocation, on a sustainable and ongoing basis, of any money deposited into the separate <br/><span id="pl.9.21" class="pl"> </span>account under section 16A.151, subdivision 2, paragraph (f), in order to address the opioid <br/><span id="pl.9.22" class="pl"> </span>abuse and overdose epidemic in Minnesota and the areas of focus specified in paragraph <br/><span id="pl.9.23" class="pl"> </span>(a).<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.9.24" class="pl"> </span>(c) The council, in consultation with the commissioner of management and budget, and <br/><span id="pl.9.25" class="pl"> </span>within available appropriations, shall select from the awarded grants projects that include <br/><span id="pl.9.26" class="pl"> </span>promising practices or theory-based activities for which the commissioner of management <br/><span id="pl.9.27" class="pl"> </span>and budget shall conduct evaluations using experimental or quasi-experimental design. <br/><span id="pl.9.28" class="pl"> </span>Grants awarded to proposals that include promising practices or theory-based activities and <br/><span id="pl.9.29" class="pl"> </span>that are selected for an evaluation shall be administered to support the experimental or <br/><span id="pl.9.30" class="pl"> </span>quasi-experimental evaluation and require grantees to collect and report information that is <br/><span id="pl.9.31" class="pl"> </span>needed to complete the evaluation. The commissioner of management and budget, under <br/><span id="pl.9.32" class="pl"> </span>section 15.08, may obtain additional relevant data to support the experimental or <br/><span id="pl.9.33" class="pl"> </span>quasi-experimental evaluation studies.<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.10.1" class="pl"> </span>(d) The council, in consultation with the commissioners of human services, health, public <br/><span id="pl.10.2" class="pl"> </span>safety, and management and budget, shall establish goals related to addressing the opioid <br/><span id="pl.10.3" class="pl"> </span>epidemic and determine a baseline against which progress shall be monitored and set <br/><span id="pl.10.4" class="pl"> </span>measurable outcomes, including benchmarks. The goals established must include goals for <br/><span id="pl.10.5" class="pl"> </span>prevention and public health, access to treatment, and multigenerational impacts. The council <br/><span id="pl.10.6" class="pl"> </span>shall use existing measures and data collection systems to determine baseline data against <br/><span id="pl.10.7" class="pl"> </span>which progress shall be measured. The council shall include the proposed goals, the <br/><span id="pl.10.8" class="pl"> </span>measurable outcomes, and proposed benchmarks to meet these goals in its initial report to <br/><span id="pl.10.9" class="pl"> </span>the legislature under subdivision 5, paragraph (a), due January 31, 2021.<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
        </div>
        <div class="subd" id="bill.1.7.2">
          <h2 class="subd_no">
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.10.10" class="pl"> </span>Subd. 2.</ins>
            <span class="sr-only">new text end</span>
          </h2>
          <h3 class="headnote">
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline">Membership.</ins>
            <span class="sr-only">new text end</span>
          </h3>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline">(a) The council shall consist of the following 19 voting members, <br/><span id="pl.10.11" class="pl"> </span>appointed by the commissioner of human services except as otherwise specified, and three <br/><span id="pl.10.12" class="pl"> </span>nonvoting members:<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.10.13" class="pl"> </span>(1) two members of the house of representatives, appointed in the following sequence: <br/><span id="pl.10.14" class="pl"> </span>the first from the majority party appointed by the speaker of the house and the second from <br/><span id="pl.10.15" class="pl"> </span>the minority party appointed by the minority leader. Of these two members, one member <br/><span id="pl.10.16" class="pl"> </span>must represent a district outside of the seven-county metropolitan area, and one member <br/><span id="pl.10.17" class="pl"> </span>must represent a district that includes the seven-county metropolitan area. The appointment <br/><span id="pl.10.18" class="pl"> </span>by the minority leader must ensure that this requirement for geographic diversity in <br/><span id="pl.10.19" class="pl"> </span>appointments is met;<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.10.20" class="pl"> </span>(2) two members of the senate, appointed in the following sequence: the first from the <br/><span id="pl.10.21" class="pl"> </span>majority party appointed by the senate majority leader and the second from the minority <br/><span id="pl.10.22" class="pl"> </span>party appointed by the senate minority leader. Of these two members, one member must <br/><span id="pl.10.23" class="pl"> </span>represent a district outside of the seven-county metropolitan area and one member must <br/><span id="pl.10.24" class="pl"> </span>represent a district that includes the seven-county metropolitan area. The appointment by <br/><span id="pl.10.25" class="pl"> </span>the minority leader must ensure that this requirement for geographic diversity in appointments <br/><span id="pl.10.26" class="pl"> </span>is met;<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.10.27" class="pl"> </span>(3) one member appointed by the Board of Pharmacy;<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.10.28" class="pl"> </span>(4) one member who is a physician appointed by the Minnesota Medical Association;<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.10.29" class="pl"> </span>(5) one member representing opioid treatment programs, sober living programs, or <br/><span id="pl.10.30" class="pl"> </span>substance use disorder programs licensed under chapter 245G;<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.10.31" class="pl"> </span>(6) one member appointed by the Minnesota Society of Addiction Medicine who is an <br/><span id="pl.10.32" class="pl"> </span>addiction psychiatrist;<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.11.1" class="pl"> </span>(7) one member representing professionals providing alternative pain management <br/><span id="pl.11.2" class="pl"> </span>therapies, including, but not limited to, acupuncture, chiropractic, or massage therapy;<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.11.3" class="pl"> </span>(8) one member representing nonprofit organizations conducting initiatives to address <br/><span id="pl.11.4" class="pl"> </span>the opioid epidemic, with the commissioner's initial appointment being a member <br/><span id="pl.11.5" class="pl"> </span>representing the Steve Rummler Hope Network, and subsequent appointments representing <br/><span id="pl.11.6" class="pl"> </span>this or other organizations;<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.11.7" class="pl"> </span>(9) one member appointed by the Minnesota Ambulance Association, who is serving <br/><span id="pl.11.8" class="pl"> </span>with an ambulance service as an emergency medical technician, advanced emergency <br/><span id="pl.11.9" class="pl"> </span>medical technician, or paramedic;<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.11.10" class="pl"> </span>(10) one member representing the Minnesota courts who is a judge or law enforcement <br/><span id="pl.11.11" class="pl"> </span>officer;<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.11.12" class="pl"> </span>(11) one public member who is a Minnesota resident and who is in opioid addiction <br/><span id="pl.11.13" class="pl"> </span>recovery;<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.11.14" class="pl"> </span>(12) two members representing Indian tribes, one representing the Ojibwe tribes and <br/><span id="pl.11.15" class="pl"> </span>one representing the Dakota tribes;<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.11.16" class="pl"> </span>(13) one public member who is a Minnesota resident and who is suffering from chronic <br/><span id="pl.11.17" class="pl"> </span>pain, intractable pain, or a rare disease or condition;<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.11.18" class="pl"> </span>(14) one mental health advocate representing persons with mental illness;<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.11.19" class="pl"> </span>(15) one member representing the Minnesota Hospital Association;<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.11.20" class="pl"> </span>(16) one member representing a local health department; and<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.11.21" class="pl"> </span>(17) the commissioners of human services, health, and corrections, or their designees, <br/><span id="pl.11.22" class="pl"> </span>who shall be ex officio nonvoting members of the council.<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.11.23" class="pl"> </span>(b) The commissioner of human services shall coordinate the commissioner's <br/><span id="pl.11.24" class="pl"> </span>appointments to provide geographic, racial, and gender diversity, and shall ensure that at <br/><span id="pl.11.25" class="pl"> </span>least one-half of council members appointed by the commissioner reside outside of the <br/><span id="pl.11.26" class="pl"> </span>seven-county metropolitan area. Of the members appointed by the commissioner, to the <br/><span id="pl.11.27" class="pl"> </span>extent practicable, at least one member must represent a community of color <br/><span id="pl.11.28" class="pl"> </span>disproportionately affected by the opioid epidemic.<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.11.29" class="pl"> </span>(c) The council is governed by section 15.059, except that members of the council shall <br/><span id="pl.11.30" class="pl"> </span>receive no compensation other than reimbursement for expenses. Notwithstanding section <br/><span id="pl.11.31" class="pl"> </span>15.059, subdivision 6, the council shall not expire.<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.12.1" class="pl"> </span>(d) The chair shall convene the council at least quarterly, and may convene other meetings <br/><span id="pl.12.2" class="pl"> </span>as necessary. The chair shall convene meetings at different locations in the state to provide <br/><span id="pl.12.3" class="pl"> </span>geographic access, and shall ensure that at least one-half of the meetings are held at locations <br/><span id="pl.12.4" class="pl"> </span>outside of the seven-county metropolitan area.<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.12.5" class="pl"> </span>(e) The commissioner of human services shall provide staff and administrative services <br/><span id="pl.12.6" class="pl"> </span>for the advisory council.<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.12.7" class="pl"> </span>(f) The council is subject to chapter 13D.<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
        </div>
        <div class="subd" id="bill.1.7.3">
          <h2 class="subd_no">
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.12.8" class="pl"> </span>Subd. 3.</ins>
            <span class="sr-only">new text end</span>
          </h2>
          <h3 class="headnote">
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline">Conflict of interest.</ins>
            <span class="sr-only">new text end</span>
          </h3>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline">Advisory council members must disclose to the council, <br/><span id="pl.12.9" class="pl"> </span>refrain from participating in discussions, and recuse themselves from voting on any matter <br/><span id="pl.12.10" class="pl"> </span>before the council if the member has a conflict of interest. A conflict of interest means a <br/><span id="pl.12.11" class="pl"> </span>financial association that has the potential to bias or have the appearance of biasing a council <br/><span id="pl.12.12" class="pl"> </span>member's decision related to the opiate epidemic response grant decision process or other <br/><span id="pl.12.13" class="pl"> </span>council activities under this section.<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
        </div>
        <div class="subd" id="bill.1.7.4">
          <h2 class="subd_no">
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.12.14" class="pl"> </span>Subd. 4.</ins>
            <span class="sr-only">new text end</span>
          </h2>
          <h3 class="headnote">
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline">Grants.</ins>
            <span class="sr-only">new text end</span>
          </h3>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline">(a) The commissioner of human services shall submit a report of the <br/><span id="pl.12.15" class="pl"> </span>grants proposed by the advisory council to be awarded for the upcoming fiscal year to the <br/><span id="pl.12.16" class="pl"> </span>chairs and ranking minority members of the legislative committees with jurisdiction over <br/><span id="pl.12.17" class="pl"> </span>health and human services policy and finance, by March 1 of each year, beginning March <br/><span id="pl.12.18" class="pl"> </span>1, 2020.<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.12.19" class="pl"> </span>(b) The commissioner of human services shall award grants from the opiate epidemic <br/><span id="pl.12.20" class="pl"> </span>response account under section 256.043. The grants shall be awarded to proposals selected <br/><span id="pl.12.21" class="pl"> </span>by the advisory council that address the priorities in subdivision 1, paragraph (a), clauses <br/><span id="pl.12.22" class="pl"> </span>(1) to (4), unless otherwise appropriated by the legislature. No more than three percent of <br/><span id="pl.12.23" class="pl"> </span>the grant amount may be used by a grantee for administration.<br/> </ins>
            <span class="sr-only">new text end</span>
          </p>
        </div>
        <div class="subd" id="bill.1.7.5">
          <h2 class="subd_no">
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.12.24" class="pl"> </span>Subd. 5.</ins>
            <span class="sr-only">new text end</span>
          </h2>
          <h3 class="headnote">
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline">Reports.</ins>
            <span class="sr-only">new text end</span>
          </h3>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline">(a) The advisory council shall report annually to the chairs and ranking <br/><span id="pl.12.25" class="pl"> </span>minority members of the legislative committees with jurisdiction over health and human <br/><span id="pl.12.26" class="pl"> </span>services policy and finance by January 31 of each year, beginning January 31, 2021. The <br/><span id="pl.12.27" class="pl"> </span>report shall include information about the individual projects that receive grants and the <br/><span id="pl.12.28" class="pl"> </span>overall role of the project in addressing the opioid addiction and overdose epidemic in <br/><span id="pl.12.29" class="pl"> </span>Minnesota. The report must describe the grantees and the activities implemented, along <br/><span id="pl.12.30" class="pl"> </span>with measurable outcomes as determined by the council in consultation with the <br/><span id="pl.12.31" class="pl"> </span>commissioner of human services and the commissioner of management and budget. At a <br/><span id="pl.12.32" class="pl"> </span>minimum, the report must include information about the number of individuals who received <br/><span id="pl.12.33" class="pl"> </span>information or treatment, the outcomes the individuals achieved, and demographic <br/><span id="pl.12.34" class="pl"> </span>information about the individuals participating in the project; an assessment of the progress <br/><span id="pl.13.1" class="pl"> </span>toward achieving statewide access to qualified providers and comprehensive treatment and <br/><span id="pl.13.2" class="pl"> </span>recovery services; and an update on the evaluations implemented by the commissioner of <br/><span id="pl.13.3" class="pl"> </span>management and budget for the promising practices and theory-based projects that receive <br/><span id="pl.13.4" class="pl"> </span>funding.<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.13.5" class="pl"> </span>(b) The commissioner of management and budget, in consultation with the Opiate <br/><span id="pl.13.6" class="pl"> </span>Epidemic Response Advisory Council, shall report to the chairs and ranking minority <br/><span id="pl.13.7" class="pl"> </span>members of the legislative committees with jurisdiction over health and human services <br/><span id="pl.13.8" class="pl"> </span>policy and finance when an evaluation study described in subdivision 1, paragraph (c), is <br/><span id="pl.13.9" class="pl"> </span>complete on the promising practices or theory-based projects that are selected for evaluation <br/><span id="pl.13.10" class="pl"> </span>activities. The report shall include demographic information; outcome information for the <br/><span id="pl.13.11" class="pl"> </span>individuals in the program; the results for the program in promoting recovery, employment, <br/><span id="pl.13.12" class="pl"> </span>family reunification, and reducing involvement with the criminal justice system; and other <br/><span id="pl.13.13" class="pl"> </span>relevant outcomes determined by the commissioner of management and budget that are <br/><span id="pl.13.14" class="pl"> </span>specific to the projects that are evaluated. The report shall include information about the <br/><span id="pl.13.15" class="pl"> </span>ability of grant programs to be scaled to achieve the statewide results that the grant project <br/><span id="pl.13.16" class="pl"> </span>demonstrated.<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.13.17" class="pl"> </span>(c) The advisory council, in its annual report to the legislature under paragraph (a) due <br/><span id="pl.13.18" class="pl"> </span>by January 31, 2024, shall include recommendations on whether the appropriations to the <br/><span id="pl.13.19" class="pl"> </span>specified entities under this act should be continued, adjusted, or discontinued; whether <br/><span id="pl.13.20" class="pl"> </span>funding should be appropriated for other purposes related to opioid abuse prevention, <br/><span id="pl.13.21" class="pl"> </span>education, and treatment; and on the appropriate level of funding for existing and new uses.<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
        </div>
      </div>
      <div class="bill_section newstatute" id="bill.1.8.0">
        <h2 class="section_number"><span id="pl.13.22" class="pl"> </span>Sec. 8. </h2>
        <h1 class="shn">
          <span class="sr-only">new text begin</span>
          <ins style="text-decoration: underline">[256.043] OPIATE EPIDEMIC RESPONSE ACCOUNT.<br/></ins>
          <span class="sr-only">new text end</span>
        </h1>
        <div class="subd" id="bill.1.8.1">
          <h2 class="subd_no">
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.13.23" class="pl"> </span>Subdivision 1.</ins>
            <span class="sr-only">new text end</span>
          </h2>
          <h3 class="headnote">
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline">Establishment.</ins>
            <span class="sr-only">new text end</span>
          </h3>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline">The opiate epidemic response account is established in <br/><span id="pl.13.24" class="pl"> </span>the special revenue fund in the state treasury. The registration fees assessed by the Board <br/><span id="pl.13.25" class="pl"> </span>of Pharmacy under section 151.066 and the license fees identified in section 151.065, <br/><span id="pl.13.26" class="pl"> </span>subdivision 7, paragraphs (b) and (c), shall be deposited into the account. Beginning in <br/><span id="pl.13.27" class="pl"> </span>fiscal year 2021, the funds in the account are appropriated each fiscal year to the <br/><span id="pl.13.28" class="pl"> </span>commissioner of human services, unless otherwise specified in law.<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
        </div>
        <div class="subd" id="bill.1.8.2">
          <h2 class="subd_no">
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.13.29" class="pl"> </span>Subd. 2.</ins>
            <span class="sr-only">new text end</span>
          </h2>
          <h3 class="headnote">
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline">Transfers from account to state agencies.</ins>
            <span class="sr-only">new text end</span>
          </h3>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline">(a) Beginning in fiscal year 2021, <br/><span id="pl.13.30" class="pl"> </span>the commissioner of human services shall transfer the following amounts each fiscal year <br/><span id="pl.13.31" class="pl"> </span>from the account to the agencies specified in this subdivision.<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.13.32" class="pl"> </span>(b) $126,000 to the Board of Pharmacy for the collection of the registration fees under <br/><span id="pl.13.33" class="pl"> </span>section 151.066.<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.14.1" class="pl"> </span>(c) $672,000 to the commissioner of public safety for the Bureau of Criminal <br/><span id="pl.14.2" class="pl"> </span>Apprehension. Of this amount, $384,000 is for drug scientists and lab supplies and $288,000 <br/><span id="pl.14.3" class="pl"> </span>is for special agent positions focused on drug interdiction and drug trafficking.<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
        </div>
        <div class="subd" id="bill.1.8.3">
          <h2 class="subd_no">
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.14.4" class="pl"> </span>Subd. 3.</ins>
            <span class="sr-only">new text end</span>
          </h2>
          <h3 class="headnote">
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline">Appropriations from account.</ins>
            <span class="sr-only">new text end</span>
          </h3>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline">(a) After the transfers described in subdivision <br/><span id="pl.14.5" class="pl"> </span>2, and the appropriations in article 3, section 1, paragraphs (e), (f), (g), and (h) are made, <br/><span id="pl.14.6" class="pl"> </span>$249,000 shall be allocated by the commissioner for the provision of administrative services <br/><span id="pl.14.7" class="pl"> </span>to the Opiate Epidemic Response Advisory Council and for the administration of the grants <br/><span id="pl.14.8" class="pl"> </span>awarded under paragraph (c).<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.14.9" class="pl"> </span>(b) After the transfers in subdivision 2 and the allocation of funds in paragraph (a) are <br/><span id="pl.14.10" class="pl"> </span>made, 50 percent of the remaining amount shall be distributed by the commissioner to <br/><span id="pl.14.11" class="pl"> </span>county social service and tribal  social service agencies to provide child protection services <br/><span id="pl.14.12" class="pl"> </span>to children and families who are affected by addiction. The commissioner shall distribute <br/><span id="pl.14.13" class="pl"> </span>this money proportionally to counties and tribal social service agencies based on out-of-home <br/><span id="pl.14.14" class="pl"> </span>placement episodes where parental drug abuse is the primary reason for the out-of-home <br/><span id="pl.14.15" class="pl"> </span>placement using data from the previous calendar year. County and tribal social service <br/><span id="pl.14.16" class="pl"> </span>agencies receiving funds from the opiate epidemic response account must annually report <br/><span id="pl.14.17" class="pl"> </span>to the commissioner on how the funds were used to provide child protection services, <br/><span id="pl.14.18" class="pl"> </span>including measurable outcomes, as determined by the commissioner. County social service <br/><span id="pl.14.19" class="pl"> </span>agencies and tribal social service agencies must not use funds received under this paragraph <br/><span id="pl.14.20" class="pl"> </span>to supplant current state or local funding received for child protection services for children <br/><span id="pl.14.21" class="pl"> </span>and families who are affected by addiction.<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.14.22" class="pl"> </span>(c) After making the transfers in subdivision 2 and the allocation of funds in paragraphs <br/><span id="pl.14.23" class="pl"> </span>(a) and (b), the commissioner shall award grants as specified by the Opiate Epidemic <br/><span id="pl.14.24" class="pl"> </span>Response Advisory Council in accordance with section 256.042, unless otherwise <br/><span id="pl.14.25" class="pl"> </span>appropriated by the legislature.<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
        </div>
        <div class="subd" id="bill.1.8.4">
          <h2 class="subd_no">
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.14.26" class="pl"> </span>Subd. 4.</ins>
            <span class="sr-only">new text end</span>
          </h2>
          <h3 class="headnote">
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline">Settlement; sunset.</ins>
            <span class="sr-only">new text end</span>
          </h3>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline">(a) If the state receives a total sum of $250,000,000 either <br/><span id="pl.14.27" class="pl"> </span>as a result of a settlement agreement or an assurance of discontinuance entered into by the <br/><span id="pl.14.28" class="pl"> </span>attorney general of the state, or resulting from a court order in litigation brought by the <br/><span id="pl.14.29" class="pl"> </span>attorney general of the state on behalf of the state or a state agency, against one or more <br/><span id="pl.14.30" class="pl"> </span>opioid manufacturers or opioid wholesale drug distributors related to alleged violations of <br/><span id="pl.14.31" class="pl"> </span>consumer fraud laws in the marketing, sale, or distribution of opioids in this state, or other <br/><span id="pl.14.32" class="pl"> </span>alleged illegal actions that contributed to the excessive use of opioids, or from the fees <br/><span id="pl.14.33" class="pl"> </span>collected under section 151.065, subdivisions 1 and 3, and section 151.066, that are deposited <br/><span id="pl.14.34" class="pl"> </span>into the opiate epidemic response account established in section 256.043, or from a <br/><span id="pl.14.35" class="pl"> </span>combination of both, the fees specified in section 151.065, subdivision 1, clause (16), and <br/><span id="pl.15.1" class="pl"> </span>section 151.065, subdivision 3, clause (14), shall be reduced to $5,260, and the opiate <br/><span id="pl.15.2" class="pl"> </span>registration fee in section 151.066, subdivision 3, shall be repealed.<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.15.3" class="pl"> </span>(b) The commissioner of management and budget shall inform the board of pharmacy, <br/><span id="pl.15.4" class="pl"> </span>the governor, and the legislature when the amount specified in paragraph (a) has been <br/><span id="pl.15.5" class="pl"> </span>reached. The board shall apply the reduced license fee for the next licensure period.<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.15.6" class="pl"> </span>(c) Notwithstanding paragraph (a), the reduction of the license fee in section 151.065, <br/><span id="pl.15.7" class="pl"> </span>subdivisions 1 and 3, and the repeal of the registration fee in section 151.066 shall not occur <br/><span id="pl.15.8" class="pl"> </span>before July 1, 2024.<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
        </div>
      </div>
      <div class="bill_section uncoded" id="bill.1.9.0">
        <h2 class="section_number"><span id="pl.15.9" class="pl"> </span>Sec. 9. <span class="headnote"><span class="sr-only">new text begin</span><ins style="text-decoration: underline">OPIATE EPIDEMIC RESPONSE ADVISORY COUNCIL FIRST MEETING.<br/></ins><span class="sr-only">new text end</span></span></h2>
        <p>
          <span class="sr-only">new text begin</span>
          <ins style="text-decoration: underline"><span id="pl.15.10" class="pl"> </span>The commissioner of human services shall convene the first meeting of the Opiate <br/><span id="pl.15.11" class="pl"> </span>Epidemic Response Advisory Council established under Minnesota Statutes, section 256.042, <br/><span id="pl.15.12" class="pl"> </span>no later than October 1, 2019. The members shall elect a chair at the first meeting.<br/></ins>
          <span class="sr-only">new text end</span>
        </p>
      </div>
      <div class="bill_section revisorInstr" id="bill.1.10.0">
        <h2 class="section_number"><span id="pl.15.13" class="pl"> </span>Sec. 10. <span class="headnote"><span class="sr-only">new text begin</span><ins style="text-decoration: underline">REVISOR INSTRUCTION.<br/></ins><span class="sr-only">new text end</span></span></h2>
        <p>
          <span class="sr-only">new text begin</span>
          <ins style="text-decoration: underline"><span id="pl.15.14" class="pl"> </span>The fee increases in Minnesota Statutes, section 151.065, subdivisions 1 and 3 in this <br/><span id="pl.15.15" class="pl"> </span>act are in addition to any other fee increases in Minnesota Statutes, section 151.065, <br/><span id="pl.15.16" class="pl"> </span>subdivisions 1 and 3, enacted in 2019 regular or special sessions. If multiple fees are enacted, <br/><span id="pl.15.17" class="pl"> </span>the revisor of statutes shall add the fees together for publication in the 2020 Minnesota <br/><span id="pl.15.18" class="pl"> </span>Statutes Supplement to effectuate the intent of the legislature.<br/></ins>
          <span class="sr-only">new text end</span>
        </p>
      </div>
    </div>
    <div class="article" id="bill.2.0.0">
      <h1 class="article_no"><span id="pl.15.19" class="pl"> </span>ARTICLE 2<br/></h1>
      <h1 class="article_header"><span id="pl.15.20" class="pl"> </span>OTHER PROVISIONS<br/></h1>
      <div class="bill_section am_subd" id="bill.2.1.0">
        <h2 class="section_number"><span id="pl.15.21" class="pl"> </span>Section 1. </h2>
        <p class="first">Minnesota Statutes 2018, section 145C.05, subdivision 2, is amended to read:<br/></p>
        <br/>
        <div class="subd" id="bill.2.1.1">
          <h2 class="subd_no"><span id="pl.15.22" class="pl"> </span>Subd. 2.</h2>
          <h3 class="headnote">Provisions that may be included.</h3>
          <p class="in">(a) A health care directive may include <br/><span id="pl.15.23" class="pl"> </span>provisions consistent with this chapter, including, but not limited to:<br/></p>
          <p class="in"><span id="pl.15.24" class="pl"> </span>(1) the designation of one or more alternate health care agents to act if the named health <br/><span id="pl.15.25" class="pl"> </span>care agent is not reasonably available to serve;<br/></p>
          <p class="in"><span id="pl.15.26" class="pl"> </span>(2) directions to joint health care agents regarding the process or standards by which the <br/><span id="pl.15.27" class="pl"> </span>health care agents are to reach a health care decision for the principal, and a statement <br/><span id="pl.15.28" class="pl"> </span>whether joint health care agents may act independently of one another;<br/></p>
          <p class="in"><span id="pl.15.29" class="pl"> </span>(3) limitations, if any, on the right of the health care agent or any alternate health care <br/><span id="pl.15.30" class="pl"> </span>agents to receive, review, obtain copies of, and consent to the disclosure of the principal's <br/><span id="pl.16.1" class="pl"> </span>medical records or to visit the principal when the principal is a patient in a health care <br/><span id="pl.16.2" class="pl"> </span>facility;<br/></p>
          <p class="in"><span id="pl.16.3" class="pl"> </span>(4) limitations, if any, on the nomination of the health care agent as guardian for purposes <br/><span id="pl.16.4" class="pl"> </span>of sections <a href="/statutes/cite/524.5-202">524.5-202</a>, <a href="/statutes/cite/524.5-211">524.5-211</a>, <a href="/statutes/cite/524.5-302">524.5-302</a>, and <a href="/statutes/cite/524.5-303">524.5-303</a>;<br/></p>
          <p class="in"><span id="pl.16.5" class="pl"> </span>(5) a document of gift for the purpose of making an anatomical gift, as set forth in chapter <br/><span id="pl.16.6" class="pl"> </span>525A, or an amendment to, revocation of, or refusal to make an anatomical gift;<br/></p>
          <p class="in"><span id="pl.16.7" class="pl"> </span>(6) a declaration regarding intrusive mental health treatment under section <a href="/statutes/cite/253B.03#stat.253B.03.6">253B.03, <br/><span id="pl.16.8" class="pl"> </span>subdivision 6d</a>, or a statement that the health care agent is authorized to give consent for <br/><span id="pl.16.9" class="pl"> </span>the principal under section <a href="/statutes/cite/253B.04#stat.253B.04.1a">253B.04, subdivision 1a</a>;<br/></p>
          <p class="in"><span id="pl.16.10" class="pl"> </span>(7) a funeral directive as provided in section <a href="/statutes/cite/149A.80#stat.149A.80.2">149A.80, subdivision 2</a>;<br/></p>
          <p class="in"><span id="pl.16.11" class="pl"> </span>(8) limitations, if any, to the effect of dissolution or annulment of marriage or termination <br/><span id="pl.16.12" class="pl"> </span>of domestic partnership on the appointment of a health care agent under section <a href="/statutes/cite/145C.09#stat.145C.09.2">145C.09, <br/><span id="pl.16.13" class="pl"> </span>subdivision 2</a>;<br/></p>
          <p class="in"><span id="pl.16.14" class="pl"> </span>(9) specific reasons why a principal wants a health care provider or an employee of a <br/><span id="pl.16.15" class="pl"> </span>health care provider attending the principal to be eligible to act as the principal's health care <br/><span id="pl.16.16" class="pl"> </span>agent;<br/></p>
          <p class="in"><span id="pl.16.17" class="pl"> </span>(10) health care instructions by a woman of child bearing age regarding how she would <br/><span id="pl.16.18" class="pl"> </span>like her pregnancy, if any, to affect health care decisions made on her behalf; <span class="sr-only">deleted text begin</span><span style="text-decoration: line-through" class="del">and<br/></span><span class="sr-only">deleted text end</span></p>
          <p class="in"><span id="pl.16.19" class="pl"> </span>(11) health care instructions regarding artificially administered nutrition or hydration<span class="sr-only">deleted text begin</span><span style="text-decoration: line-through" class="del">.</span><span class="sr-only">deleted text end</span><span class="sr-only">new text begin</span><ins style="text-decoration: underline">; <br/><span id="pl.16.20" class="pl"> </span>and<br/></ins><span class="sr-only">new text end</span></p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.16.21" class="pl"> </span>(12) health care instructions to prohibit administering, dispensing, or prescribing an <br/><span id="pl.16.22" class="pl"> </span>opioid, except that these instructions must not be construed to limit the administering, <br/><span id="pl.16.23" class="pl"> </span>dispensing, or prescribing an opioid to treat substance abuse, opioid dependence, or an <br/><span id="pl.16.24" class="pl"> </span>overdose, unless otherwise prohibited in the health care directive.<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p class="in"><span id="pl.16.25" class="pl"> </span>(b) A health care directive may include a statement of the circumstances under which <br/><span id="pl.16.26" class="pl"> </span>the directive becomes effective other than upon the judgment of the principal's attending <br/><span id="pl.16.27" class="pl"> </span>physician in the following situations:<br/></p>
          <p class="in"><span id="pl.16.28" class="pl"> </span>(1) a principal who in good faith generally selects and depends upon spiritual means or <br/><span id="pl.16.29" class="pl"> </span>prayer for the treatment or care of disease or remedial care and does not have an attending <br/><span id="pl.16.30" class="pl"> </span>physician, may include a statement appointing an individual who may determine the <br/><span id="pl.16.31" class="pl"> </span>principal's decision-making capacity; and<br/></p>
          <p class="in"><span id="pl.17.1" class="pl"> </span>(2) a principal who in good faith does not generally select a physician or a health care <br/><span id="pl.17.2" class="pl"> </span>facility for the principal's health care needs may include a statement appointing an individual <br/><span id="pl.17.3" class="pl"> </span>who may determine the principal's decision-making capacity, provided that if the need to <br/><span id="pl.17.4" class="pl"> </span>determine the principal's capacity arises when the principal is receiving care under the <br/><span id="pl.17.5" class="pl"> </span>direction of an attending physician in a health care facility, the determination must be made <br/><span id="pl.17.6" class="pl"> </span>by an attending physician after consultation with the appointed individual.<br/></p>
          <p class="in"><span id="pl.17.7" class="pl"> </span>If a person appointed under clause (1) or (2) is not reasonably available and the principal <br/><span id="pl.17.8" class="pl"> </span>is receiving care under the direction of an attending physician in a health care facility, an <br/><span id="pl.17.9" class="pl"> </span>attending physician shall determine the principal's decision-making capacity.<br/></p>
          <p class="in"><span id="pl.17.10" class="pl"> </span>(c) A health care directive may authorize a health care agent to make health care decisions <br/><span id="pl.17.11" class="pl"> </span>for a principal even though the principal retains decision-making capacity.<br/></p>
        </div>
      </div>
      <div class="bill_section newstatute" id="bill.2.2.0">
        <h2 class="section_number"><span id="pl.17.12" class="pl"> </span>Sec. 2. </h2>
        <h1 class="shn">
          <span class="sr-only">new text begin</span>
          <ins style="text-decoration: underline">[145C.17] OPIOID INSTRUCTIONS ENTERED INTO HEALTH RECORD.<br/></ins>
          <span class="sr-only">new text end</span>
        </h1>
        <p>
          <span class="sr-only">new text begin</span>
          <ins style="text-decoration: underline"><span id="pl.17.13" class="pl"> </span>At the request of the patient or health care agent, a health care provider shall enter into <br/><span id="pl.17.14" class="pl"> </span>the patient's health care record any instructions relating to administering, dispensing, or <br/><span id="pl.17.15" class="pl"> </span>prescribing an opioid.<br/></ins>
          <span class="sr-only">new text end</span>
        </p>
      </div>
      <div class="bill_section am_subd" id="bill.2.3.0">
        <h2 class="section_number"><span id="pl.17.16" class="pl"> </span>Sec. 3. </h2>
        <p class="first">Minnesota Statutes 2018, section 151.01, subdivision 27, is amended to read:<br/></p>
        <br/>
        <div class="subd" id="bill.2.3.1">
          <h2 class="subd_no"><span id="pl.17.17" class="pl"> </span>Subd. 27.</h2>
          <h3 class="headnote">Practice of pharmacy.</h3>
          <p class="in">"Practice of pharmacy" means:<br/></p>
          <p class="in"><span id="pl.17.18" class="pl"> </span>(1) interpretation and evaluation of prescription drug orders;<br/></p>
          <p class="in"><span id="pl.17.19" class="pl"> </span>(2) compounding, labeling, and dispensing drugs and devices (except labeling by a <br/><span id="pl.17.20" class="pl"> </span>manufacturer or packager of nonprescription drugs or commercially packaged legend drugs <br/><span id="pl.17.21" class="pl"> </span>and devices);<br/></p>
          <p class="in"><span id="pl.17.22" class="pl"> </span>(3) participation in clinical interpretations and monitoring of drug therapy for assurance <br/><span id="pl.17.23" class="pl"> </span>of safe and effective use of drugs, including the performance of laboratory tests that are <br/><span id="pl.17.24" class="pl"> </span>waived under the federal Clinical Laboratory Improvement Act of 1988, United States Code, <br/><span id="pl.17.25" class="pl"> </span>title 42, section 263a et seq., provided that a pharmacist may interpret the results of laboratory <br/><span id="pl.17.26" class="pl"> </span>tests but may modify drug therapy only pursuant to a protocol or collaborative practice <br/><span id="pl.17.27" class="pl"> </span>agreement;<br/></p>
          <p class="in"><span id="pl.17.28" class="pl"> </span>(4) participation in drug and therapeutic device selection; drug administration for first <br/><span id="pl.17.29" class="pl"> </span>dosage and medical emergencies; <span class="sr-only">new text begin</span><ins style="text-decoration: underline">intramuscular and subcutaneous administration used for <br/><span id="pl.17.30" class="pl"> </span>the treatment of alcohol or opioid dependence; </ins><span class="sr-only">new text end</span>drug regimen reviews; and drug or <br/><span id="pl.17.31" class="pl"> </span>drug-related research;<br/></p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.18.1" class="pl"> </span>(5) drug administration, through intramuscular and subcutaneous administration used <br/><span id="pl.18.2" class="pl"> </span>to treat mental illnesses as permitted under the following conditions:<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.18.3" class="pl"> </span>(i) upon the order of a prescriber and the prescriber is notified after administration is <br/><span id="pl.18.4" class="pl"> </span>complete; or<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.18.5" class="pl"> </span>(ii) pursuant to a protocol or collaborative practice agreement as defined by section <br/><span id="pl.18.6" class="pl"> </span>151.01, subdivisions 27b and 27c, and participation in the initiation, management, <br/><span id="pl.18.7" class="pl"> </span>modification, administration, and discontinuation of drug therapy is according to the protocol <br/><span id="pl.18.8" class="pl"> </span>or collaborative practice agreement between the pharmacist and a dentist, optometrist, <br/><span id="pl.18.9" class="pl"> </span>physician, podiatrist, or veterinarian, or an advanced practice registered nurse authorized <br/><span id="pl.18.10" class="pl"> </span>to prescribe, dispense, and administer under section 148.235. Any changes in drug therapy <br/><span id="pl.18.11" class="pl"> </span>or medication administration made pursuant to a protocol or collaborative practice agreement <br/><span id="pl.18.12" class="pl"> </span>must be documented by the pharmacist in the patient's medical record or reported by the <br/><span id="pl.18.13" class="pl"> </span>pharmacist to a practitioner responsible for the patient's care;<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p class="in"><span class="sr-only">deleted text begin</span><span style="text-decoration: line-through" class="del"><span id="pl.18.14" class="pl"> </span>(5)</span><span class="sr-only">deleted text end</span><span class="sr-only">new text begin</span><ins style="text-decoration: underline"> (6)</ins><span class="sr-only">new text end</span> participation in administration of influenza vaccines to all eligible individuals <br/><span id="pl.18.15" class="pl"> </span>six years of age and older and all other vaccines to patients 13 years of age and older by <br/><span id="pl.18.16" class="pl"> </span>written protocol with a physician licensed under chapter 147, a physician assistant authorized <br/><span id="pl.18.17" class="pl"> </span>to prescribe drugs under chapter 147A, or an advanced practice registered nurse authorized <br/><span id="pl.18.18" class="pl"> </span>to prescribe drugs under section <a href="/statutes/cite/148.235">148.235</a>, provided that:<br/></p>
          <p><span id="pl.18.19" class="pl"> </span>(i) the protocol includes, at a minimum:<br/></p>
          <p><span id="pl.18.20" class="pl"> </span>(A) the name, dose, and route of each vaccine that may be given;<br/></p>
          <p><span id="pl.18.21" class="pl"> </span>(B) the patient population for whom the vaccine may be given;<br/></p>
          <p><span id="pl.18.22" class="pl"> </span>(C) contraindications and precautions to the vaccine;<br/></p>
          <p><span id="pl.18.23" class="pl"> </span>(D) the procedure for handling an adverse reaction;<br/></p>
          <p><span id="pl.18.24" class="pl"> </span>(E) the name, signature, and address of the physician, physician assistant, or advanced <br/><span id="pl.18.25" class="pl"> </span>practice registered nurse;<br/></p>
          <p><span id="pl.18.26" class="pl"> </span>(F) a telephone number at which the physician, physician assistant, or advanced practice <br/><span id="pl.18.27" class="pl"> </span>registered nurse can be contacted; and<br/></p>
          <p><span id="pl.18.28" class="pl"> </span>(G) the date and time period for which the protocol is valid;<br/></p>
          <p class="in"><span id="pl.18.29" class="pl"> </span>(ii) the pharmacist has successfully completed a program approved by the Accreditation <br/><span id="pl.18.30" class="pl"> </span>Council for Pharmacy Education specifically for the administration of immunizations or a <br/><span id="pl.18.31" class="pl"> </span>program approved by the board;<br/></p>
          <p class="in"><span id="pl.19.1" class="pl"> </span>(iii) the pharmacist utilizes the Minnesota Immunization Information Connection to <br/><span id="pl.19.2" class="pl"> </span>assess the immunization status of individuals prior to the administration of vaccines, except <br/><span id="pl.19.3" class="pl"> </span>when administering influenza vaccines to individuals age nine and older;<br/></p>
          <p class="in"><span id="pl.19.4" class="pl"> </span>(iv) the pharmacist reports the administration of the immunization to the Minnesota <br/><span id="pl.19.5" class="pl"> </span>Immunization Information Connection; and<br/></p>
          <p><span id="pl.19.6" class="pl"> </span>(v) the pharmacist complies with guidelines for vaccines and immunizations established <br/><span id="pl.19.7" class="pl"> </span>by the federal Advisory Committee on Immunization Practices, except that a pharmacist <br/><span id="pl.19.8" class="pl"> </span>does not need to comply with those portions of the guidelines that establish immunization <br/><span id="pl.19.9" class="pl"> </span>schedules when administering a vaccine pursuant to a valid, patient-specific order issued <br/><span id="pl.19.10" class="pl"> </span>by a physician licensed under chapter 147, a physician assistant authorized to prescribe <br/><span id="pl.19.11" class="pl"> </span>drugs under chapter 147A, or an advanced practice nurse authorized to prescribe drugs <br/><span id="pl.19.12" class="pl"> </span>under section <a href="/statutes/cite/148.235">148.235</a>, provided that the order is consistent with the United States Food <br/><span id="pl.19.13" class="pl"> </span>and Drug Administration approved labeling of the vaccine;<br/></p>
          <p class="in"><span class="sr-only">deleted text begin</span><span style="text-decoration: line-through" class="del"><span id="pl.19.14" class="pl"> </span>(6)</span><span class="sr-only">deleted text end</span><span class="sr-only">new text begin</span><ins style="text-decoration: underline"> (7)</ins><span class="sr-only">new text end</span> participation in the initiation, management, modification, and discontinuation of <br/><span id="pl.19.15" class="pl"> </span>drug therapy according to a written protocol or collaborative practice agreement between: <br/><span id="pl.19.16" class="pl"> </span>(i) one or more pharmacists and one or more dentists, optometrists, physicians, podiatrists, <br/><span id="pl.19.17" class="pl"> </span>or veterinarians; or (ii) one or more pharmacists and one or more physician assistants <br/><span id="pl.19.18" class="pl"> </span>authorized to prescribe, dispense, and administer under chapter 147A, or advanced practice <br/><span id="pl.19.19" class="pl"> </span>nurses authorized to prescribe, dispense, and administer under section <a href="/statutes/cite/148.235">148.235</a>. Any changes <br/><span id="pl.19.20" class="pl"> </span>in drug therapy made pursuant to a protocol or collaborative practice agreement must be <br/><span id="pl.19.21" class="pl"> </span>documented by the pharmacist in the patient's medical record or reported by the pharmacist <br/><span id="pl.19.22" class="pl"> </span>to a practitioner responsible for the patient's care;<br/></p>
          <p class="in"><span class="sr-only">deleted text begin</span><span style="text-decoration: line-through" class="del"><span id="pl.19.23" class="pl"> </span>(7)</span><span class="sr-only">deleted text end</span><span class="sr-only">new text begin</span><ins style="text-decoration: underline"> (8)</ins><span class="sr-only">new text end</span> participation in the storage of drugs and the maintenance of records;<br/></p>
          <p class="in"><span class="sr-only">deleted text begin</span><span style="text-decoration: line-through" class="del"><span id="pl.19.24" class="pl"> </span>(8)</span><span class="sr-only">deleted text end</span><span class="sr-only">new text begin</span><ins style="text-decoration: underline"> (9)</ins><span class="sr-only">new text end</span> patient counseling on therapeutic values, content, hazards, and uses of drugs and <br/><span id="pl.19.25" class="pl"> </span>devices;<br/></p>
          <p class="in"><span class="sr-only">deleted text begin</span><span style="text-decoration: line-through" class="del"><span id="pl.19.26" class="pl"> </span>(9)</span><span class="sr-only">deleted text end</span><span class="sr-only">new text begin</span><ins style="text-decoration: underline"> (10)</ins><span class="sr-only">new text end</span> offering or performing those acts, services, operations, or transactions necessary <br/><span id="pl.19.27" class="pl"> </span>in the conduct, operation, management, and control of a pharmacy; and<br/></p>
          <p class="in"><span class="sr-only">deleted text begin</span><span style="text-decoration: line-through" class="del"><span id="pl.19.28" class="pl"> </span>(10)</span><span class="sr-only">deleted text end</span><span class="sr-only">new text begin</span><ins style="text-decoration: underline"> (11)</ins><span class="sr-only">new text end</span> participation in the initiation, management, modification, and discontinuation <br/><span id="pl.19.29" class="pl"> </span>of therapy with opiate antagonists, as defined in section <a href="/statutes/cite/604A.04#stat.604A.04.1">604A.04, subdivision 1</a>, pursuant <br/><span id="pl.19.30" class="pl"> </span>to:<br/></p>
          <p class="in"><span id="pl.19.31" class="pl"> </span>(i) a written protocol as allowed under clause (6); or<br/></p>
          <p class="in"><span id="pl.19.32" class="pl"> </span>(ii) a written protocol with a community health board medical consultant or a practitioner <br/><span id="pl.19.33" class="pl"> </span>designated by the commissioner of health, as allowed under section <a href="/statutes/cite/151.37">151.37</a>, subdivision 13.<br/></p>
        </div>
      </div>
      <div class="bill_section am_subd" id="bill.2.4.0">
        <h2 class="section_number"><span id="pl.20.1" class="pl"> </span>Sec. 4. </h2>
        <p class="first">Minnesota Statutes 2018, section 151.37, subdivision 12, is amended to read:<br/></p>
        <br/>
        <div class="subd" id="bill.2.4.1">
          <h2 class="subd_no"><span id="pl.20.2" class="pl"> </span>Subd. 12.</h2>
          <h3 class="headnote">Administration of opiate antagonists for drug overdose.</h3>
          <p>(a) A licensed <br/><span id="pl.20.3" class="pl"> </span>physician, a licensed advanced practice registered nurse authorized to prescribe drugs <br/><span id="pl.20.4" class="pl"> </span>pursuant to section <a href="/statutes/cite/148.235">148.235</a>, or a licensed physician assistant authorized to prescribe drugs <br/><span id="pl.20.5" class="pl"> </span>pursuant to section <a href="/statutes/cite/147A.18">147A.18</a> may authorize the following individuals to administer opiate <br/><span id="pl.20.6" class="pl"> </span>antagonists, as defined in section <a href="/statutes/cite/604A.04#stat.604A.04.1">604A.04, subdivision 1</a>:<br/></p>
          <p><span id="pl.20.7" class="pl"> </span>(1) an emergency medical responder registered pursuant to section <a href="/statutes/cite/144E.27">144E.27</a>;<br/></p>
          <p><span id="pl.20.8" class="pl"> </span>(2) a peace officer as defined in section <a href="/statutes/cite/626.84#stat.626.84.1">626.84, subdivision 1</a>, paragraphs (c) and (d); <br/><span class="sr-only">deleted text begin</span><span style="text-decoration: line-through" class="del"><span id="pl.20.9" class="pl"> </span>and<br/></span><span class="sr-only">deleted text end</span></p>
          <p><span id="pl.20.10" class="pl"> </span>(3) <span class="sr-only">new text begin</span><ins style="text-decoration: underline">correctional employees of a state or local political subdivision;<br/> </ins><span class="sr-only">new text end</span></p>
          <p><span class="sr-only">new text begin</span><ins style="text-decoration: underline"><span id="pl.20.11" class="pl"> </span>(4) </ins><span class="sr-only">new text end</span>staff of community-based health disease prevention or social service programs<span class="sr-only">new text begin</span><ins style="text-decoration: underline">;<br/></ins><span class="sr-only">new text end</span></p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.20.12" class="pl"> </span>(5) a volunteer firefighter; and<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p><span class="sr-only">new text begin</span><ins style="text-decoration: underline"><span id="pl.20.13" class="pl"> </span>(6) a licensed school nurse or certified public health nurse employed by, or under contract <br/><span id="pl.20.14" class="pl"> </span>with, a school board under section 121A.21</ins><span class="sr-only">new text end</span>.<br/></p>
          <p><span id="pl.20.15" class="pl"> </span>(b) For the purposes of this subdivision, opiate antagonists may be administered by one <br/><span id="pl.20.16" class="pl"> </span>of these individuals only if:<br/></p>
          <p><span id="pl.20.17" class="pl"> </span>(1) the licensed physician, licensed physician assistant, or licensed advanced practice <br/><span id="pl.20.18" class="pl"> </span>registered nurse has issued a standing order to, or entered into a protocol with, the individual; <br/><span id="pl.20.19" class="pl"> </span>and<br/></p>
          <p><span id="pl.20.20" class="pl"> </span>(2) the individual has training in the recognition of signs of opiate overdose and the use <br/><span id="pl.20.21" class="pl"> </span>of opiate antagonists as part of the emergency response to opiate overdose.<br/></p>
          <p><span id="pl.20.22" class="pl"> </span>(c) Nothing in this section prohibits the possession and administration of naloxone <br/><span id="pl.20.23" class="pl"> </span>pursuant to section <a href="/statutes/cite/604A.04">604A.04</a>.<br/></p>
        </div>
        <div class="sec_eff_date">
          <h2 class="effective_date">
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.20.24" class="pl"> </span>EFFECTIVE DATE.</ins>
            <span class="sr-only">new text end</span>
          </h2>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline">This section is effective the day following final enactment.<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
        </div>
      </div>
      <div class="bill_section am_subd" id="bill.2.5.0">
        <h2 class="section_number"><span id="pl.20.25" class="pl"> </span>Sec. 5. </h2>
        <p class="first">Minnesota Statutes 2018, section 152.105, subdivision 2, is amended to read:<br/></p>
        <br/>
        <div class="subd" id="bill.2.5.1">
          <h2 class="subd_no"><span id="pl.20.26" class="pl"> </span>Subd. 2.</h2>
          <h3 class="headnote">Sheriff to maintain collection receptacle. </h3>
          <p><span class="sr-only">new text begin</span><ins style="text-decoration: underline">(a) </ins><span class="sr-only">new text end</span>The sheriff of each county shall <br/><span id="pl.20.27" class="pl"> </span>maintain or contract for the maintenance of at least one collection receptacle for the disposal <br/><span id="pl.20.28" class="pl"> </span>of noncontrolled substances, pharmaceutical controlled substances, and other legend drugs, <br/><span id="pl.20.29" class="pl"> </span>as permitted by federal law. For purposes of this section, "legend drug" has the meaning <br/><span id="pl.20.30" class="pl"> </span>given in section <a href="/statutes/cite/151.01#stat.151.01.17">151.01, subdivision 17</a>. The collection receptacle must comply with federal <br/><span id="pl.20.31" class="pl"> </span>law. In maintaining and operating the collection receptacle, the sheriff shall follow all <br/><span id="pl.21.1" class="pl"> </span>applicable provisions of Code of Federal Regulations, title 21, parts 1300, 1301, 1304, 1305, <br/><span id="pl.21.2" class="pl"> </span>1307, and 1317, as amended through May 1, 2017.<br/></p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.21.3" class="pl"> </span>(b) A sheriff may meet the requirements of paragraph (a) by providing public educational <br/><span id="pl.21.4" class="pl"> </span>information and making an alternative method available to the public, at no charge, for <br/><span id="pl.21.5" class="pl"> </span>safely destroying unwanted legend drugs, including an at-home prescription drug deactivation <br/><span id="pl.21.6" class="pl"> </span>and disposal product, so long as the alternative method meets the requirements of the <br/><span id="pl.21.7" class="pl"> </span>Minnesota Pollution Control Agency, the United States Drug Enforcement Administration, <br/><span id="pl.21.8" class="pl"> </span>and the Board of Pharmacy.<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
        </div>
      </div>
      <div class="bill_section am_subd" id="bill.2.6.0">
        <h2 class="section_number"><span id="pl.21.9" class="pl"> </span>Sec. 6. </h2>
        <p class="first">Minnesota Statutes 2018, section 152.11, subdivision 1, is amended to read:<br/></p>
        <br/>
        <div class="subd" id="bill.2.6.1">
          <h2 class="subd_no"><span id="pl.21.10" class="pl"> </span>Subdivision 1.</h2>
          <h3 class="headnote">General prescription requirements for controlled substances.</h3>
          <p>(a) A <br/><span id="pl.21.11" class="pl"> </span>written prescription or an oral prescription reduced to writing, when issued for a controlled <br/><span id="pl.21.12" class="pl"> </span>substance in Schedule II, III, IV, or V, is void unless (1) it is written in ink and contains the <br/><span id="pl.21.13" class="pl"> </span>name and address of the person for whose use it is intended; (2) it states the amount of the <br/><span id="pl.21.14" class="pl"> </span>controlled substance to be compounded or dispensed, with directions for its use; (3) if a <br/><span id="pl.21.15" class="pl"> </span>written prescription, it contains the handwritten signature, address, and federal registry <br/><span id="pl.21.16" class="pl"> </span>number of the prescriber and a designation of the branch of the healing art pursued by the <br/><span id="pl.21.17" class="pl"> </span>prescriber; and if an oral prescription, the name and address of the prescriber and a <br/><span id="pl.21.18" class="pl"> </span>designation of the prescriber's branch of the healing art; and (4) it shows the date when <br/><span id="pl.21.19" class="pl"> </span>signed by the prescriber, or the date of acceptance in the pharmacy if an oral prescription.<br/></p>
          <p><span id="pl.21.20" class="pl"> </span>(b) An electronic prescription for a controlled substance in Schedule II, III, IV, or V is <br/><span id="pl.21.21" class="pl"> </span>void unless it complies with the standards established pursuant to section <a href="/statutes/cite/62J.497">62J.497</a> and with <br/><span id="pl.21.22" class="pl"> </span>those portions of Code of Federal Regulations, title 21, parts 1300, 1304, 1306, and 1311, <br/><span id="pl.21.23" class="pl"> </span>that pertain to electronic prescriptions.<br/></p>
          <p><span id="pl.21.24" class="pl"> </span>(c) A prescription for a controlled substance in Schedule II, III, IV, or V that is transmitted <br/><span id="pl.21.25" class="pl"> </span>by facsimile, either computer to facsimile machine or facsimile machine to facsimile machine, <br/><span id="pl.21.26" class="pl"> </span>is void unless it complies with the applicable requirements of Code of Federal Regulations, <br/><span id="pl.21.27" class="pl"> </span>title 21, part 1306.<br/></p>
          <p><span id="pl.21.28" class="pl"> </span>(d) Every licensed pharmacy that dispenses a controlled substance prescription shall <br/><span id="pl.21.29" class="pl"> </span>retain the original prescription in a file for a period of not less than two years, open to <br/><span id="pl.21.30" class="pl"> </span>inspection by any officer of the state, county, or municipal government whose duty it is to <br/><span id="pl.21.31" class="pl"> </span>aid and assist with the enforcement of this chapter. An original electronic or facsimile <br/><span id="pl.21.32" class="pl"> </span>prescription may be stored in an electronic database, provided that the database provides a <br/><span id="pl.21.33" class="pl"> </span>means by which original prescriptions can be retrieved, as transmitted to the pharmacy, for <br/><span id="pl.21.34" class="pl"> </span>a period of not less than two years.<br/></p>
          <p><span id="pl.22.1" class="pl"> </span>(e) Every licensed pharmacy shall distinctly label the container in which a controlled <br/><span id="pl.22.2" class="pl"> </span>substance is dispensed with the directions contained in the prescription for the use of that <br/><span id="pl.22.3" class="pl"> </span>controlled substance.<br/></p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.22.4" class="pl"> </span>(f) No prescription for an opiate or narcotic pain reliever listed in Schedules II through <br/><span id="pl.22.5" class="pl"> </span>IV of section 152.02 may be initially dispensed more than 30 days after the date on which <br/><span id="pl.22.6" class="pl"> </span>the prescription was issued. No subsequent refills indicated on a prescription for a Schedule <br/><span id="pl.22.7" class="pl"> </span>III or IV opiate or narcotic pain reliever may be dispensed more than 30 days after the <br/><span id="pl.22.8" class="pl"> </span>previous date on which the prescription was initially filled or refilled. After the authorized <br/><span id="pl.22.9" class="pl"> </span>refills for Schedule III or IV opiate or narcotic pain relievers have been used up or are <br/><span id="pl.22.10" class="pl"> </span>expired, no additional authorizations may be accepted for that prescription. If continued <br/><span id="pl.22.11" class="pl"> </span>therapy is necessary, a new prescription must be issued by the prescriber.<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
        </div>
      </div>
      <div class="bill_section am_subd" id="bill.2.7.0">
        <h2 class="section_number"><span id="pl.22.12" class="pl"> </span>Sec. 7. </h2>
        <p class="first">Minnesota Statutes 2018, section 152.11, subdivision 2d, is amended to read:<br/></p>
        <br/>
        <div class="subd" id="bill.2.7.1">
          <h2 class="subd_no"><span id="pl.22.13" class="pl"> </span>Subd. 2d.</h2>
          <h3 class="headnote">Identification requirement for <span class="sr-only">deleted text begin</span><span style="text-decoration: line-through" class="del">Schedule II or III</span><span class="sr-only">deleted text end</span> controlled substance <br/><span id="pl.22.14" class="pl"> </span>prescriptions.</h3>
          <p class="in"><span class="sr-only">deleted text begin</span><span style="text-decoration: line-through" class="del">(a)</span><span class="sr-only">deleted text end</span> No person may dispense a controlled substance included in <span class="sr-only">deleted text begin</span><span style="text-decoration: line-through" class="del">Schedule II <br/><span id="pl.22.15" class="pl"> </span>or III</span><span class="sr-only">deleted text end</span><span class="sr-only">new text begin</span><ins style="text-decoration: underline"> Schedules II through V</ins><span class="sr-only">new text end</span> without requiring the person purchasing the controlled <br/><span id="pl.22.16" class="pl"> </span>substance, who need not be the <span class="sr-only">deleted text begin</span><span style="text-decoration: line-through" class="del">person</span><span class="sr-only">deleted text end</span><span class="sr-only">new text begin</span><ins style="text-decoration: underline"> patient</ins><span class="sr-only">new text end</span> for whom the controlled substance prescription <br/><span id="pl.22.17" class="pl"> </span>is written, to present valid photographic identification, unless the person purchasing the <br/><span id="pl.22.18" class="pl"> </span>controlled substance<span class="sr-only">deleted text begin</span><span style="text-decoration: line-through" class="del">, or if applicable the person for whom the controlled substance <br/><span id="pl.22.19" class="pl"> </span>prescription is written,</span><span class="sr-only">deleted text end</span> is known to the dispenser.<span class="sr-only">new text begin</span><ins style="text-decoration: underline"> A doctor of veterinary medicine who <br/><span id="pl.22.20" class="pl"> </span>dispenses a controlled substance must comply with this subdivision.<br/></ins><span class="sr-only">new text end</span></p>
          <p class="in">
            <span class="sr-only">deleted text begin</span>
            <span style="text-decoration: line-through" class="del"><span id="pl.22.21" class="pl"> </span>(b) This subdivision applies only to purchases of controlled substances that are not <br/><span id="pl.22.22" class="pl"> </span>covered, in whole or in part, by a health plan company or other third-party payor.<br/></span>
            <span class="sr-only">deleted text end</span>
          </p>
        </div>
      </div>
      <div class="bill_section am_subd" id="bill.2.8.0">
        <h2 class="section_number"><span id="pl.22.23" class="pl"> </span>Sec. 8. </h2>
        <p class="first">Minnesota Statutes 2018, section 152.11, subdivision 4, is amended to read:<br/></p>
        <br/>
        <div class="subd" id="bill.2.8.1">
          <h2 class="subd_no"><span id="pl.22.24" class="pl"> </span>Subd. 4.</h2>
          <h3 class="headnote">Limit on quantity of opiates prescribed <span class="sr-only">deleted text begin</span><span style="text-decoration: line-through" class="del">for acute dental and ophthalmic <br/><span id="pl.22.25" class="pl"> </span>pain</span><span class="sr-only">deleted text end</span>.</h3>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline">(a) When used for the treatment of acute pain, prescriptions for opiates or narcotic <br/><span id="pl.22.26" class="pl"> </span>pain relievers listed in Schedules II through IV in section 152.02 shall not exceed a seven-day <br/><span id="pl.22.27" class="pl"> </span>supply for an adult and shall not exceed a five-day supply for a minor under 18 years of <br/><span id="pl.22.28" class="pl"> </span>age.<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p><span class="sr-only">deleted text begin</span><span style="text-decoration: line-through" class="del"><span id="pl.22.29" class="pl"> </span>(a)</span><span class="sr-only">deleted text end</span><span class="sr-only">new text begin</span><ins style="text-decoration: underline"> (b) Notwithstanding paragraph (a),</ins><span class="sr-only">new text end</span> when used for the treatment of acute dental pain<span class="sr-only">new text begin</span><ins style="text-decoration: underline">, <br/><span id="pl.22.30" class="pl"> </span>including acute pain associated with wisdom teeth extraction surgery</ins><span class="sr-only">new text end</span> or acute pain associated <br/><span id="pl.22.31" class="pl"> </span>with refractive surgery, prescriptions for opiate or narcotic pain relievers listed in Schedules <br/><span id="pl.22.32" class="pl"> </span>II through IV of section <a href="/statutes/cite/152.02">152.02</a> shall not exceed a four-day supply. <span class="sr-only">deleted text begin</span><span style="text-decoration: line-through" class="del">The quantity prescribed <br/><span id="pl.23.1" class="pl"> </span>shall be consistent with the dosage listed in the professional labeling for the drug that has <br/><span id="pl.23.2" class="pl"> </span>been approved by the United States Food and Drug Administration.<br/></span><span class="sr-only">deleted text end</span></p>
          <p><span class="sr-only">deleted text begin</span><span style="text-decoration: line-through" class="del"><span id="pl.23.3" class="pl"> </span>(b)</span><span class="sr-only">deleted text end</span><span class="sr-only">new text begin</span><ins style="text-decoration: underline"> (c)</ins><span class="sr-only">new text end</span> For the purposes of this subdivision, "acute pain" means pain resulting from <br/><span id="pl.23.4" class="pl"> </span>disease, accidental or intentional trauma, surgery, or another cause, that the practitioner <br/><span id="pl.23.5" class="pl"> </span>reasonably expects to last only a short period of time. Acute pain does not include chronic <br/><span id="pl.23.6" class="pl"> </span>pain or pain being treated as part of cancer care, palliative care, or hospice or other end-of-life <br/><span id="pl.23.7" class="pl"> </span>care.<br/></p>
          <p>
            <span class="sr-only">deleted text begin</span>
            <span style="text-decoration: line-through" class="del"><span id="pl.23.8" class="pl"> </span>(c) Notwithstanding paragraph (a), if in the professional clinical judgment of a practitioner <br/><span id="pl.23.9" class="pl"> </span>more than a four-day supply of a prescription listed in Schedules II through IV of section <br/><a href="/statutes/cite/152.02"><span id="pl.23.10" class="pl"> </span>152.02</a> is required to treat a patient's acute pain, the practitioner may issue a prescription <br/><span id="pl.23.11" class="pl"> </span>for the quantity needed to treat such acute pain.<br/></span>
            <span class="sr-only">deleted text end</span>
          </p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.23.12" class="pl"> </span>(d) Notwithstanding paragraph (a) or (b), if, in the professional clinical judgment of a <br/><span id="pl.23.13" class="pl"> </span>practitioner, more than the limit specified in paragraph (a) or (b) is required to treat a patient's <br/><span id="pl.23.14" class="pl"> </span>acute pain, the practitioner may issue a prescription for the quantity needed to treat the <br/><span id="pl.23.15" class="pl"> </span>patient's acute pain.<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
        </div>
      </div>
      <div class="bill_section am_subd" id="bill.2.9.0">
        <h2 class="section_number"><span id="pl.23.16" class="pl"> </span>Sec. 9. </h2>
        <p class="first">Minnesota Statutes 2018, section 152.126, subdivision 6, is amended to read:<br/></p>
        <br/>
        <div class="subd" id="bill.2.9.1">
          <h2 class="subd_no"><span id="pl.23.17" class="pl"> </span>Subd. 6.</h2>
          <h3 class="headnote">Access to reporting system data.</h3>
          <p class="in">(a) Except as indicated in this subdivision, <br/><span id="pl.23.18" class="pl"> </span>the data submitted to the board under subdivision 4 is private data on individuals as defined <br/><span id="pl.23.19" class="pl"> </span>in section <a href="/statutes/cite/13.02#stat.13.02.12">13.02, subdivision 12</a>, and not subject to public disclosure.<br/></p>
          <p class="in"><span id="pl.23.20" class="pl"> </span>(b) Except as specified in subdivision 5, the following persons shall be considered <br/><span id="pl.23.21" class="pl"> </span>permissible users and may access the data submitted under subdivision 4 in the same or <br/><span id="pl.23.22" class="pl"> </span>similar manner, and for the same or similar purposes, as those persons who are authorized <br/><span id="pl.23.23" class="pl"> </span>to access similar private data on individuals under federal and state law:<br/></p>
          <p class="in"><span id="pl.23.24" class="pl"> </span>(1) a prescriber or an agent or employee of the prescriber to whom the prescriber has <br/><span id="pl.23.25" class="pl"> </span>delegated the task of accessing the data, to the extent the information relates specifically to <br/><span id="pl.23.26" class="pl"> </span>a current patient, to whom the prescriber is:<br/></p>
          <p class="in"><span id="pl.23.27" class="pl"> </span>(i) prescribing or considering prescribing any controlled substance;<br/></p>
          <p class="in"><span id="pl.23.28" class="pl"> </span>(ii) providing emergency medical treatment for which access to the data may be necessary;<br/></p>
          <p class="in"><span id="pl.23.29" class="pl"> </span>(iii) providing care, and the prescriber has reason to believe, based on clinically valid <br/><span id="pl.23.30" class="pl"> </span>indications, that the patient is potentially abusing a controlled substance; or<br/></p>
          <p class="in"><span id="pl.23.31" class="pl"> </span>(iv) providing other medical treatment for which access to the data may be necessary <br/><span id="pl.23.32" class="pl"> </span>for a clinically valid purpose and the patient has consented to access to the submitted data, <br/><span id="pl.24.1" class="pl"> </span>and with the provision that the prescriber remains responsible for the use or misuse of data <br/><span id="pl.24.2" class="pl"> </span>accessed by a delegated agent or employee;<br/></p>
          <p class="in"><span id="pl.24.3" class="pl"> </span>(2) a dispenser or an agent or employee of the dispenser to whom the dispenser has <br/><span id="pl.24.4" class="pl"> </span>delegated the task of accessing the data, to the extent the information relates specifically to <br/><span id="pl.24.5" class="pl"> </span>a current patient to whom that dispenser is dispensing or considering dispensing any <br/><span id="pl.24.6" class="pl"> </span>controlled substance and with the provision that the dispenser remains responsible for the <br/><span id="pl.24.7" class="pl"> </span>use or misuse of data accessed by a delegated agent or employee;<br/></p>
          <p><span id="pl.24.8" class="pl"> </span>(3) a licensed pharmacist who is providing pharmaceutical care for which access to the <br/><span id="pl.24.9" class="pl"> </span>data may be necessary to the extent that the information relates specifically to a current <br/><span id="pl.24.10" class="pl"> </span>patient for whom the pharmacist is providing pharmaceutical care: (i) if the patient has <br/><span id="pl.24.11" class="pl"> </span>consented to access to the submitted data; or (ii) if the pharmacist is consulted by a prescriber <br/><span id="pl.24.12" class="pl"> </span>who is requesting data in accordance with clause (1);<br/></p>
          <p class="in"><span id="pl.24.13" class="pl"> </span>(4) an individual who is the recipient of a controlled substance prescription for which <br/><span id="pl.24.14" class="pl"> </span>data was submitted under subdivision 4, or a guardian of the individual, parent or guardian <br/><span id="pl.24.15" class="pl"> </span>of a minor, or health care agent of the individual acting under a health care directive under <br/><span id="pl.24.16" class="pl"> </span>chapter 145C<span class="sr-only">new text begin</span><ins style="text-decoration: underline">. For purposes of this clause, access by individuals includes persons in the <br/><span id="pl.24.17" class="pl"> </span>definition of an individual under section 13.02</ins><span class="sr-only">new text end</span>;<br/></p>
          <p class="in"><span id="pl.24.18" class="pl"> </span>(5) personnel or designees of a health-related licensing board listed in section <a href="/statutes/cite/214.01#stat.214.01.2">214.01, <br/><span id="pl.24.19" class="pl"> </span>subdivision 2</a>, or of the Emergency Medical Services Regulatory Board, assigned to conduct <br/><span id="pl.24.20" class="pl"> </span>a bona fide investigation of a complaint received by that board that alleges that a specific <br/><span id="pl.24.21" class="pl"> </span>licensee is impaired by use of a drug for which data is collected under subdivision 4, has <br/><span id="pl.24.22" class="pl"> </span>engaged in activity that would constitute a crime as defined in section <a href="/statutes/cite/152.025">152.025</a>, or has <br/><span id="pl.24.23" class="pl"> </span>engaged in the behavior specified in subdivision 5, paragraph (a);<br/></p>
          <p class="in"><span id="pl.24.24" class="pl"> </span>(6) personnel of the board engaged in the collection, review, and analysis of controlled <br/><span id="pl.24.25" class="pl"> </span>substance prescription information as part of the assigned duties and responsibilities under <br/><span id="pl.24.26" class="pl"> </span>this section;<br/></p>
          <p class="in"><span id="pl.24.27" class="pl"> </span>(7) authorized personnel of a vendor under contract with the state of Minnesota who are <br/><span id="pl.24.28" class="pl"> </span>engaged in the design, implementation, operation, and maintenance of the prescription <br/><span id="pl.24.29" class="pl"> </span>monitoring program as part of the assigned duties and responsibilities of their employment, <br/><span id="pl.24.30" class="pl"> </span>provided that access to data is limited to the minimum amount necessary to carry out such <br/><span id="pl.24.31" class="pl"> </span>duties and responsibilities, and subject to the requirement of de-identification and time limit <br/><span id="pl.24.32" class="pl"> </span>on retention of data specified in subdivision 5, paragraphs (d) and (e);<br/></p>
          <p class="in"><span id="pl.24.33" class="pl"> </span>(8) federal, state, and local law enforcement authorities acting pursuant to a valid search <br/><span id="pl.24.34" class="pl"> </span>warrant;<br/></p>
          <p class="in"><span id="pl.25.1" class="pl"> </span>(9) personnel of the Minnesota health care programs assigned to use the data collected <br/><span id="pl.25.2" class="pl"> </span>under this section to identify and manage recipients whose usage of controlled substances <br/><span id="pl.25.3" class="pl"> </span>may warrant restriction to a single primary care provider, a single outpatient pharmacy, and <br/><span id="pl.25.4" class="pl"> </span>a single hospital;<br/></p>
          <p><span id="pl.25.5" class="pl"> </span>(10) personnel of the Department of Human Services assigned to access the data pursuant <br/><span id="pl.25.6" class="pl"> </span>to paragraph (i);<br/></p>
          <p><span id="pl.25.7" class="pl"> </span>(11) personnel of the health professionals services program established under section <br/><a href="/statutes/cite/214.31"><span id="pl.25.8" class="pl"> </span>214.31</a>, to the extent that the information relates specifically to an individual who is currently <br/><span id="pl.25.9" class="pl"> </span>enrolled in and being monitored by the program, and the individual consents to access to <br/><span id="pl.25.10" class="pl"> </span>that information. The health professionals services program personnel shall not provide this <br/><span id="pl.25.11" class="pl"> </span>data to a health-related licensing board or the Emergency Medical Services Regulatory <br/><span id="pl.25.12" class="pl"> </span>Board, except as permitted under section <a href="/statutes/cite/214.33#stat.214.33.3">214.33, subdivision 3</a><span class="sr-only">deleted text begin</span><span style="text-decoration: line-through" class="del">.</span><span class="sr-only">deleted text end</span><span class="sr-only">new text begin</span><ins style="text-decoration: underline">; and<br/></ins><span class="sr-only">new text end</span></p>
          <p class="in">
            <span class="sr-only">deleted text begin</span>
            <span style="text-decoration: line-through" class="del"><span id="pl.25.13" class="pl"> </span>For purposes of clause (4), access by an individual includes persons in the definition of <br/><span id="pl.25.14" class="pl"> </span>an individual under section <a href="/statutes/cite/13.02">13.02</a>; and<br/></span>
            <span class="sr-only">deleted text end</span>
          </p>
          <p class="in"><span id="pl.25.15" class="pl"> </span>(12) personnel or designees of a health-related licensing board listed in section <a href="/statutes/cite/214.01#stat.214.01.2">214.01, <br/><span id="pl.25.16" class="pl"> </span>subdivision 2</a>, assigned to conduct a bona fide investigation of a complaint received by that <br/><span id="pl.25.17" class="pl"> </span>board that alleges that a specific licensee is inappropriately prescribing controlled substances <br/><span id="pl.25.18" class="pl"> </span>as defined in this section.<br/></p>
          <p class="in"><span id="pl.25.19" class="pl"> </span>(c) By July 1, 2017, every prescriber licensed by a health-related licensing board listed <br/><span id="pl.25.20" class="pl"> </span>in section <a href="/statutes/cite/214.01#stat.214.01.2">214.01, subdivision 2</a>, practicing within this state who is authorized to prescribe <br/><span id="pl.25.21" class="pl"> </span>controlled substances for humans and who holds a current registration issued by the federal <br/><span id="pl.25.22" class="pl"> </span>Drug Enforcement Administration, and every pharmacist licensed by the board and practicing <br/><span id="pl.25.23" class="pl"> </span>within the state, shall register and maintain a user account with the prescription monitoring <br/><span id="pl.25.24" class="pl"> </span>program. Data submitted by a prescriber, pharmacist, or their delegate during the registration <br/><span id="pl.25.25" class="pl"> </span>application process, other than their name, license number, and license type, is classified <br/><span id="pl.25.26" class="pl"> </span>as private pursuant to section <a href="/statutes/cite/13.02#stat.13.02.12">13.02, subdivision 12</a>.<br/></p>
          <p class="in"><span id="pl.25.27" class="pl"> </span>(d)<span class="sr-only">new text begin</span><ins style="text-decoration: underline"> Notwithstanding paragraph (b), beginning January 1, 2021, a prescriber or an agent <br/><span id="pl.25.28" class="pl"> </span>or employee of the prescriber to whom the prescriber has delegated the task of accessing <br/><span id="pl.25.29" class="pl"> </span>the data, must access the data submitted under subdivision 4 to the extent the information <br/><span id="pl.25.30" class="pl"> </span>relates specifically to the patient:<br/></ins><span class="sr-only">new text end</span> </p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.25.31" class="pl"> </span>(1) before the prescriber issues an initial prescription order for a Schedules II through <br/><span id="pl.25.32" class="pl"> </span>IV opiate controlled substance to the patient; and<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.26.1" class="pl"> </span>(2) at least once every three months for patients receiving an opiate for treatment of <br/><span id="pl.26.2" class="pl"> </span>chronic pain or participating in medically assisted treatment for an opioid addiction.<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.26.3" class="pl"> </span>(e) Paragraph (d) does not apply if:<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.26.4" class="pl"> </span>(1) the patient is receiving palliative care, or hospice or other end-of-life care;<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.26.5" class="pl"> </span>(2) the patient is being treated for pain due to cancer or the treatment of cancer;<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.26.6" class="pl"> </span>(3) the prescription order is for a number of doses that is intended to last the patient five <br/><span id="pl.26.7" class="pl"> </span>days or less and is not subject to a refill;<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.26.8" class="pl"> </span>(4) the prescriber and patient have a current or ongoing provider/patient relationship of <br/><span id="pl.26.9" class="pl"> </span>a duration longer than one year;<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.26.10" class="pl"> </span>(5) the prescription order is issued within 14 days following surgery or three days <br/><span id="pl.26.11" class="pl"> </span>following oral surgery or follows the prescribing protocols established under the opioid <br/><span id="pl.26.12" class="pl"> </span>prescribing improvement program under section 256B.0638;<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.26.13" class="pl"> </span>(6) the controlled substance is prescribed or administered to a patient who is admitted <br/><span id="pl.26.14" class="pl"> </span>to an inpatient hospital;<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.26.15" class="pl"> </span>(7) the controlled substance is lawfully administered by injection, ingestion, or any other <br/><span id="pl.26.16" class="pl"> </span>means to the patient by the prescriber, a pharmacist, or by the patient at the direction of a <br/><span id="pl.26.17" class="pl"> </span>prescriber and in the presence of the prescriber or pharmacist;<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.26.18" class="pl"> </span>(8) due to a medical emergency, it is not possible for the prescriber to review the data <br/><span id="pl.26.19" class="pl"> </span>before the prescriber issues the prescription order for the patient; or<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.26.20" class="pl"> </span>(9) the prescriber is unable to access the data due to operational or other technological <br/><span id="pl.26.21" class="pl"> </span>failure of the program so long as the prescriber reports the failure to the board.<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p class="in"><span class="sr-only">new text begin</span><ins style="text-decoration: underline"><span id="pl.26.22" class="pl"> </span>(f) </ins><span class="sr-only">new text end</span>Only permissible users identified in paragraph (b), clauses (1), (2), (3), (6), (7), (9), <br/><span id="pl.26.23" class="pl"> </span>and (10), may directly access the data electronically. No other permissible users may directly <br/><span id="pl.26.24" class="pl"> </span>access the data electronically. If the data is directly accessed electronically, the permissible <br/><span id="pl.26.25" class="pl"> </span>user shall implement and maintain a comprehensive information security program that <br/><span id="pl.26.26" class="pl"> </span>contains administrative, technical, and physical safeguards that are appropriate to the user's <br/><span id="pl.26.27" class="pl"> </span>size and complexity, and the sensitivity of the personal information obtained. The permissible <br/><span id="pl.26.28" class="pl"> </span>user shall identify reasonably foreseeable internal and external risks to the security, <br/><span id="pl.26.29" class="pl"> </span>confidentiality, and integrity of personal information that could result in the unauthorized <br/><span id="pl.26.30" class="pl"> </span>disclosure, misuse, or other compromise of the information and assess the sufficiency of <br/><span id="pl.26.31" class="pl"> </span>any safeguards in place to control the risks.<br/></p>
          <p class="in"><span class="sr-only">deleted text begin</span><span style="text-decoration: line-through" class="del"><span id="pl.27.1" class="pl"> </span>(e)</span><span class="sr-only">deleted text end</span><span class="sr-only">new text begin</span><ins style="text-decoration: underline"> (g)</ins><span class="sr-only">new text end</span> The board shall not release data submitted under subdivision 4 unless it is provided <br/><span id="pl.27.2" class="pl"> </span>with evidence, satisfactory to the board, that the person requesting the information is entitled <br/><span id="pl.27.3" class="pl"> </span>to receive the data.<br/></p>
          <p class="in"><span class="sr-only">deleted text begin</span><span style="text-decoration: line-through" class="del"><span id="pl.27.4" class="pl"> </span>(f)</span><span class="sr-only">deleted text end</span><span class="sr-only">new text begin</span><ins style="text-decoration: underline"> (h)</ins><span class="sr-only">new text end</span> The board shall maintain a log of all persons who access the data for a period of <br/><span id="pl.27.5" class="pl"> </span>at least three years and shall ensure that any permissible user complies with paragraph (c) <br/><span id="pl.27.6" class="pl"> </span>prior to attaining direct access to the data.<br/></p>
          <p><span class="sr-only">deleted text begin</span><span style="text-decoration: line-through" class="del"><span id="pl.27.7" class="pl"> </span>(g)</span><span class="sr-only">deleted text end</span><span class="sr-only">new text begin</span><ins style="text-decoration: underline"> (i)</ins><span class="sr-only">new text end</span> Section <a href="/statutes/cite/13.05#stat.13.05.6">13.05, subdivision 6</a>, shall apply to any contract the board enters into <br/><span id="pl.27.8" class="pl"> </span>pursuant to subdivision 2. A vendor shall not use data collected under this section for any <br/><span id="pl.27.9" class="pl"> </span>purpose not specified in this section.<br/></p>
          <p><span class="sr-only">deleted text begin</span><span style="text-decoration: line-through" class="del"><span id="pl.27.10" class="pl"> </span>(h)</span><span class="sr-only">deleted text end</span><span class="sr-only">new text begin</span><ins style="text-decoration: underline"> (j)</ins><span class="sr-only">new text end</span> The board may participate in an interstate prescription monitoring program data <br/><span id="pl.27.11" class="pl"> </span>exchange system provided that permissible users in other states have access to the data only <br/><span id="pl.27.12" class="pl"> </span>as allowed under this section, and that section <a href="/statutes/cite/13.05#stat.13.05.6">13.05, subdivision 6</a>, applies to any contract <br/><span id="pl.27.13" class="pl"> </span>or memorandum of understanding that the board enters into under this paragraph.<br/></p>
          <p><span class="sr-only">deleted text begin</span><span style="text-decoration: line-through" class="del"><span id="pl.27.14" class="pl"> </span>(i)</span><span class="sr-only">deleted text end</span><span class="sr-only">new text begin</span><ins style="text-decoration: underline"> (k)</ins><span class="sr-only">new text end</span> With available appropriations, the commissioner of human services shall establish <br/><span id="pl.27.15" class="pl"> </span>and implement a system through which the Department of Human Services shall routinely <br/><span id="pl.27.16" class="pl"> </span>access the data for the purpose of determining whether any client enrolled in an opioid <br/><span id="pl.27.17" class="pl"> </span>treatment program licensed according to chapter 245A has been prescribed or dispensed a <br/><span id="pl.27.18" class="pl"> </span>controlled substance in addition to that administered or dispensed by the opioid treatment <br/><span id="pl.27.19" class="pl"> </span>program. When the commissioner determines there have been multiple prescribers or multiple <br/><span id="pl.27.20" class="pl"> </span>prescriptions of controlled substances, the commissioner shall:<br/></p>
          <p><span id="pl.27.21" class="pl"> </span>(1) inform the medical director of the opioid treatment program only that the <br/><span id="pl.27.22" class="pl"> </span>commissioner determined the existence of multiple prescribers or multiple prescriptions of <br/><span id="pl.27.23" class="pl"> </span>controlled substances; and<br/></p>
          <p><span id="pl.27.24" class="pl"> </span>(2) direct the medical director of the opioid treatment program to access the data directly, <br/><span id="pl.27.25" class="pl"> </span>review the effect of the multiple prescribers or multiple prescriptions, and document the <br/><span id="pl.27.26" class="pl"> </span>review.<br/></p>
          <p class="bl"><span id="pl.27.27" class="pl"> </span>If determined necessary, the commissioner of human services shall seek a federal waiver <br/><span id="pl.27.28" class="pl"> </span>of, or exception to, any applicable provision of Code of Federal Regulations, title 42, section <br/><span id="pl.27.29" class="pl"> </span>2.34, paragraph (c), prior to implementing this paragraph.<br/></p>
          <p><span class="sr-only">deleted text begin</span><span style="text-decoration: line-through" class="del"><span id="pl.27.30" class="pl"> </span>(j)</span><span class="sr-only">deleted text end</span><span class="sr-only">new text begin</span><ins style="text-decoration: underline"> (l)</ins><span class="sr-only">new text end</span> The board shall review the data submitted under subdivision 4 on at least a quarterly <br/><span id="pl.27.31" class="pl"> </span>basis and shall establish criteria, in consultation with the advisory task force, for referring <br/><span id="pl.27.32" class="pl"> </span>information about a patient to prescribers and dispensers who prescribed or dispensed the <br/><span id="pl.27.33" class="pl"> </span>prescriptions in question if the criteria are met.<br/></p>
        </div>
      </div>
      <div class="bill_section add_subd" id="bill.2.10.0">
        <h2 class="section_number"><span id="pl.28.1" class="pl"> </span>Sec. 10. </h2>
        <p class="first">Minnesota Statutes 2018, section 214.12, is amended by adding a subdivision to <br/><span id="pl.28.2" class="pl"> </span>read:<br/></p>
        <br/>
        <div class="subd" id="bill.2.10.1">
          <h2 class="subd_no">
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.28.3" class="pl"> </span>Subd. 6.</ins>
            <span class="sr-only">new text end</span>
          </h2>
          <h3 class="headnote">
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline">Opioid and controlled substances prescribing.</ins>
            <span class="sr-only">new text end</span>
          </h3>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline">(a) The Board of Medical <br/><span id="pl.28.4" class="pl"> </span>Practice, the Board of Nursing, the Board of Dentistry, the Board of Optometry, and the <br/><span id="pl.28.5" class="pl"> </span>Board of Podiatric Medicine shall require that licensees with the authority to prescribe <br/><span id="pl.28.6" class="pl"> </span>controlled substances obtain at least two hours of continuing education credit on best practices <br/><span id="pl.28.7" class="pl"> </span>in prescribing opioids and controlled substances, including nonpharmacological and <br/><span id="pl.28.8" class="pl"> </span>implantable device alternatives for treatment of pain and ongoing pain management, as part <br/><span id="pl.28.9" class="pl"> </span>of the continuing education requirements for licensure renewal. Licensees shall not be <br/><span id="pl.28.10" class="pl"> </span>required to complete more than two credit hours of continuing education on best practices <br/><span id="pl.28.11" class="pl"> </span>in prescribing opioids and controlled substances before this subdivision expires. Continuing <br/><span id="pl.28.12" class="pl"> </span>education credit on best practices in prescribing opioids and controlled substances must <br/><span id="pl.28.13" class="pl"> </span>meet board requirements.<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.28.14" class="pl"> </span>(b) Paragraph (a) does not apply to any licensee who is participating in the opioid <br/><span id="pl.28.15" class="pl"> </span>prescribing improvement program under section 256B.0638, unless the licensee has been <br/><span id="pl.28.16" class="pl"> </span>terminated as a medical assistance provider under section 256B.0638, subdivision 5, <br/><span id="pl.28.17" class="pl"> </span>paragraph (d).<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.28.18" class="pl"> </span>(c) This subdivision expires January 1, 2023.<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
        </div>
        <div class="sec_eff_date">
          <h2 class="effective_date">
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline"><span id="pl.28.19" class="pl"> </span>EFFECTIVE DATE.</ins>
            <span class="sr-only">new text end</span>
          </h2>
          <p>
            <span class="sr-only">new text begin</span>
            <ins style="text-decoration: underline">This section is effective January 1, 2020.<br/></ins>
            <span class="sr-only">new text end</span>
          </p>
        </div>
      </div>
    </div>
    <div class="article" id="bill.3.0.0">
      <h1 class="article_no"><span id="pl.28.20" class="pl"> </span>ARTICLE 3<br/></h1>
      <h1 class="article_header"><span id="pl.28.21" class="pl"> </span>APPROPRIATIONS<br/></h1>
      <div class="bill_section appropriations" id="bill.3.1.0">
        <h2 class="section_number"><span id="pl.28.22" class="pl"> </span>Section 1. <span class="headnote"><span class="sr-only">new text begin</span><ins style="text-decoration: underline">APPROPRIATIONS.<br/></ins><span class="sr-only">new text end</span></span></h2>
        <p>
          <span class="sr-only">new text begin</span>
          <ins style="text-decoration: underline"><span id="pl.28.23" class="pl"> </span>(a) <b>Board of Pharmacy; administration. </b>$244,000 in fiscal year 2020 is appropriated <br/><span id="pl.28.24" class="pl"> </span>from the general fund to the Board of Pharmacy for onetime information technology and <br/><span id="pl.28.25" class="pl"> </span>operating costs for administration of licensing activities under Minnesota Statutes, section <br/><span id="pl.28.26" class="pl"> </span>151.066. This is a onetime appropriation.<br/></ins>
          <span class="sr-only">new text end</span>
        </p>
        <p>
          <span class="sr-only">new text begin</span>
          <ins style="text-decoration: underline"><span id="pl.28.27" class="pl"> </span>(b) <b>Commissioner of human services; administration. </b>$309,000 in fiscal year 2020 <br/><span id="pl.28.28" class="pl"> </span>is appropriated from the general fund and $60,000 in fiscal year 2021 is appropriated from <br/><span id="pl.28.29" class="pl"> </span>the opiate epidemic response account to the commissioner of human services for the provision <br/><span id="pl.28.30" class="pl"> </span>of administrative services to the Opiate Epidemic Response Advisory Council and for the <br/><span id="pl.28.31" class="pl"> </span>administration of the grants awarded under paragraphs (f), (g), and (h). The opiate epidemic <br/><span id="pl.28.32" class="pl"> </span>response account base for this appropriation is $60,000 in fiscal year 2022, $60,000 in fiscal <br/><span id="pl.28.33" class="pl"> </span>year 2023, $60,000 in fiscal year 2024, and $0 in fiscal year 2025.<br/></ins>
          <span class="sr-only">new text end</span>
        </p>
        <p>
          <span class="sr-only">new text begin</span>
          <ins style="text-decoration: underline"><span id="pl.29.1" class="pl"> </span>(c) <b>Board of Pharmacy; administration. </b>$126,000 in fiscal year 2020 is appropriated <br/><span id="pl.29.2" class="pl"> </span>from the general fund to the Board of Pharmacy for the collection of the registration fees <br/><span id="pl.29.3" class="pl"> </span>under section 151.066.<br/></ins>
          <span class="sr-only">new text end</span>
        </p>
        <p>
          <span class="sr-only">new text begin</span>
          <ins style="text-decoration: underline"><span id="pl.29.4" class="pl"> </span>(d) <b>Commissioner of public safety; enforcement activities. </b>$672,000 in fiscal year <br/><span id="pl.29.5" class="pl"> </span>2020 is appropriated from the general fund to the commissioner of public safety for the <br/><span id="pl.29.6" class="pl"> </span>Bureau of Criminal Apprehension. Of this amount, $384,000 is for drug scientists and lab <br/><span id="pl.29.7" class="pl"> </span>supplies and $288,000 is for special agent positions focused on drug interdiction and drug <br/><span id="pl.29.8" class="pl"> </span>trafficking.<br/></ins>
          <span class="sr-only">new text end</span>
        </p>
        <p>
          <span class="sr-only">new text begin</span>
          <ins style="text-decoration: underline"><span id="pl.29.9" class="pl"> </span>(e) <b>Commissioner of management and budget; evaluation activities. </b>$300,000 in <br/><span id="pl.29.10" class="pl"> </span>fiscal year 2020 is appropriated from the general fund and $300,000 in fiscal year 2021 is <br/><span id="pl.29.11" class="pl"> </span>appropriated from the opiate epidemic response account to the commissioner of management <br/><span id="pl.29.12" class="pl"> </span>and budget for evaluation activities under Minnesota Statutes, section 256.042, subdivision <br/><span id="pl.29.13" class="pl"> </span>1, paragraph (c). The opiate epidemic response account base for this appropriation is $300,000 <br/><span id="pl.29.14" class="pl"> </span>in fiscal year 2022, $300,000 in fiscal year 2023, $300,000 in fiscal year 2024, and $0 in <br/><span id="pl.29.15" class="pl"> </span>fiscal year 2025.<br/></ins>
          <span class="sr-only">new text end</span>
        </p>
        <p>
          <span class="sr-only">new text begin</span>
          <ins style="text-decoration: underline"><span id="pl.29.16" class="pl"> </span>(f) <b>Commissioner of human services; grants for Project ECHO. </b>$400,000 in fiscal <br/><span id="pl.29.17" class="pl"> </span>year 2020 is appropriated from the general fund and $400,000 in fiscal year 2021 is <br/><span id="pl.29.18" class="pl"> </span>appropriated from the opiate epidemic response account to the commissioner of human <br/><span id="pl.29.19" class="pl"> </span>services for grants of $200,000 to CHI St. Gabriel's Health Family Medical Center for the <br/><span id="pl.29.20" class="pl"> </span>opioid-focused Project ECHO program and $200,000 to Hennepin Health Care for the <br/><span id="pl.29.21" class="pl"> </span>opioid-focused Project ECHO program. The opiate epidemic response account base for this <br/><span id="pl.29.22" class="pl"> </span>appropriation is $400,000 in fiscal year 2022, $400,000 in fiscal year 2023, $400,000 in <br/><span id="pl.29.23" class="pl"> </span>fiscal year 2024, and $0 in fiscal year 2025.<br/></ins>
          <span class="sr-only">new text end</span>
        </p>
        <p>
          <span class="sr-only">new text begin</span>
          <ins style="text-decoration: underline"><span id="pl.29.24" class="pl"> </span>(g) <b>Commissioner of human services; opioid overdose prevention grant. </b>$100,000 <br/><span id="pl.29.25" class="pl"> </span>in fiscal year 2020 is appropriated from the general fund and $100,000 in fiscal year 2021 <br/><span id="pl.29.26" class="pl"> </span>is appropriated from the opiate epidemic response account to the commissioner of human <br/><span id="pl.29.27" class="pl"> </span>services for a grant to a nonprofit organization that has provided overdose prevention <br/><span id="pl.29.28" class="pl"> </span>programs to the public in at least 60 counties within the state, for at least three years, has <br/><span id="pl.29.29" class="pl"> </span>received federal funding before January 1, 2019, and is dedicated to addressing the opioid <br/><span id="pl.29.30" class="pl"> </span>epidemic. The grant must be used for opioid overdose prevention, community asset mapping, <br/><span id="pl.29.31" class="pl"> </span>education, and overdose antagonist distribution. The opiate epidemic response account base <br/><span id="pl.29.32" class="pl"> </span>for this appropriation is $100,000 in fiscal year 2022, $100,000 in fiscal year 2023, $100,000 <br/><span id="pl.29.33" class="pl"> </span>in fiscal year 2024, and $0 in fiscal year 2025.<br/></ins>
          <span class="sr-only">new text end</span>
        </p>
        <p>
          <span class="sr-only">new text begin</span>
          <ins style="text-decoration: underline"><span id="pl.30.1" class="pl"> </span>(h) <b>Commissioner of human services; traditional healing.</b> $2,000,000 in fiscal year <br/><span id="pl.30.2" class="pl"> </span>2020 is appropriated from the general fund and $2,000,000 in fiscal year 2021 is appropriated <br/><span id="pl.30.3" class="pl"> </span>from the opiate epidemic response account to the commissioner of human services to award <br/><span id="pl.30.4" class="pl"> </span>grants to tribal nations and five urban Indian communities for traditional healing practices <br/><span id="pl.30.5" class="pl"> </span>to American Indians and to increase the capacity of culturally specific providers in the <br/><span id="pl.30.6" class="pl"> </span>behavioral health workforce. The opiate epidemic response account base for this appropriation <br/><span id="pl.30.7" class="pl"> </span>is $2,000,000 in fiscal year 2022, $2,000,000 in fiscal year 2023, $2,000,000 in fiscal year <br/><span id="pl.30.8" class="pl"> </span>2024, and $0 in fiscal year 2025.<br/></ins>
          <span class="sr-only">new text end</span>
        </p>
        <p>
          <span class="sr-only">new text begin</span>
          <ins style="text-decoration: underline"><span id="pl.30.9" class="pl"> </span>(i) <b>Board of Dentistry; continuing education. </b>$11,000 in fiscal year 2020 is <br/><span id="pl.30.10" class="pl"> </span>appropriated from the state government special revenue fund to the Board of Dentistry to <br/><span id="pl.30.11" class="pl"> </span>implement the continuing education requirements under Minnesota Statutes, section 214.12, <br/><span id="pl.30.12" class="pl"> </span>subdivision 6.<br/></ins>
          <span class="sr-only">new text end</span>
        </p>
        <p>
          <span class="sr-only">new text begin</span>
          <ins style="text-decoration: underline"><span id="pl.30.13" class="pl"> </span>(j) <b>Board of Medical Practice; continuing education. </b>$17,000 in fiscal year 2020 is <br/><span id="pl.30.14" class="pl"> </span>appropriated from the state government special revenue fund to the Board of Medical Practice <br/><span id="pl.30.15" class="pl"> </span>to implement the continuing education requirements under Minnesota Statutes, section <br/><span id="pl.30.16" class="pl"> </span>214.12, subdivision 6.<br/></ins>
          <span class="sr-only">new text end</span>
        </p>
        <p>
          <span class="sr-only">new text begin</span>
          <ins style="text-decoration: underline"><span id="pl.30.17" class="pl"> </span>(k) <b>Board of Nursing; continuing education. </b>$17,000 in fiscal year 2020 is appropriated <br/><span id="pl.30.18" class="pl"> </span>from the state government special revenue fund to the Board of Nursing to implement the <br/><span id="pl.30.19" class="pl"> </span>continuing education requirements under Minnesota Statutes, section 214.12, subdivision <br/><span id="pl.30.20" class="pl"> </span>6.<br/></ins>
          <span class="sr-only">new text end</span>
        </p>
        <p>
          <span class="sr-only">new text begin</span>
          <ins style="text-decoration: underline"><span id="pl.30.21" class="pl"> </span>(l) <b>Board of Optometry; continuing education. </b>$5,000 in fiscal year 2020 is <br/><span id="pl.30.22" class="pl"> </span>appropriated from the state government special revenue fund to the Board of Optometry to <br/><span id="pl.30.23" class="pl"> </span>implement the continuing education requirements under Minnesota Statutes, section 214.12, <br/><span id="pl.30.24" class="pl"> </span>subdivision 6.<br/></ins>
          <span class="sr-only">new text end</span>
        </p>
        <p>
          <span class="sr-only">new text begin</span>
          <ins style="text-decoration: underline"><span id="pl.30.25" class="pl"> </span>(m) <b>Board of Podiatric Medicine; continuing education. </b>$5,000 in fiscal year 2020 <br/><span id="pl.30.26" class="pl"> </span>is appropriated from the state government special revenue fund to the Board of Podiatric <br/><span id="pl.30.27" class="pl"> </span>Medicine to implement the continuing education requirements under Minnesota Statutes, <br/><span id="pl.30.28" class="pl"> </span>section 214.12, subdivision 6.<br/></ins>
          <span class="sr-only">new text end</span>
        </p>
        <p>
          <span class="sr-only">new text begin</span>
          <ins style="text-decoration: underline"><span id="pl.30.29" class="pl"> </span>(n) <b>Commissioner of health; nonnarcotic pain management and wellness. </b>$1,250,000 <br/><span id="pl.30.30" class="pl"> </span>is appropriated in fiscal year 2020 from the general fund to the commissioner of health, to <br/><span id="pl.30.31" class="pl"> </span>provide funding for:<br/></ins>
          <span class="sr-only">new text end</span>
        </p>
        <p>
          <span class="sr-only">new text begin</span>
          <ins style="text-decoration: underline"><span id="pl.30.32" class="pl"> </span>(1) statewide mapping and assessment of community-based nonnarcotic pain management <br/><span id="pl.30.33" class="pl"> </span>and wellness resources; and<br/></ins>
          <span class="sr-only">new text end</span>
        </p>
        <p>
          <span class="sr-only">new text begin</span>
          <ins style="text-decoration: underline"><span id="pl.31.1" class="pl"> </span>(2) up to five demonstration projects in different geographic areas of the state to provide <br/><span id="pl.31.2" class="pl"> </span>community-based nonnarcotic pain management and wellness resources to patients and <br/><span id="pl.31.3" class="pl"> </span>consumers.<br/></ins>
          <span class="sr-only">new text end</span>
        </p>
        <p class="bl">
          <span class="sr-only">new text begin</span>
          <ins style="text-decoration: underline"><span id="pl.31.4" class="pl"> </span>The demonstration projects must include an evaluation component and scalability analysis. <br/><span id="pl.31.5" class="pl"> </span>The commissioner shall award the grant for the statewide mapping and assessment, and the <br/><span id="pl.31.6" class="pl"> </span>demonstration project grants, through a competitive request for proposal process. Grants <br/><span id="pl.31.7" class="pl"> </span>for statewide mapping and assessment and demonstration projects may be awarded <br/><span id="pl.31.8" class="pl"> </span>simultaneously. In awarding demonstration project grants, the commissioner shall give <br/><span id="pl.31.9" class="pl"> </span>preference to proposals that incorporate innovative community partnerships, are informed <br/><span id="pl.31.10" class="pl"> </span>and led by people in the community where the project is taking place, and are culturally <br/><span id="pl.31.11" class="pl"> </span>relevant and delivered by culturally competent providers. This is a onetime appropriation.<br/></ins>
          <span class="sr-only">new text end</span>
        </p>
        <p>
          <span class="sr-only">new text begin</span>
          <ins style="text-decoration: underline"><span id="pl.31.12" class="pl"> </span>(o) <b>Commissioner of health; administration.</b> $38,000 in fiscal year 2020 is appropriated <br/><span id="pl.31.13" class="pl"> </span>from the general fund to the commissioner of health for the administration of the grants <br/><span id="pl.31.14" class="pl"> </span>awarded in paragraph (n).<br/></ins>
          <span class="sr-only">new text end</span>
        </p>
      </div>
      <div class="bill_section uncoded" id="bill.3.2.0">
        <h2 class="section_number"><span id="pl.31.15" class="pl"> </span>Sec. 2. <span class="headnote"><span class="sr-only">new text begin</span><ins style="text-decoration: underline">TRANSFER.<br/></ins><span class="sr-only">new text end</span></span></h2>
        <p>
          <span class="sr-only">new text begin</span>
          <ins style="text-decoration: underline"><span id="pl.31.16" class="pl"> </span>By June 30, 2021, the commissioner of human services shall transfer $5,439,000 from <br/><span id="pl.31.17" class="pl"> </span>the opiate epidemic response account to the general fund. This is a onetime transfer.<br/></ins>
          <span class="sr-only">new text end</span>
        </p>
      </div>
      <div class="bill_section uncoded" id="bill.3.3.0">
        <h2 class="section_number"><span id="pl.31.18" class="pl"> </span>Sec. 3. <span class="headnote"><span class="sr-only">new text begin</span><ins style="text-decoration: underline">EXPIRATION OF UNCODIFIED LANGUAGE.<br/></ins><span class="sr-only">new text end</span></span></h2>
        <p>
          <span class="sr-only">new text begin</span>
          <ins style="text-decoration: underline"><span id="pl.31.19" class="pl"> </span>The uncodified language in this article shall not expire on June 30, 2021.<br/></ins>
          <span class="sr-only">new text end</span>
        </p>
      </div>
    </div>
  </div>
</div>
    </div>
</div>

<script>
$('#document').on('mousedown', function(event){
    $('#document span.sr-only').remove();
});

remove_brs();
</script>

            
            </div>
          </div>
      </div>

      <div id="legFooter" class="leg-footer d-print-none">
      <footer class="footer bg-light">
        <div class="container" style="">
          <div class="row pt-3">
            <div class="col-sm-6 col-md-3">
              <h5 class="title-widget text-left">About the Legislature</h5>
              <ul  class="list-unstyled clear-margins">
                <li>
                  <a href="http://www.leg.state.mn.us/lrl/history/">Historical Information</a>
                </li>
                <li>
                  <a href="http://www.leg.state.mn.us/leg/jobs.aspx">Employment/Internships</a>
                </li>
                <li>
                  <a href="http://www.leg.state.mn.us/leg/faq/faqtoc.aspx?subject=14">Visiting the Capitol</a>
                </li>

                <li>
                  <a href="https://www.leg.state.mn.us/leg/faq/faqtoc?subject=19">Special Needs Access</a>
                </li>
                <li>
                  <a href="http://www.leg.state.mn.us/leg/faq/faqtoc.aspx">Frequently Asked Questions</a>
                </li>
              </ul>
            </div>
            <div class="col-sm-6 col-md-3">
              <h5 class="title-widget text-left">Contact Your Legislator</h5>
              <ul  class="list-unstyled clear-margins">
                <li   class="mt-2"><a href="http://www.gis.leg.mn/OpenLayers/districts/">Who Represents Me?</a></li>
                <li><a href="http://www.house.leg.state.mn.us/members/hmem.asp">House Members</a></li>
                <li><a href="http://www.senate.leg.state.mn.us/members/index.php">Senators</a></li>
              </ul>
            </div>
            <div class="col-sm-6 col-md-3">
              <h5 class="title-widget text-left">General Contact</h5>
              <ul class="list-unstyled clear-margins">
                <li class="mt-2">Contact a legislative librarian:</li>
                <li><a href="tel:651-296-8338">(651) 296-8338</a> or <a href="http://www.leg.state.mn.us/leg/comments.aspx">Email</a></li>
                <li class="mt-2"><a href="http://www.leg.state.mn.us/leg/legdir.aspx">Phone Numbers</a></li>
                <li><a href="http://www.leg.state.mn.us/leg/comments.aspx">Submit website comments</a></li>
              </ul>
            </div>
            <div class="col-sm-6 col-md-3">
              <h5 class="title-widget">Get Connected</h5>
              <ul class="list-unstyled clear-margins">
                <li><a href="http://www.house.mn/hinfo/news.asp">House News</a></li>
                <li><a href="http://www.senate.leg.state.mn.us/media/">Senate News</a></li>
                <li><a href="http://www.leg.state.mn.us/mybills/">MyBills</a></li>
                <li><a href="http://www.leg.state.mn.us/leg/elists.aspx">Email Updates &amp; RSS Feeds</a></li>
              </ul>
            </div>
          </div>
        </div>
      </footer>
        <div class="row">
          <div class="col-12 bg-dark">
            <div class="text-center text-light py-1 leg-subfooter">Minnesota House of Representatives &middot; 100 Rev. Dr. Martin Luther King Jr. Blvd. Saint Paul, MN 55155 &middot; <a href="mailto:Webmaster@house.mn">Webmaster@house.mn</a></div>
          </div>
        </div>
      </div>
</div> <!-- container -->
<script src="/static/js/jquery-ui-1.12.1.custom/jquery-ui.min.js"></script>
<script src="https://cdnjs.cloudflare.com/ajax/libs/popper.js/1.11.0/umd/popper.min.js"></script>
<script src="https://stackpath.bootstrapcdn.com/bootstrap/4.1.3/js/bootstrap.min.js" integrity="sha384-ChfqqxuZUCnJSK3+MXmPNIyE6ZbWh2IMqE241rYiqJxyMiZ6OW/JmZQ5stwEULTy" crossorigin="anonymous"></script>
</body>
</html>		